Saab Receives Order for Maintenance of Polish Navy´s RBS15 Mk3 Missiles

Contracted in 2006, the RBS15 Mk3 is in service on-board the Polish Navy’sOrkan-class fast attack craft. Included in the contract is scheduled maintenance of the missile system and additional ILS in the form of training and additional tool sets. “The RBS15 Mk3 is a world leading surface-to-surface missile system providing excellent performance in all weathers. It is a vital part of the ship-borne Polish Navy offensive capability and we are happy to assist the Naval Port Gdynia in their professional work ensuring the readiness and availability of this versatile and powerful missile system”, says Michael Höglund, head of marketing and sales at business unit Missile Systems within Saab business area Dynamics. The RBS15 Mk3 is the most modern surface-to-surface missile system available on the market. As a long-range system, it excels as the main anti-surface armament for any type of naval vessel. It is designed to operate in a diverse range of scenarios, from anti-ship engagement in blue to littoral waters as well as land attack missions. The RBS15 Mk3 allows for true fire-and-forget operability in all weather conditions, thanks to its advanced pre-launch programmable active radar seeker. The missile is jointly produced and marketed by Saab, Sweden and Diehl Defence, Germany. For further information, please contact: Saab Press Centre, +46 (0)734 180 018 presscentre@saabgroup.com www.saabgroup.com  www.saabgroup.com/YouTube  Follow us on twitter: @saab Saab serves the global market with world-leading products, services and solutions within military defence and civil security. Saab has operations and employees on all continents around the world. Through innovative, collaborative and pragmatic thinking, Saab develops, adopts and improves new technology to meet customers’ changing needs. 

Invitation to Telia Company’s Interim Report January-March 2017

Telia Company’s Interim Report January-March 2017 will be announced on Wednesday April 26, 2017, at around 7:00 (CET) and a presentation will be available at www.teliacompany.com before the press and analyst conference. Wednesday April 26, 2017Press and Analyst ConferenceTime: 9.30 (CET)Place: Telia Company’s Head Office, Stjärntorget, Solna Mr Johan Dennelind, President and Chief Executive Officer of Telia Company and Mr Christian Luiga, Executive Vice President and Chief Financial Officer of Telia Company will present the Interim Report January-March 2017. Press identification card or similar is required to attend. The press and analyst conference will be held in English and will be webcasted at www.teliacompany.com . Telephone conference in connection to the press and analyst conferenceYou can also listen to the conference live over the phone and attend the Q&A session after the presentation. To ensure that you are connected to the conference call, please dial in a few minutes before the start of the press and analyst conference to register your attendance. Dial-in numbers:+44 (0) 2071 928 000, 0800 376 79 22Access code:10499748 Please note that there might be a time lag of up to 30 seconds between the webcast and the conference call if you are simultaneously watching and calling in to the press and analyst conference. You can also listen to the conference call afterwards until April 30, 2017. Replay number:+44 (0) 1452 550 000Access code:                      10499748  For more information, please contact our press office +46 771 77 58 30, visit our Newsroom  or follow us on Twitter @Teliacompany .  We’re Telia Company, the New Generation Telco. Our 21,000 talented colleagues serve millions of customers every day in one of the world’s most connected regions. With a strong connectivity base, we’re the hub in the digital ecosystem, empowering people, companies and societies to stay in touch with everything that matters 24/7/365 - on their terms. Headquartered in Stockholm, the heart of innovation and technology, we’re set to change the industry and bring the world even closer for our customers. Read more at www.teliacompany.com.

Asetek presents First Quarter Results 2017 on Wednesday, 26 April

Asetek will release its financial results for the first quarter 2017 on Wednesday, 26 April at 7:00 AM CEST. This is followed by a presentation by CEO André Sloth Eriksen and CFO Peter Dam Madsen at 8:30 AM CEST. The presentation is expected to last one hour, including Q&A, and can be followed through live webcast or by conference call. Conference call – audio onlyPlease dial in 5-10 minutes prior using the phone numbers and confirmation code below: +-----------------------+----------------------+|Copenhagen, Denmark | +45 3271 1658 |+-----------------------+----------------------+|Oslo, Norway | +47 2316 2729 |+-----------------------+----------------------+|Frankfurt, Germany | +49 (0)69 2222 10629 |+-----------------------+----------------------+|London, United Kingdom | +44 (0)20 3427 1901 |+-----------------------+----------------------+|Paris, France | +33 (0)1 76 77 22 21 |+-----------------------+----------------------+|New York, USA  | +1212 444 0481 |+-----------------------+----------------------+|Confirmation code: 868 49 38 |+-----------------------+----------------------+ Webcast – audio and slide presentationA link to the webcast will be released on Asetek’s website in due time before the presentation. Please go to www.asetek.com/investor-relations/reports-presentations. The First Quarter Report and presentation will also be made available on www.asetek.com and www.newsweb.no, as well as through news agencies. A recorded version of the presentation will be made available on www.asetek.com approximately two hours after the broadcast has concluded. For further information, please contact:Peter Dam MadsenChief Financial OfficerMobile: +45 2080 7200 investor.relations@asetek.com

Reminder: Pandox invitation to capital market day in Stockholm 9 May 2017

Participants from Pandox are CEO Anders Nissen, CFO Liia Nõu and other key members of Pandox’s executive management. Date: 9 May, 2017 (all times are CEST). Starting location: Hilton Stockholm Slussen, Guldgränd 8, Stockholm, Sweden. 08:00    Registration (Hilton Stockholm Slussen)08:30    Presentations and hotel introduction (Hilton Stockholm Slussen)11:00    Hotell introduction (Scandic Malmen)12:00    Presentations, Q&A workshops and hotel introduction (Scandic Järva Krog)15:15    Presentations and hotel introduction (The Hub Hotel & Livingroom)16:45    Summary and hotel introduction (Radisson Blu Arlandia)17:30    Light dinner and networking For a detailed agenda and introduction to the capital market day please see www.pandox.se/cmd2017/. Here information from the capital market day will also be published, including a webcast of Anders Nissens’ initial presentation. Registration should be made no later than 28 April, 2017. For practical questions and registration please contact Annelie Sundström by mail annelie.sundstrom@pandox.se or phone +46 (0) 73 707 9778. Warm welcome!    FOR MORE INFORMATION, PLEASE CONTACT:Anders Berg, Head of Communications and IR, +46 (0) 760 95 19 40Marika Hilldoff, Sustainability and IR Manager, +46 (0) 708 91 50 79 The information was submitted for publication at 13:00 CEST on 19 April 2017.      About PandoxPandox is a leading owner of hotel properties in Northern Europe with a focus on sizeable hotels in key leisure and corporate destinations. Pandox’s hotel property portfolio currently comprises 120 hotels with more than 26,000 hotel rooms in ten countries. Pandox’s business is organised into Property management, which comprises hotel properties leased on a long-term basis to market leading regional hotel operators and leading international hotel operators, and Operator activities, which comprises hotel operations executed by Pandox in its owner-occupied hotel properties. Pandox was founded in 1995 and the company’s B shares are, as of 18 June 2015, listed on Nasdaq Stockholm. www.pandox.se

Presentation of Gränges’ interim report for January-March 2017

Gränges’ interim report for the period January-March 2017 will be published at 07.30 CET on Thursday, 27 April, 2017. Investors, analysts and media are invited to a webcasted conference call on Thursday 27 April, 2017, at 10.00 CET. CEO Johan Menckel and CFO Oskar Hellström will present the report.  The webcast will be available on http://investors.granges.com/en. To participate in the conference call, please call +46 856642661 (Sweden), +44 2031940544 (United Kingdom) or +1 8552692604 (USA). Call a few minutes before the conference call begins. A presentation will be available on the Company’s web site before the webcast begins. For further information, please contact: Pernilla Grennfelt, SVP Communications and Investor Relations of Grängespernilla.grennfelt@granges.com, tel: +46 702 90 99 55 About Gränges Gränges is a leading global supplier of rolled aluminium products for heat exchanger applications and other niche markets. In materials for brazed heat exchangers Gränges is the global leader with a market share of approximately 20%. The company develops, produces and markets advanced materials that enhance efficiency in the customer manufacturing process and the performance of the final products; brazed heat exchangers. The company’s geographical markets are Europe, Asia and the Americas. Its production facilities are located in Sweden, China and the United States, and have a combined annual capacity of 400,000 metric tonnes. Gränges has some 1,500 employees and net sales of more than SEK 10 billion. The share is listed on Nasdaq Stockholm. More information on Gränges is available at granges.com.

Initiator Pharma selects Syngene and Research Toxicology Centre (RTC) as primary partners for the preclinical development of IPED2015

PRESS RELEASEApril 19th 2017 In order to accelerate Initiator Pharma’s erectile dysfunction (ED) development program, Initiator Pharma has selected Syngene, India and Research Toxicology Centre, Italy (RTC) as contract research organizations (CROs) to conduct the pre-clinical development of the drug candidate IPED2015 for the treatment of ED. The goal is to file a clinical trial application and to start a clinical Phase I trial in the early autumn of 2018 as planned. Both CROs are internationally highly recognized and serve pharmaceutical companies of all sizes worldwide (for more details on the companies please see below).  Comment from the CEO‘We are very happy and confident with our choice of CROs for the ongoing clinical trial enabling studies. Syngene and RTC are both highly experienced operators with substantial expertise and impeccable track records of delivering quality work.’ Initiator Pharma have designed a solid preclinical development program that meets the requirements of the regulatory authorities. The program will be conducted at the Syngene and RTC facilities under direct supervision of Initiator Pharma’s CDO Mikael Thomsen, who has more than 25 years’ experience of taking projects from the preclinical stage to clinical Phase I and II trials.  Comment from the CEO‘Since we secured funding from preferential rights issue, we have made great progress on clinical trial enabling work and are on track to get an approval to start a clinical Phase I trial in the early Autumn of 2018’  About Erectile dysfunctionErectile dysfunction is sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity. ED affects more than 150 million men worldwide and that number is expected to increase to more than 320 million by 2025, fueled by aging demographics and increasing prevalence of life style diseases such as diabetes. ED patients have decreased quality of life due to various psychosocial factors such as low self-esteem, depression, sadness, anger, frustration, anxiety, relationship problems etc. (Althof, 2002; Shabsigh et al., 1998, Tsai, 2008; Litwin et al., 1998)   For additional information about Initiator Pharma, please contact:  Claus Elsborg Olesen, CEOTelephone: +45 6126 0035E-mail: ceo@initiatorpharma.com This information is the information that Initiator Pharma is required to disclose under the EU Market Abuse Regulation. The information was provided under the above contact person’s auspices, for publication on April 19th 2017.  About SyngeneSyngene International Limited, (Mumbai Stock Exchange code: 539268, National Stock Exchange Id: SYNGENE, ISIN Id: INE398R01022) is one of Asia’s largest Contract Research Organizations providing integrated discovery and development services for new molecular entities across multiple platforms including Small Molecules, Large Molecules, Antibody-Drug Conjugates and Oligonucleotides. Syngene with its well experienced and integrated quality and regulatory organization provides compliance across EU and US regulations to its multi-national clients servicing Research and Development, all phases of Manufacturing (Pre-Clinical to Phase I – III). It offers an integrated platform for R&D focussed organizations across diverse sectors like pharma, biotechnology, nutrition, animal health, agriculture, consumer goods, specialty chemicals and cosmetics to optimize their R&D investments and develop their novel molecules with a distinctive cost advantage. Syngene has a rich scientific talent pool of over 3100 scientists and 1.3 mn sq ft of world-class research and manufacturing infrastructure that has been inspected by leading global regulatory authorities. Its client list of 250 clients includes 8 of the top 10 global pharma companies. Some of its major collaborations are with Bristol-Myers Squibb, Baxter, Amgen, Abbott Nutrition and Herbalife Nutrition. For more details, visit: www.syngeneintl.com   About Research Toxicology Centre (RTC)RTC is a leading European Contract Research Organization with more than four decades of worldwide experience, providing a broad selection of services within non-clinical studies to pharmaceutical companies and other health-related organizations. RTC’s Headquarters are based in Pomezia, Rome, Italy and the company has 153 employees. All studies are performed according to international guidelines and regulations. RTC’s high standard of quality is guaranteed through European, American and Japanese authorities’ approval. RTC can support the Client from a very early stage of the project, providing a full range of experimental and consultancy services, in order to offer a tailored approach in the preclinical development process. Scientific and technological expertise, combined with skills in project management and communication, qualify RTC as the partner of choice for any product development. The quality of the services offered by RTC  is assured by personnel highly specialized in their respective disciplines and with high communication skills. Our facilities and equipment are regularly updated in response to scientific, technical and regulatory demands. We constantly improve our methods and techniques to meet current standards, thus providing the best up-to-date solutions to our clients. Our organization is committed to ensuring efficient communication and timely, reliable and high quality services. For more details, visit: www.rtc.it    About Initiator PharmaInitiator Pharma is a pharmaceutical company based in Aarhus, Denmark, established via a spin out from Saniona AB (listed on Nasdaq Stockholm First North Premier). The primary focus of the Company is the pharmaceutical candidate IPED2015, which constitutes a new treatment for the indication of ED – the inability of a man to achieve and maintain an erection and thus be able to complete sexual intercourse. Initiator Pharma’s new treatment method with IPED2015 is intended to treat the large group of patients suffering from ED who are none responsive to the current available treatment. The company's share is listed on Aktietorget and is traded under the ticker INIT. For more details, visit: www.initiatorpharma.com  

PSA Airlines selects IFS Maintenix as its maintenance management solution

This latest deal comes on the heels of other recent contracts with leading airlines such as Copa Airlines, Cape Air and Southwest Airlines, and reflects the IFS Maintenix software’s expanding footprint among operators of all sizes across the Americas. It is the first order to be announced since the IFS acquisition of Mxi closed in January 2017. As a flourishing carrier owned by the largest airline in the world, PSA recently embarked on a strategic growth plan that has seen its fleet more than double from 49 aircraft to 115 since 2014, with plans to operate up to 150 Bombardier CRJ aircraft. To meet evolving operational demands, the airline was looking to replace its legacy maintenance system with a modern, scalable software solution that could significantly reduce reliance on manual processes and drive greater standardization and process efficiencies across its maintenance management chain. Following an extensive market review, PSA selected IFS Maintenix as its maintenance IT system to deliver complete lifecycle MRO functionality across the engineering, planning, line maintenance and materials management departments. By enabling more real-time, automated maintenance management, PSA Airlines is taking the necessary steps to meeting strategic objectives while staying focused on their mission of safety, quality and compliance. “In this competitive market, PSA Airlines prides itself on providing customers with the highest degree of customer service and operational performance that comes from well-maintained aircraft, professional and dedicated staff, and on-time passenger services delivery,” said Gary Pratt, Vice President, Maintenance and Engineering at PSA Airlines. “Throughout the evaluation process, it readily became apparent that IFS Maintenix was the right solution capable of meeting our needs for a modern, flexible, and user-friendly approach to maintenance management and compliance control.” Scott Helmer, SVP, Aviation and Defense at IFS added, “It is always a tremendous source of pride when a respected organization such as PSA Airlines joins our growing customer community. This relationship is indicative of aviation services providers recognizing the inherent business gains that come with using a system that can deliver on the promise of standard, lean and predictable aviation maintenance. We look forward to working closely with PSA Airlines in helping them continue to be among the top brand names in the regional airlines market.” IFS Maintenix is a fully-integrated, web-enabled and mobile-ready software platform specifically built to address the complete spectrum of aviation maintenance in a single integrated business solution. It features capabilities including controlled workflow, graphical maintenance planning, point-of-maintenance access to real-time information, and paperless execution and compliance, enabling aviation organizations of all sizes to maximize the revenue potential of their mission-critical aviation assets. For more information, please visit www.mxi.com.

Interim report January-March 2017

· Incoming orders amounted to SEK 731.1m (738.8), which adjusted for currency effects is a decrease of 4.8% compared with the same period last year. · Net sales amounted to SEK 760.6m (724.7), which adjusted for currency effects is an increase of 1.0% compared with the same period last year. · Operating profit was SEK 48.8m (30.8), giving an operating margin of 6.4% (4.3). · Net profit was SEK 31.9m (20.1). · Earnings per share were SEK 2.73 (1.72).  CEO’s comments“Nederman had a good sales development in the first quarter of the year. Sales grew to SEK 760.6m (724.7). Profitability was also strengthened in the quarter with an operating profit of SEK 48.8m (30.8), corresponding to an operating margin of 6.4 percent (4.3). The positive development of sales was achieved through good growth in the EMEA and APAC regions, while development in the Americas was considerably weaker. Profitability was boosted, particularly in EMEA and APAC. Incoming orders for the Group as a whole decreased to SEK 731.1m (738.8).The European market continues to be stable and is characterised by cautious optimism. In the Americas, the market situation continues to be characterised by great uncertainty with prolonged decision-making processes, although there are positive undertones in the USA. In Canada and Mexico, uncertainty has increased about the US administration's intentions, particularly in regard to a possible renegotiation of the NAFTA trade agreement. The uncertain situation in the region is expected to continue for several quarters to come.Our greatest challenge continues to be the uncertainty around sales of major projects in the USA and China. Demand in the USA has been affected by a downturn in industrial production in 2016. In China, we see lower economic activity, which limits the number of major investments and the economic development in the country continues to be difficult to assess. In the longer-term, however, Nederman sees future business opportunities in China due to increased environmental awareness.In the Americas, development was generally weak in all markets, while many countries in EMEA saw good growth. With the exception of China, the majority of markets in APAC developed positively in the quarter. Growth was particularly marked in India and Australia. In Australia, the business climate has improved recently with rising optimism for the future.Overall, the first quarter of the year was a good quarter for Nederman with good growth in both sales and earnings."Sven Kristensson, CEO For further information, please contact:Sven Kristensson, CEOTelephone: +46 42 18 87 00e-mail: sven.kristensson@nederman.comMatthew Cusick, CFOTelephone: +46 42 18 87 00e-mail: matthew.cusick@nederman.comThis information is information that Nederman Holding AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, at 16:00 a.m.  CET on April 19, 2017. Facts about NedermanNederman is one of the world's leading companies supplying products and solutions in the environmental technology sector focusing on industrial air filtration. The company's products and solutions contribute to reducing the environmental impact, create safe and clean working environments and improve production efficiency. Nederman offers complete solutions, including engineering and design, commissioning, installation, training and aftermarket. Sales are managed through the Group’s own sales offices and distributors in over 50 countries. Production is performed in 11 countries on five continents. The Nederman Group is listed on Nasdaq Stockholm and has around 1,800 employees.Learn more at www.nedermangroup.comNederman Holding AB (publ), P.O. Box 602, SE-251 06 Helsingborg, Sweden.Corporate registration number: 556576-4205

Paradox Interactive and Introversion Software to Bring Prison Architect to Mobile Devices

STOCKHOLM – Apr. 19, 2017 — Paradox Interactive, a publisher of games and an opponent of jailbreaking on mobile devices, today announced a partnership with Introversion Software, an independent developer of award-winning games, to publish Prison Architect: Mobile for iOS and Android tablets. Prison Architect, a management simulation game that challenges players to design and maintain a maximum security prison, is a BAFTA award-winning title with over two million players across PC and console platforms. This new partnership will make the game available to players on iOS and Android later this year.“Mobile devices are more than capable of delivering the kind of experience that we think of as authentically ‘Paradox’ – deep, replayable, challenging games that maintain the high level of quality our fans expect from us,” said Kim Nordström, SVP of Innovation at Paradox Interactive. “Prison Architect fits that mold perfectly, and we’re eager to help Introversion bring the game to more players across more platforms.”“We’ve been actively supporting Prison Architect to keep expanding and improving the game since late 2012, and our community has continued to grow as well,” said Mark Morris, co-founder at Introversion Software. “A partner who understands long-term support and iteration is crucial for the future of Prison Architect, and it’s safe to say Paradox has experience in that area.”In Prison Architect: Mobile, players are tasked with the construction and maintenance of a maximum security prison, from laying out cell blocks and inmate facilities to managing staff pay and prisoner morale. Inspired by management simulators like Theme Hospital, Dwarf Fortress, and Dungeon Keeper, the game has won a BAFTA award for the “Persistent Game” category and has sold two million copies across PC and console platforms.Prison Architect: Mobile will be free to download and play, with additional content and gameplay modes available for purchase in-game.Ahead of the official mobile launch, Paradox and Introversion will make Prison Architect: Mobile available to a limited number of players via the Google Play Store and the App Store in the Netherlands, starting today. Similar to the game’s original launch on Steam’s Early Access program, players will have the chance to experience the game early and help shape the development process as Prison Architect: Mobile is refined for a mobile experience.To join in the mobile early access program (available only in the Netherlands), simply download the game from the Google Play Store or the App Store using your mobile device. For more information on Prison Architect: Mobile, visit https://www.facebook.com/PrisonArchitectMobile/

Stena Imagination named in Dubai

“Naming the Stena Imagination in Dubai is very much a strategic choice. Stena Bulk recently opened an office here together with Stena Weco and Golden Stena Weco. We already had a presence in the market in the region but wanted to get even closer to our customers. The naming ceremony gives us the opportunity to further reinforce our image and forge more contacts with customers, partners and suppliers in the region”, says Erik Hånell, President & CEO of Stena Bulk and CEO of Stena Weco. Dubai is an important meeting-place for the oil industry in the Middle East. Stena’s tanker business already has a presence in the area with contacts in the neighbouring region. For Stena Bulk and Stena Weco, which, with their IMOIIMAX fleet, are focusing increasingly on trade in chemicals, Dubai is an important hub. Here, the oil industry is building several refineries closer to the oil wells in the region. Stena Weco is now wholly owned by Stena Bulk while Golden Stena Weco is a joint venture between Stena Weco and Golden Agri Resources (GAR). With its new office in Dubai, Stena Bulk now does business in six countries. In addition to Dubai, it has offices in Houston, Copenhagen, Singapore and Shanghai while its head office is located in Gothenburg. The Stena Imagination was built at the Chinese shipyard GSI (Guangzhou Shipbuilding International) like all the 13 IMOIIMAX tankers ordered by Stena Bulk – both delivered and under construction. The vessel is jointly owned on a 50-50 basis by Stena Bulk and Indonesian Golden Agri Resources (GAR). The Stena Imagination is operated by Stena Weco and sails in the company’s global logistics system, which currently employs more than 60 vessels. Deliveries of IMOIIMAX tankers2015: Stena Impression, Stena Image, Stena Imperial and Stena Important2016: Stena Imperative, Stenaweco Impulse, Stena Imagination, Stena Immortal, Stena Immaculate and Stena Impeccable. The remaining three vessels will be delivered by 2018. Five of the 13 IMOIIMAX tankers are wholly owned by Stena Bulk, four together with GAR (Golden Agri Resources), two by Stena Bulk’s sister company Concordia Maritime and two by Stena Weco. Facts - the IMOIIMAX conceptThe chemical and product tanker has a length of 183 metres, a beam of 32 metres and a deadweight of 50,000 tons. IMOIIMAX is a further development of an already well-established concept and the innovative technical design was developed by Stena Teknik together with the Chinese shipyard GSI. It offers several advantages such as extra large cargo flexibility, a high level of safety and economical fuel consumption – 10-20% lower than that of equivalent vessels when sailing at service speed. Technical data: length: 183 metres, beam: 32 metres, deadweight: 50,000 tons. For further information, please contact: Erik HånellPresident & CEOStena Bulk ABMobile: +46 704 855 002erik.hanell@stenabulk.com With offices in six countries, Stena Bulk is one of the world’s leading tanker shipping companies. The company controls a combined fleet of around 100 vessels. Stena Bulk is part of the Stena Sphere, which has more than 20,000 employees and sales of SEK 60 billion. www.stenabulk.com

Nederman Holding AB’s Annual General Meeting 2017

The AGM of Nederman Holding AB (publ) took place on 19 April 2017. A total of  9 322 850 shares were represented at the meeting, equivalent to 79,74% of all shares outstanding. DividendThe income statement and balance sheets were adopted and the meeting resolved in accordance with the proposal of the Board and the CEO for a dividend for 2016 of SEK 5.50 per share. Fees to the Board of Directors and the auditorThe meeting approved Board fees for 2017 to a total fee of SEK 1,575,000, of which SEK 450,000 to the Chairman of the Board and SEK 225,000 to each of the other AGM elected Board members, with the exception of the CEO. Fee to the auditor shall be paid according to approved invoices. Election of the Board of Directors and auditorJan Svensson, Gunnar Gremlin, Per Borgvall, Ylva Hammargren, Johan Menckel, Gunilla Fransson and Sven Kristensson were re-elected as Board members. Jan Svensson was re-elected as the Chairman of the Board. Ernst & Young AB was re-elected as accounting firm, until the end of the AGM 2018 with authorized public accountant Staffan Landén as principal auditor. Guidelines for remuneration for senior executivesThe AGM resolved in accordance with the Board’s proposal for guidelines for remuneration and other terms of employment for senior executives. Transfer of own shares under the LTI programme 2015-2016The AGM resolved in accordance with the Board’s proposal for transfer of own shares under LTI programme 2015-2016. LTI Programme 2015-2016 were closed according to plan on 31 December 2016 and six senior executives shall receive a bonus in accordance with the programme’s terms and conditions. The Board’s proposal entails that Nederman Holding AB shall transfer 4,282 own shares to the participants, free of charge, and the participants shall hold the shares for at least three years. Introduction of the LTI programme 2017-2018The AGM resolved in accordance with the Board’s proposal for introduction of the LTI programme 2017-2018 for the CEO, senior executives and senior management positions within the Nederman Group, currently seven persons. Remuneration under the LTI programme shall be a maximum of 35 per cent of an annual salary for the CEO and 20 per cent of an annual salary for other senior executives and for the remuneration to be paid it is required that a minimum level of accumulated earnings per share for the financial years 2017 and 2018 is reached or exceeded. The remuneration which, in accordance with the terms and conditions, accrues to the senior executives shall be invested in Nederman shares. The shareholding must be retained for at least three years. With full outcome, the cost for LTI 2017-2018 will amount to approximately MSEK 3.26. Authorisation for the Board of Directors to acquire and transfer of the company’s own sharesThe AGM resolved in accordance with the Board’s proposal for authorisation for the Board to acquire and transfer of the company’s own shares. The authorisation entails that the Board has the right to acquire and transfer of own shares, respectively, on one or more occasions during the period until the AGM 2018. Acquisition of own shares may take place on Nasdaq Stockholm at a price within the interval between the highest buying price and lowest selling price, respectively, and the company’s holdings of own shares may amount to a maximum of ten per cent of all outstanding shares. Transfer of own shares may be made of a maximum number of shares that are held by the company at the time of the Board’s decision and which are not required for the delivery of shares under the company’s incentive programme. Transfer of own shares may take place on Nasdaq Stockholm and as payment of the purchase price for the acquisition of companies or businesses or in connection with a merger, whereby the payment shall correspond to the assessed market value and may be made in cash, in kind or by set-off of a receivable. Transfer may be made with deviation from the shareholders’ preferential rights. Instructions for the Nomination CommitteeThe AGM resolved in accordance with the proposal for instruction for the Nomination Committee and shall apply until further notice. Sven Kristensson, President and CEO, Nederman Tel: +46 (0)42 18 87 00email: sven.kristensson@nederman.com Matthew Cusick, CFO Tel: +46 (0)42 18 87 00email: matthew.cusick@nederman.com Facts about NedermanNederman is one of the world's leading companies supplying products and solutions in the environmental technology sector focusing on industrial air filtration. The company's products and solutions contribute to reducing the environmental impact, create safe and clean working environments and improve production efficiency. Nederman offers complete solutions, including engineering and design, commissioning, installation, training and aftermarket. Sales are managed through the Group’s own sales offices and distributors in over 50 countries. Production is performed in 11 countries on five continents. The Nederman Group is listed on Nasdaq Stockholm and has around 1,800 employees. Learn more at www.nedermangroup.com  Nederman Holding AB (publ), P.O. Box 602, SE-251 06 Helsingborg, Sweden. Corporate registration number: 556576-4205

Vattenfall broadens customer offer in Sweden with geothermal energy

“Geothermal energy is a good complement for owners of single houses in locations beyond the reach of our district heating network and for those who prefer a different solution. It makes us even more customer-oriented and takes us an important step closer to becoming a full-range supplier of heating solutions. It also complements our offer of local energy solutions such as solar cells, air heat pumps and solutions for charging electric cars,” says Magnus Hall, CEO of Vattenfall. Starting today, 20th April, Vattenfall is now for the first time offering geothermal heating and cooling solutions to owners of single homes in Sweden. This has become possible through the acquisition of a 35 per cent share in BrainHeart Energy Sweden, the country’s largest supplier of geothermal solutions to private customers. BrainHeart Energy has an annual turnover of some SEK 200 million and installs about four geothermal energy solutions per day in Sweden. “In the transition of the market to energy-efficient and CO2-minimising solutions, Vattenfall is a perfect partner for us. Vattenfall’s part share strengthens our cooperation and means greater opportunities for the continued fast development of competitive offers and continued growth,” says Ulf Jonströmer, founder and main shareholder of BrainHeart Energy. Together with BrainHeart Energy’s local subsidiaries, Vattenfall’s offer will include competitive new installations and replacements as well as servicing and monitoring. It is part of Vattenfall’s strategy to enable climate-smart solutions with the customer at the centre. Both parties have agreed not to disclose the acquisition price. Facts:Some 400,000 Swedish detached homes currently use geothermal energy. Sweden’s bedrock maintains a temperature of between 6 and 8 degrees all year round. This heat can be utilised by means of a geothermal energy pump. BrainHeart Energy Sweden includes the following subsidiaries: BrainHeart Energy Services, BGE Energi-and Vattenborrning, BGE Värmepumpar, Mälardalens Värmepumpcenter, Morkarlby Elektromekaniska, Höjdens Energi, Höjdens Brunnsborrning and Värmepumpcenter in Karlstad. For further information, please contact:Heidi Stenström, Press Officer Vattenfall, mobile +46 70-611 81 92, heidi.stenstrom@vattenfall.com (heidi.stenstrom@vattenfall.com) (heidi.stenstrom@vattenfall.com) (heidi.stenstrom@vattenfall.com)Vattenfall’s Press Office, telephone, +46 8-739 50 10, e-mail: press@vattenfall.com Facebook:    facebook.com/vattenfallpressrum Twitter:         twitter.com/Vattenfall_Se 

Good growth and stable profitability

President and CEO Klas Balkow’s comments on the first quarter:− Axfood showed good growth in an otherwise soft market. With sales growth of more than 3%, Axfood gained additional market shares during the first quarter. All concepts continued to grow and showed stable profitability.          During the quarter we increased our e-commerce initiatives. The integration of mat.se is being carried out with full strength, and more customers can shop online from Willys and Hemköp. This gives us favourable conditions to strengthen our position in the rapidly growing online segment. First quarter summary ·  Consolidated net sales amounted to SEK 10,639 m (10,305), an increase of 3.2%. ·  Operating profit was SEK 397 m (408), corresponding to an operating margin of 3.7% (4.0%). ·  Net profit for the period was SEK 309 m (316), and earnings per share were SEK 1.47 (1.51). ·  Klas Balkow took office as President and CEO on 16 March. ·  Axfood completed the offer to acquire all of the shares in Matse Holding AB on 31 January. Axfood’s holding as per 31 March was more than 99% of the shares. ·  The Swedish Competition Authority approved the acquisition of Eurocash Food AB, and the company is thereby consolidated in the Axfood Group as from 1 April 2017. Approval from the EU Competition Authority is still pending for Norgesgruppen’s share of the acquisition (49%). ·  Axfood is focusing on growth and new investments, and the forecast is an operating profit in 2017 that is level with the outcome for 2016. Significant events after the balance sheet date ·  Axfood’s board of directors has decided to carry out share repurchases of a maximum of 200,000 shares coupled to the long-term share-based incentive programme. Repurchases can take place starting on 15 May. Axfood currently has no holdings of treasury shares.   Welcome to today’s presentation where President and CEO Klas Balkow together with Acting CFO Anders Lexmon present the first quarter 2017. The presentation will be held at Hemköp’s “Rekobutik”, Norra Stationsgatan 80 A, at 9 a.m. The presentation can also be followed via axfood.se or monitored by phone:Sweden: +46 8 566 426 66Great Britain: +44 203 0089 804USA: +1 855 8315 945.

INTERIM REPORT January–March 2017

Q1 2017 · Net sales SEK 5 636 m · EBITDA SEK 923 m · EBITDA margin 16% · Earnings per share SEK 1.94 KEY HIGHLIGHTS · BillerudKorsnäs reached all-time high sales- and production volumes for a single quarter. · Net sales have increased with 5% compared to the same period previous year as a result of volume growth. · EBITDA margin for the quarter was 16% which is lower than the previous year’s 19%. EBITDA was burdened with SEK 80 million of one-off costs for quality issues and extra costs for mill re-build. · EBITDA was also impacted by SEK 75 million costs for maintenance shutdown that was not included in Q1 in the previous year. · Earnings per share for the quarter amounted to SEK 1.94 (2.33). OUTLOOK · Demand and order situation for the second quarter is expected to be strong with normal seasonal variances for all business areas. · For business areas Packaging Paper and Corrugated Solutions there are potential for local price increases in the coming quarter. · No changes are anticipated for the wood costs or wood prices in the second quarter compared to the first quarter. · The production unit in Rockhammar may incur additional costs in Q2, approximately SEK 5-10 million. · Costs for planned maintenance shutdown in Q2 are estimated to SEK 205 million.  Comments by BillerudKorsnäs’ CEO Per Lindberg:Growing again“The first quarter of 2017 saw growth on the back of high demand in the markets across all business areas. Sales are showing better than expected growth, and our production is in fact at an all-time high for a single quarter. However, our operating profit during the quarter suffered from spillover effects from 2016, and we have as a consequence undertaken significant measures to address both our start-up performance as well as quality performance. Two of the key elements in our growth strategy and production capacity are our major ongoing investments in Skärblacka and Gruvön. We are glad to see that the start-up of these projects has been successful and that they are well under way. Together with new solution sales initiatives we have laid a strong foundation for continued growth.”    THE RESULTOur operating profit SEK 550 million falls short of our expectations. This is due to the ramp up of Rockhammar after the rebuild in 2016 and quality costs emanating from production disturbances during the second half of 2016. Even if the situation has improved and stabilized in Rockhammar, we may experience some minor costs also in the upcoming quarter. However, looking at the current market, we see an overall positive development across the board and a solid performance in terms of sales growth, 5% during the first quarter compared to the same quarter last year. Within Consumer Board we even exceeded our expectations during the beginning of the year, driven by strong sales to all major liquid packaging board customers. During the quarter we were subject to an unexpected inspection under EU competition rules as part of a larger investigation of the market for bleached and unbleached kraft papers. We have no indications of the outcome from the inspection.MARKET OUTLOOKAll of our business areas are currently showing a favourable development, partly due to underlying strong demand but also some seasonal improvement in Packaging Paper. We believe this will continue also in the second quarter and we now need to meet this strong demand with high production volume and quality.The growing demand for sustainable packaging does not only drive demand for sustainable materials. We can also detect an increasing need for holistic packaging solutions throughout the whole value chain of the packaged product, especially in developing markets. Such solutions are necessary to enable a shift toward packaging that help create better packaging performance, especially in terms of sustainability. We are already in a position where we can offer such solutions – Managed Packaging within Corrugated Solutions, Sack Sales and system sales such as Axello Zap within Packaging Paper to name a few. Today these new solutions offerings still constitute a small part of our total business but they are growing more rapidly than material sales and we expect that development to continue and accelerate.STRATEGYOur target is to deliver profitable growth through offering both materials and solutions. Sustainability is becoming an increasingly integrated part of our core offer along with cost, protective and appearance performance criteria. It is often an entry ticket to new business and a result of our efforts to challenge customers to choose more sustainable alternatives, BillerudKorsnäs alternatives. One clear example of this is the launch in March of a Sack Sales partnership in Malaysia to serve the market throughout South East Asia. We can through delivering a complete packaging solution based on our material, but by sourcing the converting, provide the market with a product that replaces less sustainable solutions made of plastic. Our solution provides a better carbon footprint but also a much better working environment for the end user which for instance can be cement. Such examples of new sustainable solutions and business models in combination with the growth in production of sustainable materials generated by the large investments in our production structure show that we have the ability to deliver on our strategy for profitable growth.BillerudKorsnäs’ President and CEO Per Lindberg and CFO Susanne Lithander will present the interim  report at a press and analyst conference at 10.00 CET on Thursday 20 April 2017.Venue: Tändstickspalatset, Västra Trädgårdsgatan 15, StockholmFor further information, please contact:Per Lindberg, President and CEO +46 (0)8 553 335 00Susanne Lithander, CFO, +46 (0)8 553 335 00This information constituted inside information before publication. This is information that BillerudKorsnäs AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 07.00 CET on 20 April 2017. This information has been prepared in both a Swedish and an English version.BillerudKorsnäs provides packaging materials and solutions that challenge conventional packaging for a sustainable future. We are a world leading provider of primary fiber based packaging materials and have customers in over 100 countries. The company has 7 production sites in Sweden, Finland and the UK and about 4 300 employees in over 13 countries. BillerudKorsnäs has an annual turnover of about SEK 22 billion and is listed on Nasdaq Stockholm. www.billerudkorsnas.com

Growing again

THE RESULT Our operating profit SEK 550 million falls short of our expectations. This is due to the ramp up of Rockhammar after the rebuild in 2016 and quality costs emanating from production disturbances during the second half of 2016. Even if the situation has improved and stabilized in Rockhammar, we may experience some minor costs also in the upcoming quarter. However, looking at the current market, we see an overall positive development across the board and a solid performance in terms of sales growth, 5% during the first quarter compared to the same quarter last year. Within Consumer Board we even exceeded our expectations during the beginning of the year, driven by strong sales to all major liquid packaging board customers. During the quarter we were subject to an unexpected inspection under EU competition rules as part of a larger investigation of the market for bleached and unbleached kraft papers. We have no indications of the outcome from the inspection. MARKET OUTLOOK All of our business areas are currently showing a favourable development, partly due to underlying strong demand but also some seasonal improvement in Packaging Paper. We believe this will continue also in the second quarter and we now need to meet this strong demand with high production volume and quality. The growing demand for sustainable packaging does not only drive demand for sustainable materials. We can also detect an increasing need for holistic packaging solutions throughout the whole value chain of the packaged product, especially in developing markets. Such solutions are necessary to enable a shift toward packaging that help create better packaging performance, especially in terms of sustainability. We are already in a position where we can offer such solutions – Managed Packaging within Corrugated Solutions, Sack Sales and system sales such as Axello Zap within Packaging Paper to name a few. Today these new solutions offerings still constitute a small part of our total business but they are growing more rapidly than material sales and we expect that development to continue and accelerate. STRATEGY Our target is to deliver profitable growth through offering both materials and solutions. Sustainability is becoming an increasingly integrated part of our core offer along with cost, protective and appearance performance criteria. It is often an entry ticket to new business and a result of our efforts to challenge customers to choose more sustainable alternatives, BillerudKorsnäs alternatives. One clear example of this is the launch in March of a Sack Sales partnership in Malaysia to serve the market throughout South East Asia. We can through delivering a complete packaging solution based on our material, but by sourcing the converting, provide the market with a product that replaces less sustainable solutions made of plastic. Our solution provides a better carbon footprint but also a much better working environment for the end user which for instance can be cement. Such examples of new sustainable solutions and business models in combination with the growth in production of sustainable materials generated by the large investments in our production structure show that we have the ability to deliver on our strategy for profitable growth. For further information, please contact: Per Lindberg, President and CEO +46 (0)8 553 335 00Susanne Lithander, CFO, +46 (0)8 553 335 00 This information constituted inside information before publication. This is information that BillerudKorsnäs AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 07.02 CET on 20 April 2017.

Interim report January–March 2017

Quote from Per Eriksson, President and CEO- ”We continued to deliver on our growth strategy in the first quarter and revenues increased in line with our earlier comments about the quarter. For the first time, NetEnt’s games were launched on the regulated market in Mexico and the Company announced that the first game for Virtual Reality (VR) will be developed in 2017. For the rest of 2017, we see conditions for continued solid growth supported by new games, increasing market shares in the UK, mobile growth, many new customers to be launched and our ongoing expansion in North America.” First quarter 2017 · Revenues for the first quarter increased by 15.2% to SEK 398 (345) million · Operating profit amounted to SEK 136 (128) million, an increase of 6.3% · Operating margin was 34.2 (37.1)%  · Profit after tax amounted to SEK 124 (122) million, an increase of 1.8% · Earnings per share amounted to SEK 0.52 (0.51) before and after dilution  · 15 new customer agreements were signed, a new record, and six new customers’ casinos were launched Important events in the first quarter · Games were launched with Codere on the regulated market in Mexico  · NetEnt announced that it will develop its first VR game and revealed two new branded game titles for 2017: Planet of the Apes and Emojis® · The Live Casino product offering was strengthened with the launch of Common Draw Black Jack for mobile Comments by Per Eriksson, President and CEO: A good start to 2017The first quarter of 2017 featured continued growth and exciting product news for NetEnt. Compared to the very strong quarter of last year, revenues increased by 15.2 percent (13.0 percent in euro terms) to 398 SEKm, which corresponds to our earlier comments about the quarter. Operating profit increased by 6.3 percent to 136 SEKm and the operating margin was 34.2 percent, compared to 37.1 percent in the same quarter of last year. Costs increased in the quarter in line with previous communication about the future, mainly due to higher office rents and IT costs. The number of gaming transactions in our games amounted to 9.8 billion in the first quarter, representing an increase of 11 percent compared to the first quarter of last year. During the quarter, we signed 15 new customers, which is the highest number ever, and launched 6 new customers. We follow our growth strategy focusing on regulated markets and the expansion continues both in Europe and outside of Europe. In January, we launched our games on the regulated market in Mexico with Codere, one of the leading operators. The UK continues to contribute significantly to our growth and the potential is still significant, considering our relatively low market share in what is by far Europe’s largest gaming market. Mobile games also remain an important growth factor and accounted for 47 percent of revenues in the quarter. Exciting product newsAt ICE, the gaming industry trade fair in London, we revealed several exciting product news. We announced that we will develop our first game for the fast-growing Virtual Reality (VR) market, based on our previous game success Gonzo’s Quest. I am convinced that VR will play an important role in future gaming and I am really pleased that NetEnt is at the forefront of this development. We also revealed two new branded game titles for 2017 – Planet of the Apes and Emojis® – well-known brands that we expect to turn into truly unique and thrilling games. For Live Casino, we showcased our new mobile product, Common Draw Black Jack, which is strengthening our mobile offering. We also revealed an entirely new bonus function called Live Rewards, set to be launched in the second quarter. The proposed new gaming legislation in Sweden supports a sustainable gaming industryIn March, the gaming commission presented its proposal for new gaming legislation in Sweden. Overall, the proposal seems to set commercially viable conditions for industry participants while at the same time opening up for new, substantial tax income for the government. We welcome such a new legislation. A modern gaming legislation that leads to a high channelization to regulated gaming forms creates a more secure environment for both players and the industry. We intend to apply for a B2B-license as an industry supplier. Over the years, NetEnt has invested and built up an organization and the expertise to obtain and maintain gaming licenses. NetEnt has licenses and certifications in many European countries such as Denmark, UK, Malta, Portugal, Romania, Bulgaria, Italy, Belgium, Estonia and Spain. Regulated markets are an important part of our growth and sustainability strategies and no other gaming supplier is present on so many regulated markets like we are. Future outlookFor the rest of 2017, we see conditions for continued solid growth supported by new games, increasing market shares in the UK, mobile growth, many new customers to launch and our ongoing expansion in North America. We continue to hire more employees and develop our platform. We strengthen the organization to increase our production capacity, enter more regulated markets and integrate a large number of new customers. With this in mind, we foresee an ongoing need to invest during 2017. We do this to enable continued solid growth with increasing economies of scale for NetEnt going forward – the future outlooks remains bright. Presentation of earnings reportOn Thursday, April 20, 2017, at 9.00 a.m. the interim report will be presented by CEO Per Eriksson live via webcast. The presentation can be followed in real-time on NetEnt’s website at https://www.netent.com/en/section/invest/. For additional information please contact:Per ErikssonPresident and CEOPhone: +46 8 5785 4500per.eriksson@netent.com This information is information that NetEnt AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 7:30 CET on April 20, 2017.

Mycronic, first quarter January-March, 2017

Mycronic reports growth in all market segments for the first quarter Mycronic's net sales rose 97 percent compared to the first quarter of 2016. The underlying EBIT margin amounted to 31 percent. "Growth in the quarter proves that our product offering meets the customers’ challenges," says Lena Olving, President and CEO. First quarter January-March 2017 · Order intake reached SEK 653 (794) million · Net sales reached SEK 676 (344) million · EBIT was SEK 159 (32) million · Underlying EBIT was SEK 208 (32) million · Earnings per share was SEK 1.15 (0.24) Outlook 2017It is the Board’s assessment that net sales in 2017 will be at the level SEK 2,800 million.Events since end of the quarterToday, on 20 April, 2017, Mycronic launches the all new product platform, MY700, of the next generation product series MYPro. With the MY700, for application of solder paste and dispensing of assembly fluids, Mycronic addresses more application areas and a larger market in the electronics industry. The MY700 can apply two different media in the same process step. CEO commentsDuring the first quarter, consolidated net sales increased 97 percent. As presented in the table on the previous page, the increase is from both organic growth in Assembly Solutions and Pattern Generators, and from the acquired operations. During the quarter, we delivered two mask writers and a MY600 multiple order among other things, and we had a closing order backlog of SEK 1.3 billion.Consolidated EBIT continued to develop favorably and was 23 percent for the first quarter. EBIT is charged with costs related to the acquisitions, which are not related to operational activities. These costs will remain for some time to come, even if they are greatest during the current year. In this report we refer to the concept of underlying EBIT to show how our operations develop and perform. The underlying business achieved an EBIT margin of 31 percent.As we have said many times since the strategy for growth was decided in 2013, Mycronic continues to invest in product development. The largest financial investments are being made in Assembly Solutions, both within our SMT operations and in the acquired companies, which has affected the profitability in this business area. These investments enable us to continue providing our customers with efficient production solutions. And today I am happy to announce the launch of MY700, an all new product platform as one result from these investments. We expect to remain at the current level this year. Market data shows that after a sluggish first half-year 2016, the global SMT equipment market grew for the full-year. There is no prognosis for the trend for SMT equipment in 2017, but the assessment is for positive development in the electronics and semiconductor industries, creating favorable conditions for the SMT market. Through our acquisitions, Assembly Solutions now addresses a larger share of the electronics industry. This broadens our product offering and reach a larger market, product wise as well as geographically.Both the display and photomask markets declined in 2016. There is a shift towards a greater proportion of AMOLED displays. During the reconstruction phase of factories, capacity is temporarily reduced and development activities are also decreasing during this phase. The assessment is that production capacity will increase in 2017 as the re-modeled production lines are brought into operation and development activities can be resumed. The continuous contact we maintain with our customers, and with the customers’ customers, shows continued demand for equipment that enables efficient photomask production for the advanced displays of the future. Lena Olving,CEO and President   Contacts at Mycronic:Lena OlvingCEO+46 8 - 638 52 00lena.olving@mycronic.com  Torbjörn WingårdhCFO+46 8 - 638 52 00torbjorn.wingardh@mycronic.com  The Information in this report is published in accordance with the EU Market Abuse Regulation and the Swedish Securities Act. The information was submitted for publication, through the contact persons stated below, on 20 April 2017, at 8 am.

NeuroVive Presents Preclinical Findings of NV556 in NASH Showing Confirmatory Anti-fibrotic Effects

NV556 has previously shown similar anti-fibrotic effects in the experimental STAM™ NASH model. Today, NeuroVive’s scientists present novel data demonstrating anti-fibrotic effects of NV5556 also in the experimental MCD NASH model, strengthening and confirming the previous findings. In addition, in the STAM model where NASH is followed by liver cancer development, long term treatment with NV556 was well tolerated and significantly reduced liver weight increase, indicating a reduced tumor burden. Furthermore, there was a trend that NV556 reduced both the number and the size of tumors on the liver surface. “We are encouraged by the confirmation of an anti-fibrotic effect of NV556 in a second well validated experimental model. Also, the preventive effect on liver cancer development is a highly appealing observation that adds to the attractiveness of NV556 as a possible treatment candidate for patients with progressing NASH for which there is a high unmet medical need”, says Magnus Hansson, M.D., Ph.D., Chief Medical Officer at NeuroVive. Dr. Hansson and colleagues will present the poster titled “Anti-fibrotic effect of NV556, a sanglifehrin-based cyclophilin inhibitor, in a preclinical model of non-alcoholic steatohepatitis1” at The International Liver Congress™ taking place in Amsterdam, the Netherlands, 19-23 April 2017. The International Liver Congress ™ is the main annual scientific conference of the European Association for the Study of the Liver (EASL), with about 11,000 attendees, including scientific and medical experts from around the world, meeting to share and discuss the latest liver research findings. About NV556 NV556 is a potent cyclophilin inhibitor in NeuroVive’s Sangamide class of compounds. NV556 is undergoing preclinical development and has so far showed an excellent safety profile. The first preclinical results for the effects of NV556 on fibrosis development in an experimental model of NASH were received during the autumn of 2016. In addition to NV556, NeuroVive is developing a new class of compounds with a different mode of action. This project is complementary to NV556 and may offer an alternative treatment opportunity of NASH patients. This discovery project, titled NVP022, utilizes NeuroVive’s core competence in mitochondrial energy regulation, and NeuroVive’s partner company Isomerase’s innovative chemistry capabilities are providing chemical compounds currently undergoing experimental concept testing. About NASH Inflammation and excess fat in the liver are symptoms of non-alcoholic steatohepatitis (NASH), a condition that causes scarring of the liver which can lead to cirrhosis of the liver and liver cancer (hepatocellular carcinoma). There is a strong link between NASH and other metabolic disorders, such as diabetes and obesity. The disease is common all over the world, and about 3-5% of all Americans (roughly 15 million people) suffer from NASH,2 for which there are currently no registered treatment options available. 1) Grönberg Alvar, Elmér Eskil, Gregory Matthew, Moss Steven, Hansson Magnus (accepted abstract)2) Vernon G. et al. Aliment Pharmacol Ther. 2011;34(3):274-85 About NeuroVive NeuroVive Pharmaceutical AB is a leader in mitochondrial medicine. The company is committed to the discovery and development of medicines that preserve mitochondrial integrity and function in areas of unmet medical need. The company’s strategy is to advance drugs for rare diseases through clinical development and into the market. The strategy for projects within larger indications outside the core focus area is out-licensing in the preclinical phase. NeuroVive enhances the value of its projects in an organization that includes strong international partnerships and a network of mitochondrial research institutions, as well as expertise in drug development and production. NeuroVive has a project in early clinical phase II development for the prevention of moderate to severe traumatic brain injury (NeuroSTAT®). NeuroSTAT has orphan drug designation in Europe and in the US. The R&D portfolio consists of several late stage research programs in areas ranging from genetic mitochondrial disorders to cancer and metabolic diseases such as NASH. NeuroVive is listed on Nasdaq Stockholm, Sweden (ticker: NVP). The share is also traded on the OTCQX Best Market in the US (OTC: NEVPF). For investor relations and media questions, please contact:Cecilia Hofvander, NeuroVive, Tel: +46 (0)46 275 62 21 or ir@neurovive.com NeuroVive Pharmaceutical AB (publ)Medicon Village, SE-223 81 Lund, SwedenTel: +46 (0)46 275 62 20 (switchboard)www.neurovive.com This information is information that NeuroVive Pharmaceutical AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 08:00 a.m. CEST on 20 April 2017.

Citycon Q1: Good start to the year – EPRA Earnings growth fuelled by Sweden and Norway

JANUARY—MARCH 2017-Net rental income increased to EUR 56.6 million (Q1/2016: 55.2) mainly due to (re)development projects coming online (mainly Iso Omena) and the acquisition of the adjacent building to Citycon’s Oasen shopping centre in Bergen, Norway. In addition, positive like-for-like growth contributed to net rental income growth by EUR 0.5 million. The non-core property divestments in 2016 and 2017 decreased net rental income by EUR 2.0 million.-EPRA Earnings increased by EUR 2.4 million, or 6.6%, to EUR 38.3 million, especially due to the growth in net rental income and lower direct administrative expenses. EPRA Earnings per share (basic) increased to EUR 0.043 (EUR 0.040).-Earnings per share decreased to EUR 0.03 (0.06) mainly due to lower fair value gains. KEY FIGURES Q1/2017 Q1/2016 %1) 2016Net rental income MEUR 56.6 55.2 2.5 224.9Direct operating MEUR 50.3 47.9 5.0 198.5profit2)Earnings per EUR 0.03 0.06 -50.3 0.18share (basic)Fair value MEUR 4,447.3 4,079.1 9.0 4,337.6of investmentpropertiesLoan to Value (LTV)2) % 47.1 45.0 4.8 46.6EPRA based key figures2)EPRA Earnings MEUR 38.3 36.0 6.6 151.1EPRA Earnings EUR 0.043 0.040 6.6 0.170per share (basic)EPRA NAV EUR 2.83 2.78 1.7 2.82per share 1) Change from previous year. Change-% is calculated from exact figures.2) Citycon presents alternative performance measures according to the European Securities and Markets Authority (ESMA) guidelines.More information is presented in Basis of Preparation and Accounting Policies in the notes to the accounts. CEO, MARCEL KOKKEEL:Citycon had a good start to the year 2017. The Swedish and Norwegian portfolio showed continued strong performance, while the ongoing (re)developments and performance of the non-core properties weighted negatively on the Finnish like-for-like results. Overall, like-for-like net rental income growth including Kista Galleria (50%) totalled 1.1%.  The outlook for the Finnish economy is gradually improving. We have seen leasing demand increasing for our assets in the Helsinki area, including our large (re)development projects, whereas we still expect some pressure on rental levels in other parts of Finland. The second phase of the Iso Omena extension will open on 20 April almost fully leased. With the opening of the new extended M.E.E.T restaurant concept, seven-screen cinema and Espoo’s first Zara, Iso Omena has become the natural heart of Espoo and one of the leading shopping and leisure destinations in the Helsinki area. In 2017, Citycon’s focus will remain on operational improvement and upgrading the portfolio quality via asset rotation and (re)developments. Since the strategy update in 2011, Citycon has divested 52 properties for a total value of EUR 400 million and we aim to expedite further capital recycling. As previously communicated, our plan is to divest EUR 200–250 million of non-core assets, mainly in Finland, within the coming 1.5 years. Additionally, we have identified further potential to recycle capital in Norway and plan to divest smaller, non-urban Norwegian assets for up to EUR 200-250 million over the next three years.  BUSINESS ENVIRONMENTThere were no major changes in Citycon’s macroeconomic environment during the first quarter of 2017. The Finnish economy grew last year at its fastest pace in five years and the economy is expected to continue to grow. Other Citycon’s operating countries are expected to show positive economic development for the on-going year: the business environment in Sweden, Estonia and Denmark remains strong or relatively strong and the Norwegian economy is picking up momentum.According to the European Commission (forecast), GDP growth for the Euro area in 2017 is expected to be approximately 1.6%. Sweden and Estonia are showing stronger growth figures than the Euro area average and Denmark is in line with the Euro area forecast, while the GDP growth for Finland and Norway is expected to be slightly lower than the Euro area average. Overall the GDP growth is expected to gradually converge in Citycon’s operating countries.Business environment key figures   % Finland Norway Sweden Estonia Denmark Euro areaGDP growth 1.2 1.2 2.4 2.2 1.5 1.6forecast, 2017GDP growth 1.5 1.5 2.1 2.6 1.8 1.8forecast, 2018Unemployment, 8.7 4.2 6.8 5.8 6.4 9.5Feb 2017Retail sales 1.1 1.7 0.7 1.0 -1.8 1.8growth, Jan-Feb2017 Sources: European Commission, Eurostat, Statistics Finland/ Norway/Sweden/ Estonia/ Denmark The unemployment decreased in Sweden, Estonia and Norway during the first quarter of 2017, but increased slightly in Denmark. In Finland the unemployment has remained unchanged during the reporting period. The unemployment rates in all of Citycon’s operating countries remained below the Euro area average (9.5%). For the first two months retail sales growth has been positive in Finland, Norway, Sweden and Estonia, while Danish retail sales has been negative. (Source: Statistics Finland/Norway/Sweden/Estonia/Denmark)In Sweden, Finland and Denmark the consumer confidence levels during the reporting period have continued a positive trend. The consumer confidence in Estonia and on average in the Euro area is still negative. (Source: Eurostat) Consumer prices have increased in all of Citycon’s operating countries during the reporting period, and also in the Euro area generally. In Norway, Sweden and Estonia the consumer prices have increased faster than the Euro area average. (Source: Statistics Finland/Norway/Sweden/Estonia/Denmark)In Finland, prime shopping centre rents have stayed unchanged quarter-to-quarter and are forecast to remain stable or increase slightly in 2017. In Norway, prime rents are forecast to remain unchanged. In Sweden, prime shopping centre rents have increased marginally over the quarter while in Estonia rents have decreased by 1% quarter-to-quarter. A slight decrease is forecasted to continue in Estonia in 2017 due to intensifying competition. (Source: JLL)In Finland, the demand for core properties remains strong and the demand for secondary properties has alsoincreased. In Norway, the investment demand continues strong but some upward pressure on yields may be expected. In Sweden and in Estonia, the prime shopping centre yields have stabilized. (Source: JLL) RISKS AND UNCERTAINTIESThe most significant near-term risks and uncertainties in Citycon's business operations are associated with the general development of the economy and consumer confidence in the Nordic countries and Estonia as well as how this affects the fair values, occupancy rates and rental levels of the shopping centres and thereby Citycon’s financial result. Especially a slower economic recovery in Finland could hamper the achievement of the set financial objectives.The main risks that can materially affect Citycon's business and financial results, along with the main risk management actions, are presented in detail in Note 3.5 A) and on pages 73-74 in the Financial Statements 2016 as well as on Citycon’s website in the Corporate Governance section. No material changes are estimated to have taken place during the first quarter of the year in the risks described. DIVIDEND AND EQUITY REPAYMENTCitycon’s dividends and equity repayments in 2017: Dividends and Record date Payment date EUR / shareequityrepaymentspaid on31 March20171)Dividend for 24 March 2017 31 March 2017 0.012016Equity 24 March 2017 31 March 2017 0.0225repayment Q1Remaining Preliminary record date Preliminary payment date 0.0975Boardauthorisationforequityrepayment2)Equity 22 June 2017 30 June 2017repayment Q2Equity 22 September 2017 29 September 2017repayment Q3Equity 14 December 2017 29 December 2017repayment Q4 1) Board decision based on the authorisation issued by the AGM 2017.2) The AGM 2017 authorised the Board of Directors to decide in its discretion on the distribution of dividend and assets from the invested unrestricted equity fund. Based on the authorisation the maximum amount of dividend to be distributed shall not exceed EUR 0.01 per share and the maximum amount of equity repayment distributed from the invested unrestricted equity fund shall not exceed EUR 0.12 per share. Unless the Board of Directors decides otherwise for a justified reason, the authorisation will be used to distribute dividend and/or equity repayment four times during the period of validity of the authorisation. In this case, the Board of Directors will make separate resolutions on each distribution of the dividend and/or equity repayment so that the preliminary record and payment dates will be as stated above. Citycon shall make separate announcements of such Board resolutions. OUTLOOKCitycon forecasts the 2017 Direct operating profit to change by EUR -7 to 12 million and EPRA Earnings to change by EUR -13 to 5 million from the previous year. Additionally, the company expects EPRA EPS (basic) to be EUR 0.155–0.175. These estimates are based on the existing property portfolio as well as on the prevailing level of inflation, the EUR—SEK and EUR—NOK exchange rates, and current interest rates. Premises taken offline for planned or ongoing (re)development projects reduce net rental income during the year. Financial calendarCitycon will issue a half-year financial report and interim report of the third quarter in accordance with the following schedule:   January–June 2017 on Thursday, 13 July 2017 at about 9:00 a.m.  January–September 2017 on Thursday, 19 October 2017 at about 9:00 a.m. Helsinki, 19 April 2017 Citycon OyjBoard of Directors For further information, please contact:Eero Sihvonen, Executive VP and CFOTel. +358 50 557 9137eero.sihvonen@citycon.com Henrica Ginström, VP, IR and CommunicationsTel. +358 50 554 4296henrica.ginstrom@citycon.com Citycon is an owner, developer and manager of urban grocery-anchored shopping centres in the Nordic and Baltic region, managing assets that total EUR 5 billion and with market capitalisation of EUR 2 billion. Citycon is the No. 1 shopping centre owner in Finland and Estonia and among the market leaders in Norway and Sweden. Citycon has also established a foothold in Denmark. Citycon has investment-grade credit ratings from Moody's (Baa1) and Standard & Poor's (BBB). Citycon Oyj’s share is listed in Nasdaq Helsinki. www.citycon.com 

Interim Report Q1 2017

Financial overview Q1 2017 · Total net revenues SEK 127.4 million (151.0) · Zubsolv® net revenue SEK 114.1 million (98.4) · EBIT SEK -23.2 million (-26.2) · EBITDA SEK -18.1 million (-19.4) · Earnings per share, before and after dilution, SEK -1.00/-1.00 (-1.00/-1.00) · Cash flow from operating activities SEK 28.2 million (33.5) · Cash and cash equivalents SEK 250.6 million (233.0) · Guidance issued in connection with Full Year Report 2016 confirmed Other highlights Q1 2017 · Completion of another bond buyback program amounting to a nominal value of SEK 59 million · Orexo commenced a patent infringement litigation against Actavis for their generic versions of Suboxone® and Subutex® tablets in the US CEO comments Zubsolv® growth in the US drives improved profitability in the commercial operations In a dynamic market environment, I am pleased to report that net sales for Zubsolv US in Q1 2017 increased with 15.9 percent from Q1 2016 and our US business continues to contribute positively to the Orexo revenues and earnings. With this growth and positive contribution from our US business, I can confirm our financial guidance of positive EBITDA for the full year. We are encouraged to see an accelerating growth in the market for treatment of opioid dependence reaching 9.7 percent in the first quarter compared to a growth of 7.6 percent in Q4 2016. This is a trend break as Q1 traditionally is weaker than Q4. The growth this year is primarily driven by the physicians certified to expand to 275 patients and most of the growth is in the public segment. The commercial segment has followed the trend from previous years with Q1 slightly below Q4 volumes. We expect the commercial segment to improve in the next quarters and we are pleased to see the growth in commercial pick-up late in the quarter. This is important for Orexo as we have better market access, market share and pay less rebates in the commercial segment. During the quarter, I have spent time in the US meeting healthcare professionals treating opioid dependence. The feedback on Zubsolv and our work in the US is positive, we have a strong brand awareness both as a company and on a product level with Zubsolv. However, market access remains an important driver of physicians’ choice of medication and we need to work relentlessly to open up the market for more unrestricted access for Zubsolv. I know our message resonates well, but physicians need to move out of their comfort zone and direct their patients to get a treatment with Zubsolv versus a “drug” most patients have tried before even starting medical treatment, since they were buying it on the street as a part of their illicit opioid misuse. Another key event during the quarter was a new litigation against Actavis for infringement of our patent 8,454,996 with their generic versions of Suboxone® and Subutex®. The validity of the ‘996 patent was confirmed by the district court and Actavis has not appealed the decision. Actavis has been successful with the generic version of Suboxone and was the market leader the first year after launch in March 2013. The total cumulated gross sales of the generic versions of Suboxone and Subutex exceed USD 500 million and Orexo will seek compensation for damages caused by Actavis’s infringement of the ‘996 patent. I remain confident that we will continue to see a positive development of Zubsolv and Orexo, spurred by improved market and volume growth in the US. Beyond Zubsolv in the US, our pipeline is progressing well. Zubsolv launch in Europe is anticipated early next year, we have concrete discussions with partners for OX51 and OX-MPI and we have some exciting new formulation technologies which could be ready for first clinical trials already this year. With our continued strengthening of our financial position, with six consecutive quarters with positive cash flow from operating activities, we are well positioned to capture the opportunities and continue the development of Orexo.   Nikolaj SørensenPresident and CEO   For further information, please contact  Nikolaj Sørensen, President and CEO, or Henrik Juuel, EVP and CFOTel +46 18 780 88 00 E-mail ir@orexo.com Teleconference CEO Nikolaj Sørensen and CFO Henrik Juuel will present the report at a teleconference on April 20, 2017, at 2:00pm CET. Please view instructions below on how to participate. Internet: https://wonderland.videosync.fi/orexo-q1-report-2017. Telephone: (SE) +46 8 566 425 09, (UK) +44 20 300 89 807 or (US) +1 855 831 5945. There will be a Q&A session and questions can also be sent in advance to ir@orexo.com at latest 11am CET. The presentation will be available at Orexo´s website one hour prior to the teleconference. This information is information that Orexo AB (publ.) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 8.00am CET on April 20, 2017.

Evolution Gaming: Interim report January-March 2017

First quarter of 2017 (Q1 2016) · Operating revenues increased by 60% to EUR 39.7 million (24.8) · EBITDA increased by 65% to EUR 17.0 million (10.3), corresponding to a margin of 43% (42) · Profit for the period amounted to EUR 12.7 million (7.6) · Earnings per share amounted to EUR 0.35 (0.21) Events during the first quarter of 2017 · Overall very high demand for Live Casino games among the customers · Agreement with the Spanish gaming operator Codere for exclusive provision of Live Casino in Mexico · Additional new agreements with mybet, Matchbook and White Hat Gaming Events following the balance sheet date · Entry into the Canadian market through an agreement with British Columbia Lottery Corporation for provision of Live Casino services CEO Martin Carlesund comments: The strong momentum that we experienced towards the end of last year continued into 2017, and January and February were particularly strong, with a very high level of activity among our customers. Compared with the first quarter of 2016, sales increased by 60 percent. EBITDA for the quarter amounted to EUR 17 million, corresponding to a margin of 43 percent, which is roughly in line with the first quarter of 2016. There tends to be favourable activity early in the year and 2017 has been no exception. We have seen generally high player volumes among all types of customers, both small and large well-established operators, while customers are also increasingly optimising their Live Casino offerings. In line with this, growth has, as in the past, derived primarily from existing customers, while new customers initially focus on adjusting their offer to attract end users to start playing Live Casino. Many of our existing customers have launched new environments and expanded with additional tables during the quarter. Furthermore, our poker products have been launched with additional customers, with Three Card Poker and our exclusive live version of Ultimate Texas Hold’em, in particular, gaining increased exposure to end users. We have also secured several new customers in the quarter, including myBet, Matchbook, White Hat Gaming and Codere. For the latter, we will be the exclusive provider of Live Casino in Mexico, one of Codere’s key markets. This will also be Evolution’s first step into the Mexican gaming market. On the product side, we continue to maintain a high pace. During the quarter, we launched Speed Baccarat and Speed Roulette (faster versions of the originals) and a progressive jackpot for Caribbean Stud Poker. We have also enhanced the user experience in mobile mode by enabling gaming in portrait view for Baccarat and Blackjack. Previously, our mobile products could only be played in landscape view. As mentioned in the previous report, we have also initiated the launch of our new game category Live Lucky Wheel, which could, in time, get a new target audience to discover the thrill of live. Following the end of the quarter, we have signed an agreement with Canadian operator British Columbia Lottery Corporation, which will mark our first launch in the North American market. As a result of the deal, we will later this year build a new Live Casino studio in the Metro Vancouver area in Canada, our eighth studio in total. It is an agreement of high strategic importance to Evolution and the start of a potential expansion in North America. Canada is a regulated market, where each province has its own gaming and lottery operations under government management. The studio is initially being built for BCLC, but with the intention of serving other provinces over time. The new studio will create over 180 jobs and the gross winnings of BCLC are reinvested in various community initiatives in British Columbia. I am convinced that Live Casino will be a popular product, just as in Europe, and that the new studio will lay the foundation for Evolution’s global leadership in live. Looking ahead in 2017, we see continued strong demand for our products, even if the second and third quarters tend to have less activity than the winter months. Furthermore, we have no major sporting event driving traffic during the summer this year. However, we view our continued growth confidently, with good opportunities to further widen the gap to our competitors, through our strategy with its clear focus on profitable growth. To support future expansion, we intend to start the establishment of our third major studio in Europe during the year, which like our production studios in Riga and Malta will be able to serve multiple markets and customers. Presentation to investors, analysts and media CEO Martin Carlesund and CFO Jacob Kaplan will present the report and answer questions on Thursday, 20 April 2017 at 10:30 a.m. CET by conference call. The presentation will be held in English and can also be followed online. Number for participation by phone: +46 8 566 42 663. Follow the presentation at https://wonderland.videosync.fi/evolution-gaming-group-q1-report-2017.

Statement by Vigmed’s bid committee in relation to the increased public offer by Greiner Bio-One

On 27 February 2017, Greiner Bio-One GmbH (“GBO”) announced a public cash offer to the shareholders of Vigmed Holding AB (publ) (“Vigmed”) at the price of SEK 1.00 in cash per share (the “Offer”).On 13 April 2917, GBO announced its decision to increase the Offer consideration to SEK 1.20 in cash per share[1]. The total value of the increased Offer, based on all outstanding 65,749,998 shares in Vigmed, amounts to approximately SEK 78.9 million.The increased Offer represents a premium of[2]: · 3.4 per cent compared to the volume-weighted average trading price over the 30 calendar days ending on 24 February 2017 of SEK 1.16 for the Vigmed share; and · 21.2 per cent compared to the closing price of SEK 0.99 for the Vigmed share on 24 February 2017, the last day of trading prior to the announcement of the Offer. In addition, GBO announced on 13 April 2017 its decision to extend the acceptance period until and including 27 April 2017 at 5:00 p.m. CEST, and that all conditions for completion of the Offer would remain unchanged, including, inter alia, the Offer being accepted to such extent that GBO becomes the owner of more than 90 percent of all shares in Vigmed[3]. The independent bid committee appointed by the Vigmed board (the “Bid Committee”)[4] has previously on 27 February 2017 and on 10 April 2017 unanimously recommended the shareholders of Vigmed to accept the Offer of SEK 1.00 per share. For information on the assessment of the Bid Committee on the impact that the completion of the Offer may have on Vigmed, especially employment, and its views on GBO’s strategic plans for Vigmed and the impact that these could have on employment and on the locations where Vigmed operates its business, as well as the Bid Committee’s view on the financing proposal announced by Beijing Topraise Medical Technology and its partner, please refer to the Bid Committee’s statements of 27 February 2017 and on 10 April 2017, which are available on https://se.vigmed.com/investor/uppkoepserbjudande.aspx. The increase of the consideration of the Offer does not change assessments and views the Bid Committee as announced previously, and, accordingly, the Bid Committee repeats, unanimously, its recommendation that the shareholders of Vigmed accept the Offer from GBO. ___________________This statement shall in all respects be governed by and construed in accordance with substantive Swedish law. Any dispute arising from this statement shall be exclusively settled by Swedish courts, and the Stockholm District Court (Sw. Stockholms tingsrätt) shall be the court of first instance.___________________Helsingborg, 20 April 2017Vigmed Holding AB (publ)The Bid Committee--------------------------This announcement was submitted for publication at 08.00 am CET on 20 April 2017.For further information, contact:Sten Dahlborg, Chairman of the Board of Directors and the Bid Committee,+46 708-369 419, budkommitte@vigmed.com ---------------------------------------------------------------------- [1] The consideration under the Offer will be reduced accordingly should Vigmed, prior to the settlement of the Offer, distribute a dividend or in any other way distribute or transfer value to its shareholders. [2] Source for Vigmed share prices: Capital IQ.[3] GBO has reserved the right to fully or partially waive this and other conditions to completion of the Offer. For further information regarding the Offer, please refer to GBOs Offer announcement. [4] The Bid Committee consists of Board Sten Dahlborg (Chairman), Thomas Baier and Axel Sjöblad, which have no conflict of interest in relation to the GBO or Offer.

Interim Report January-March 2017

First quarter 2017 compared to first quarter 2016 · Customer growth remained strong and the number of new customers was 38,400 (26,100) · Net inflow in the quarter was SEK 8,620 million, an increase of 74 per cent · Operating income increased by 9 per cent, mainly due to higher fund volumes and currency-related income as well as good activity within corporate transactions · Operating expenses increased by 13 per cent, mainly due to an increased number of employees in IT and product development · Net profit of SEK 103 million, an increase of 5 per cent, mainly due to higher income · Digital stock trading was launched on some major European exchanges, and the brokerage fee was reduced to 1 euro at the lowest · The Annual General Meeting on 21 March 2017 resolved to re-elect all members of the Board of Directors. The dividend proposal of SEK 10.50 per share was approved · After the end of the quarter, Chief Legal Officer Teresa Schechter was elected to Avanza’s Group Management and CFO Birgitta Hagenfeldt was appointed deputy CEO, succeeding Henrik Källén · Cooperation agreement with Stabelo has been signed, with the purpose of distributing mortgages to broader customer groups Quote from Johan Prom, CEO Avanza “We have had a record start to 2017 despite more intense competition in terms of price pressure and new challengers. The transformation of the financial services industry has just begun, and as consumers have more providers to choose from, they will need a better overview of their finances. We continue to improve our offering and user experience to satisfy customer needs. Avanza’s platform, customer focus and innovation capabilities are well suited to the new market climate.” Q1 Q4 Change Q1 Change  2017 2016 % 2016 %Operating income, SEK m 247 247 – 226 9Operating expenses, SEK –126 –130 –3 –112 13mOperating profit, SEK m 121 117 3 115 5Net profit, SEK m 103 101 2 98 5Earnings per share, SEK 3.46 3.39 2 3.35 3Operating margin, % 49 47 2 51 –2 Net inflow, SEK m 8,620 6,210 39 4,960 74No. new customers (net) 38,400 29,300 31 26,100 47Savings capital at the 246,300 231,000 7 188,900 30end of the period, SEKm This information is information that Avanza Bank Holding AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out below, at 08.15 (CEST) on 20 April 2017. This Interim Report is published in Swedish and English. In the event of any difference between the English version and the Swedish original, the Swedish version shall prevail.

Strong first quarter for Södra

“Södra’s first quarter was strong with increased net sales, higher earnings and an improved operating margin. Robust demand contributed to the favourable volume and price trend, and the currency trend was also positive. Based on its Group strategy, Södra will continue to strengthen and focus on increased digitisation, innovation and sustainability,” said Lars Idermark, President and CEO. “One important reason for the positive result was the improvement for the sawmill operations, where the ongoing restructuring process – with a customer and market focus, and the development of new products and services – is progressing according to plan,” said Lars Idermark. In the Södra Wood business area, earnings rose SEK 96 million to SEK 3 million (loss: 93). The Södra Cell business area was positively impacted by higher volumes due to expanded capacity at the Värö pulp mill. Earnings were also affected by favourable price levels and a positive trend for the business area’s currencies. Operating profit totalled SEK 457 million (371). The Södra Skog business area reported operating profit of SEK 16 million (18) for the first quarter. “Due to the positive trend we have seen since autumn 2016, the second quarter should also be strong. At the same time, our efficiency measures will continue with the aim of further improving profitability. However, there are still a number of geopolitical concerns and our business environment is rapidly changing,” said Lars Idermark. +-----------------------------------------+-----+-----+------------+|January-March 2017 in brief: |2017 |2016 |2016 |+-----------------------------------------+-----+-----+------------+|  |1 Jan|1 Jan|1 Jan-31 Dec|| |-31 |-31 | || |March|March| |+-----------------------------------------+-----+-----+------------+|Net sales, SEK million |5,098|4,545|18,482 |+-----------------------------------------+-----+-----+------------+|Operating profit before depreciation, |761 |484 |2,101 ||amortisation and impairment (EBITDA), SEK| | | ||million | | | |+-----------------------------------------+-----+-----+------------+|Operating profit, SEK million |451 |249 |1,005 |+-----------------------------------------+-----+-----+------------+|Profit before income tax, SEK million |430 |233 |939 |+-----------------------------------------+-----+-----+------------+|Operating margin, % |9 |5 |5 |+-----------------------------------------+-----+-----+------------+|Return on capital employed, % |11 |7 |7 |+-----------------------------------------+-----+-----+------------+ Read the complete report here  See the interview with Lars Idermark  For questions, please contact:Anna Belfrage, CFO Södra,Tel: +46 (0)470-890 40 Annica Gerentz, Director of Communications, Södra,Tel: +46 (0)470-894 81 Södra's Pressroom,Tel: +46 (0)470-890 90Email: press@sodra.com

Immunovia Interim report, January-March 2017

“During the quarter we reported from a significant study that showed our ability to differentiate between SLE and other common autoimmune diseases. The very good results of the study, which indicated that SLE can be differentiated with 96% accuracy against a mix of healthy, rheumatoid arthritis, Sjögren’s disease and vasculitis patient samples, give us a very strong reason to invest further in the autoimmune area." "Also during the quarter we identified retrospective biobanks that contain relevant and well-documented blood samples from individuals who are afflicted with pancreatic cancer after being diagnosed with diabetes, and we will now conclude an agreement giving us access to these individuals so that we can perform the retrospective study we announced earlier." "We are now planning the details of our market access program and preparing those marketing activities that will best create awareness among key decision-makers about the link between pancreatic cancer and diabetes and the possibilities that our test offer for improved survival.” Key indicators +----------------------------+--------+-------------------+--------------+|Key indicators (SEK thousand|1 Jan-31|1 Jan-31 March 2016|Full year 2016||unless otherwise stated) |March | | || |2017 | | |+----------------------------+--------+-------------------+--------------+|Net sales |28 |0 |177 |+----------------------------+--------+-------------------+--------------+|Operating earnings |-7 870 |-2 435 |-14 978 |+----------------------------+--------+-------------------+--------------+|Earnings before tax |-7 771 |-2 406 |-14 723 |+----------------------------+--------+-------------------+--------------+|Net earnings |-7 771 |-2 406 |-14 723 |+----------------------------+--------+-------------------+--------------+|Earnings per share before |-0,46 |-0,17 |-0,98 ||and after dilution | | | ||(SEK/share) | | | |+----------------------------+--------+-------------------+--------------+| | | | |+----------------------------+--------+-------------------+--------------+| |31 March|31 March 2016  |31 Dec. 2016 || |2017  | | |+----------------------------+--------+-------------------+--------------+|Equity ratio, % |97 |97 |98 |+----------------------------+--------+-------------------+--------------+|No. of shares at the end of |16 804 |14 291 216 |16 804 059 ||the period |059 | | |+----------------------------+--------+-------------------+--------------+|Average number of shares |16 804 |14 291 216 |14 985 688 ||before and after dilution |059 | | |+----------------------------+--------+-------------------+--------------+ This financial statement has been produced in accordance with IFRS for the Immunovia Group, which comprises Immunovia AB and the wholly-owned subsidiary Immunovia Inc. Outlook*Immunovia is focused on fundamentally transforming diagnosis of complex forms of cancer and autoimmune diseases. The antibody-based platform, IMMray™, is the result of 15 years of research at CREATE Health – the Center for Translational Cancer Research at Lund University, Sweden. IMMray™ is a technology platform for the development of diagnostic tests and the company’s primary test. IMMray™ PanCan –d is the first test in the world for early diagnosis of pancreatic cancer. ·  It is planned to launch IMMray™ PanCan –d on the American and European markets with sales to out-of-pocket customers, to start when the accreditation and production upscaling have been completed, with revenues expected to begin in 2018. IMMray™ PanCan –d will address a market that in total is worth around SEK 30 billion. ·  Immunovia sees great potential in the development of tests for other unsolved problems in cancer and autoimmune diseases via its IMMray™ platform. The next focus area will be tests within SLE, based on the positive results announced in early 2017.  For more information, please contact: Mats Grahn   Chief Executive Officer, CEO, Immunovia  Tel.: +46-70-5320230  Email: mats.grahn@immunovia.com  About Immunovia Immunovia AB was founded in 2007 by investigators from the Department of Immunotechnology at Lund University and CREATE Health, the Center for Translational Cancer Research in Lund, Sweden. Immunovia’s strategy is to decipher the wealth of information in blood and translate it into clinically useful tools to diagnose complex diseases such as cancer, earlier and more accurately than previously possible. Immunovia´s core technology platform, IMMray™, is based on antibody biomarker microarray analysis. The company is now performing clinical validation studies for the commercialization of IMMray™ PanCan-d that could be the first blood based test for early diagnosis of pancreatic cancer. In the beginning of 2016, the company started a program focused on autoimmune diseases diagnosis, prognosis and therapy monitoring. The first test from this program, IMMray™ SLE-d, is a biomarker signature derived for differential diagnosis of lupus, now undergoing evaluation and validation. (Source: www.immunovia.com)  This information is information that Immunovia AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above.  Immunovia’s shares (IMMNOV) are listed on Nasdaq First North in Stockholm and Wildeco is the company’s Certified Adviser. For more information, please visit www.immunovia.com.  ###

NOTE’s Interim Report January–March 2017

Financial performance January–March · Sales were SEK 277.1 (279.1) million. Excluding divestments, sales increased by 4%. · Operating profit was SEK 30.4 (14.2) million, and adjusted for non-recurring items, operating profit increased to SEK 14.7 (14.2) million. · Operating margin was 11.0% (5.1%), and adjusted for non-recurring items, operating margin expanded by 0.2 percentage points to 5.3% (5.1%). · Profit after financial items increased to SEK 29.1 (12.9) million. · Profit after tax was up to SEK 26.9 (10.2) million, corresponding to SEK 0.93 (0.35) per share. · Cash flow after investments increased to SEK 77.8 (27.1) million, or SEK 2.70 (0.94) per share. CEO’s comment”Our positive progress in the first quarter continued. We secured several new customers, as well as new and exciting projects in our already-strong customer base. Sales increased in Sweden and Finland. In China, the market for some of our major customers was cooler. However, there is good reason to believe that our sales growth in China will recover momentum going forwards. Positive is the very brisk start for our unit in Estonia, one of our larger units, this year–sales in the first quarter were at record levels. For the first quarter sales were SEK 277 million. Adjusting for the divestment of our Norwegian entity, we achieved sales growth of over 4%. Our Operating profit increased by SEK 16.2 MSEK to SEK 30.4 million. The Operating profit had positive impact from the divestment of industrial property, and negative from restructuring costs, primarily at one of our Swedish sites. Adjusting for these non-recurring items, underlying Operating profit increased by SEK 0,5 million to SEK 14.7 million, and operating margin expanded by 0.2 percentage points to 5,3%, which was positive. Including the property sale, our cash flow after investments increased some SEK 50 million to SEK 77,8 million, or SEK 2.70 per share. We are well placed financially for the future–our Balance Sheet remains one of the sector’s strongest with an equity to assets ratio of 45.2%”, says Stefan Hedelius, CEO and President. NOTE’s Interim Report for January–March is now available in PDF format on the corporate web site, www.note.eu, and attached to this message. The Interim Report for January–June will be published on 17 July.  For more information, please contact:Stefan Hedelius, CEO and President, tel. +46 (0)76 100 0731Henrik Nygren, CFO, tel. +46 (0)70 977 0686 About NOTENOTE is one of the leading Northern European manufacturing and logistics partners for production of electronics-based products. NOTE produces PCBAs, subassemblies and box build products. NOTE's offering covers the complete product lifecycle, from design to after-sales. NOTE has a presence in Sweden, Finland, the UK, Estonia and China. Net sales in the last 12 months were SEK 1,096 million; the group has approximately 900 employees. NOTE is listed on Nasdaq Stockholm. For more information, please go to www.note.eu. This information is information that NOTE AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of Stefan Hedelius, at 8:30 a.m. CET on 20 April 2017. 

Episurf Medical AB’s 2016 annual report is now available

Episurf Medical’s annual report for 2016 is available as of today at the company’s website, www.episurf.com. Episurf Medical has of environmental and cost reasons chosen not to print the annual report. A printed version of the annual report will be distributed to shareholders and others who made such request. The annual report can also be ordered from Episurf Medical on the following address: Episurf Medical AB Karlavägen 60 114 49 Stockholm Sweden Or by email: ir@episurf.com For more information, please contact: Pål Ryfors, acting CEO, Episurf Medical  Tel: +46 (0) 709 62 36 69 Email: pal.ryfors@episurf.com About Episurf Medical Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and personalized treatment alternatives. Episurf Medical’s Episealer® personalized implants and Epiguide® surgical drill guides are developed for treating localized cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com. This information is information that Episurf Medical AB (publ) is obliged to make public pursuant to the Securities Markets Act. The information was submitted, through the agency of the contact person set out above, for publication at 8.30 CET on 20 April 2017.

Notice of Annual General Meeting of Episurf Medical AB (publ)

Notice of attendance, etc. Shareholders who wish to attend and vote at the Meeting must be registered in the share register maintained by Euroclear Sweden AB on Tuesday 16 May 2017, and no later than on Tuesday 16 May 2017 give notice of attendance via the Company’s website, www.episurf.com, or by post to Episurf Medical AB (publ), Karlavägen 60, 114 49 Stockholm, Sweden. Notice of attendance must be received by the Company no later than on Tuesday 16 May 2017. Notification shall include the shareholder’s name, personal identification number/corporate registration number and daytime telephone number. The notice of attendance shall also include the number of accompanying advisors (not more than two) who are attending the Meeting. Shareholders who are represented by a proxy must submit a dated and signed power of attorney. The original of the power of attorney and, for legal entities, a certified copy of a certificate of registration, should be sent to the Company at the postal address above in ample time prior to the Meeting. The power of attorney may not be valid for a longer period than one year from its issuance. However, the power of attorney may be valid for up to five years from its issuance if so explicitly stated.  A form of power of attorney is available on the Company’s website, www.episurf.com. Shareholders whose shares are registered in the name of a nominee must temporarily re-register their shares in their own name to be entitled to participate at the Meeting. Such registration must be completed at Euroclear Sweden AB no later than on Tuesday 16 May 2017. The nominee should therefore be instructed well in advance of this date. Proposed agenda 1)                  Opening of the Meeting 2)                  Appointment of a chairman of the Meeting 3)                  Preparation and approval of the voting list 4)                  Election of one or two persons to approve the minutes of the Meeting 5)                  Approval of the agenda 6)                  Determination of whether the Meeting has been duly convened 7)                  Presentation of the annual accounts and the auditors’ report and the consolidated accounts and the auditors’ report on the consolidated accounts 8)                  Presentation by the CEO, and shareholders’ questions to the Board of Directors and management of the Company 9)                  Resolution on: a)                   adoption of the income statement and the balance sheet and the consolidated income statement and balance sheet b)                  allocation of the result of the Company in accordance with the adopted balance sheet c)                   discharge of liability for the members of the Board of Directors and the CEO 10)              Resolution on the number of members of the Board of Directors 11)              Determination of fees for the members of the Board of Directors and auditor 12)              Election of members of the Board of Directors, chairman of the Board of Directors and auditor. 13)              Resolution on the Nomination Committee for the annual general meeting of 2018 14)              Resolution regarding guidelines for remuneration to the senior management 15)              Resolutions on: a)                   adoption of an employee stock option and warrant programme b)                  an issue of warrants of series 2017/2020(A) c)                   an issue of warrants of series 2017/2020(B) and approval of transfers of warrants of series 2017/2020(B) 16)              Resolution regarding authorisation for the Board of Directors to resolve on new issues of shares 17)              Closing of the Meeting Proposals for resolutions Proposals from the Nomination Committee under item 2 and 10-13 The Nomination Committee, established in accordance with the principles adopted at the annual general meeting of 2016, appointed by the three, in terms of votes, largest shareholders makes the following proposals under items 2, 10, 11 and 12. · Advokat Carl Westerberg is proposed to be appointed as chairman of the Meeting · The Board of Directors is proposed to consist of six members with no deputy members. · Proposed re-election of Dennis Stripe, Saeid Esmaeilzadeh, Wilder Fulford, Christian Krüeger and Leif Ryd and election of Laura Shunk as members of the Board of Directors until the end of the next annual general meeting. Wil Boren has informed the Nomination Committee that he is not available for re-election. · Proposed re-election of Dennis Stripe as Chairman of the Board of Directors until the end of the next annual general meeting. · Total fees of SEK 1,100,000 are proposed to be paid to the Board of Directors, of which SEK 400,000 are proposed to be paid to the Chairman of the Board of Directors, SEK 200,000 are proposed to be paid to each of Wilder Fulford and Laura Shunk and SEK 100,000 are proposed to be paid to each of Saeid Esmaeilzadeh, Leif Ryd and Christian Krüeger. No fees are proposed to be paid for committee work. · Proposed re-election of KPMG AB as auditor of the Company until the end of the next annual general meeting. Should the proposal be adopted, KPMG intends to appoint Duane Swanson as auditor in charge. · Auditors’ fees are proposed to be payable in accordance with approved invoice. Laura Shunk is a senior and founding partner in the law firm of Hudak, Shunk and Farine, Co LPA in Cuyahoga Falls, Ohio, USA, where she has practiced in the field of Intellectual Property Law since 1987.  Laura’s career has included patent and trademark prosecution work focused in the healthcare and medical device field with representations including InvaCare, Cross Medical, Biomet, OrthoHelix Surgical Designs, Tornier, and Wright Medical. The Nomination Committee proposes that the Meeting resolves on the following principles for appointing the Nomination Committee for the next annual general meeting. The Nomination Committee shall consist of four members. The three, in terms of votes, largest shareholders/owner groups (the “Largest Shareholders”) as per 31 August the year prior to the next annual general meeting, according to the list of shareholders in the share register maintained by Euroclear Sweden AB or that in another way are proved to be one of the Largest Shareholders, are entitled to appoint one member of the Nomination Committee each. In addition, the chairman of the Board of Directors shall be appointed as member of the Nomination Committee. The chairman of the Board of Directors shall summon the Largest Shareholders by 15 October the latest. If any of these shareholders waive their right to appoint a member of the Nomination Committee, the next shareholder/owner groups in order of size shall be given the opportunity to appoint a member of the Nomination Committee. The CEO or any other person from the senior management shall not be a member of the Nomination Committee. The chairman of the Board of Directors shall summon the Nomination Committee’s first meeting. The chairman of the Board of Directors shall not be appointed chairman of the Nomination Committee. The Nomination Committee’s term of office extends until a new Nomination Committee is appointed. The composition of the Nomination Committee shall be made public no later than 6 months before the annual general meeting. If it becomes known that a shareholder that has appointed a member of the Nomination Committee, as a result of changes in the said owner’s shareholdings or due to changes in other owners’ shareholdings, is no longer one of the Largest Shareholders, the committee member who was appointed by said shareholder shall, if the Nomination Committee so decides, resign and be replaced by a new member appointed by the shareholder who at the time is the largest registered shareholder that has not already appointed a member of the Nomination Committee. If the registered ownership structure is otherwise significantly changed prior to the completion of the Nomination Committee’s work, the composition of the Nomination Committee shall, if the Nomination Committee so decides, be changed in accordance with the above stated principles. The tasks of the Nomination Committee shall be to prepare, for the next annual general meeting, proposals in respect of number of directors of the Board of Directors, remuneration to the Chairman of the Board of Directors, the other directors of the Board of Directors and the auditors respectively, remuneration, if any, for committee work, the composition of the Board of Directors, the Chairman of the Board of Directors, resolution regarding the Nomination Committee, chairman at the annual general meeting and election of auditors. The Company shall pay for reasonable costs that the Nomination Committee has considered to be necessary in order for the Nomination Committee to be able to complete its assignment. Proposal under item 14; Resolution regarding guidelines for remuneration to the senior management The Board of Directors of Episurf Medical AB (publ) proposes that the meeting resolves on the following guidelines for remuneration to the senior management for the period until the annual general meeting of 2018. Compensation and conditions of employment for the senior management, by which is meant the Chief Executive Officer, the Chief Financial Officer and the Chief Operating Officer, Head of Quality & Regulatory Affairs, Sales Director and Marketing Director shall be designed to ensure the Company’s access to executives with the right set of skills. The remuneration shall consist of a fixed salary, a possible variable compensation, an incentive program and other benefits including a company car and pension. The remuneration shall be on market terms and competitive, and be related to the executive’s responsibilities and authorities. Any variable remuneration shall be related to established, well-defined objectives and to the fixed salary and shall be limited to a maximum amount equivalent to 6 month’s salary (gross). Besides from the CEO, no other senior executive or other employee is entitled to severance pay. The Board of Directors is given the possibility to deviate from the above guidelines in individual cases should special reasons justify this. If this is the case, the information and the reasons for the deviation shall be reported at the next annual general meeting. Proposal under item 15; Resolution on (a) adoption of an employee stock option and warrant programme, (b) an issue of warrants of series 2017/2020(A), and (c) an issue of warrants of series 2017/2020(B) and approval of transfers of warrants of series 2017/2020(B) Proposal under item 15(a); Resolution on adoption of an employee stock option and warrant programme General The Board of Directors proposes that the Meeting resolves to adopt an employee stock option and warrant programme for the employees of the Company and its subsidiaries (the “Programme”). The rationale for the proposal is to achieve optimum alignment of interests between the employees and the shareholders in Company, to create conditions for retaining and recruiting competent personnel to the Episurf group and to drive performance among the employees. The Board of Directors is of the opinion that the Programme is in the favour of Episurf and its shareholders. The Programme means that the participants will, in accordance with the below (i) be entitled to subscribe for a certain number of warrants of series 2017/2020 (A) (the “Incentive Warrants”) for a price calculated in accordance with the below, and (ii) be allotted a certain number of employee stock options (the “Stock Options”) free of charge. The Programme is proposed to comprise all employees in the Episurf group as of the date of this notice (27 persons). No more than 117,400 Incentive Warrants and no more than 513,700 Stock Options will be issued. This implies a maximum dilution of 2.0 per cent of the share capital and 1.4 per cent of the votes in the Company. Allocation, etc. The Incentive Warrants shall be allocated in accordance with the following. a)                  the acting CEO is entitled to subscribe for up to 15,000 Incentive Warrants; b)                  the other members of the senior management (four persons) are entitled to subsribe for 8,000 Incentive Warrants each (i.e. a total of 32,000 Incentive Warrants); c)                  the other participants (22 persons) are entitled to subscribe for 3,200 Incentive Warrants each. (i.e. a total of 70,400 Incentive Warrants). The Stock Options shall be allocated in accordance with the following. Each participant is proposed to be allotted, free of charge: a)                  6,000 Stock Options (except the acting CEO, who is alloted 10,000 Stock Options), plus b)                  350 Stock Options per month he or she has been employed by the Episurf group, plus c)                  one (1) Stock Option for each Employee Warrant subscribed for in accordance with the below. Stock Options Provided that the participant is still employed by the Episurf group at the exercise of the options, each Stock Option entitles the employee to purchase one share of series B in the Company during the period from and including 1 June 2020 until and include 31 May 2021. The price for the shares of series B shall be equal to an amount corresponding to 130 per cent of the average volume weighted share price for the Company’s share of series B on Nasdaq Stockholm during the period from and including 15 May 2017 until and including 19 May 2017 (the “Calculation Period”), provided however that the purchase price shall never be less than the quota value of the share. The Stock Options may not be transferred or pledged. In case of special circumstances, the Board of Directors shall be authorised to resolve that Stock Options may be kept and exercised despite the fact that the employment in the Episurf group has ceased, for example due to illness. The Board of Directors shall be entitled to make adjustments to the Programme if significant changes in the Episurf group, or its markets, result in a situation where the decided terms and conditions for exercising the Stock Option are no longer appropriate. Incentive Warrants The Incentive Warrants are issued for a price corresponding to the Incentive Warrants’ market value calculated according to the Black & Scholes formula based on the volume-weighted average of the price for the Company’s share of series B on Nasdaq Stockholm during the Calculation Period. Each Incentive Warrant entitles its holder to subscribe for one (1) share of series B in the Company during the period from and including 1 June 2020 until and including 31 may 2021 for a subscription price corresponding to 130 per cent of the volume-weighted average of the price for the Company’s share of series B on Nasdaq Stockholm during the Calculation Period. Proposal under item 15(b); Resolution on an issue of warrants of series 2017/2020(A) As further described under item 15(a) above, the Board of Directors proposes that the Company shall issue a maximum of 117,400 Incentive Warrants. The right to subscribe for the Incentive Warrants shall, with deviation from the shareholders’ preferential rights, belong to employees of the Episurf group. Subscription of the Incentive Warrants shall take place on a separate subscription list not later than 30 June 2017. Payment shall be made no later than on the same date. The increase of the Company’s share capital will, upon exercise of the Incentive Warrants, amount to not more than approximately SEK 35,249.81 calculated as per the date of this notice. Proposal under item 15(c); Resolution on an issue of warrants of series 2017/2020(B) and approval of transfers of warrants of series 2017/2020(B) To ensure delivery of shares to holders of Stock Options, the Board of Directors proposes that the Company shall issue a maximum of 513,700 warrants of series 2017/2020(B) (“Hedge Warrants”). The right to subscribe for the Hedge Warrants shall, with deviation from the shareholders’ preferential rights, belong to Episurf Operations AB (the “Subsidiary”), a wholly-owned Swedish subsidiary of the Company. The Hedge Warrants shall be issued to the Subsidiary without compensation and subscription shall take place on a separate subscription list not later than on 30 June 2017. Each Hedge Warrants entitles the holder to subscribe for one new share of series B in the Company during the period from and including 1 June 2020 up until and including 31 May 2021. The subscription price shall be equal to an amount corresponding to 130 per cent of the volume-weighted average of the price for the Company’s share of series B on Nasdaq Stockholm during Calculation Period. The increase of the Company’s share capital will, upon exercise of the Hedge Warrants, amount to not more than approximately SEK 154,240.45 calculated as per the date of this notice. The Board of Directors finally proposes that the meeting approves that up to 513,700 Hedge Warrants during the period from and including 1 June 2020 up until and including 31 May 2021 are transferred by the Subsidiary to participants in the Programme or to third parties in order to ensure delivery of shares of series B pursuant to the Stock Options. Majority requirements and conditions, etc. The Board of Directors proposals for resolution pursuant to item 15(a)–(c) above constitute a ”package”, since the various proposals are dependent on and strongly tied to each other. On account of this, it is proposed that the Meeting only pass one resolution in relation to the above-mentioned proposals with observance of the majority rules that are stated in Chapter 16 of the Swedish Companies Act, meaning that the resolution must be supported by shareholders representing at least nine tenths of both the votes cast and of the shares represented at the Meeting. Proposal under item 16; Resolution on authorising the Board of Directors to resolve on new issues of shares The Board of Directors proposes that the Meeting authorises the Board of Directors during the period until the next annual general meeting, on one or more occasions, to resolve on a new issue of shares of series A or series B with or without deviation from the shareholders’ preferential rights. The number of shares, issued by virtue of authorisation of the AGM, shall be equivalent to a maximum of 10 (ten) per cent of the total number of shares at the date of the Meeting. The board shall be authorised to resolve that shares issued pursuant to the authorisation, wholly or partly, shall be subscribed for against payment in cash, in kind or by right of set-off. New shares issued by virtue of authorisation shall be issued at market terms and shall be used by the Company as payment in connection with acquisition of shares or assets or participations in legal entities or in order to capitalise the Company before such acquisition or capitalise the Company in other respects. A valid resolution under this item must be supported by shareholders representing at least two-thirds of the votes cast as well as the shares represented at the Meeting. Miscellaneous On the date of this notice, the total number of shares in Episurf is 30,549,495, of which 6,386,468 are shares of series A with three votes each, and 24,163,027 are shares of series B with one vote each. Accordingly, the total number of votes amounts to 43,322,431. The Company does not hold any shares in treasury. The Nomination Committee’s complete proposals are, together with the annual report and the auditors’ report, available at the Company’s website www.episurf.com and at the Company’s head of office at Karlavägen 60, 114 49 Stockholm, Sweden. A proxy form as well as the Board of Directors’ complete proposals and reports prepared in accordance with the Swedish Companies Act will not later than 28 April 2017 be available to the shareholders on the Company’s website and at the Company’s head office. All documents will also be sent free of charge to those shareholders who so request and provide the Company with their address. The shareholders are informed of their right to request information from the Board of Directors and the CEO at the Meeting in accordance with Chapter 7, Section 32 of the Swedish Companies Act. Welcome! Stockholm in April 2017 The Board of Directors www.episurf.com For more information, please contact: Pål Ryfors, acting CEO, Episurf Medical  Tel: +46 (0) 709 62 36 69 Email: pal.ryfors@episurf.com About Episurf Medical Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and personalized treatment alternatives. Episurf Medical’s Episealer® personalized implants and Epiguide® surgical drill guides are developed for treating localized cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com.

Crown Energy signs agreement with Proger, a major International Engineering Company for technical work on the Iraq project

Proger has over 60 years’ experience in the engineering and construction industries and has a number of major oil industry clients for whom it has provided significant services. Proger has over the past years developed a significant expertise and operating experience in Iraq and throughout the Middle East. Proger is ready to assist Crown Energy from the ground up in providing the full complement of support services needed to complete an oil and gas development and production project. Proger is keen on exploring the potential of our Iraqi Licence and to get involved in its development. We are very much looking forward to having a strong relationship with Proger which will be to the benefit of Crown Energy and our shareholders. About Proger Founded in Italy in 1951 in Pescara (Italy) and ranked number one in Italy last year, Proger SpA provides Engineering & Management and EPC services in a range of Civil, Energy and Oil & Gas sectors with more than 1,300 employees in 15 countries and a consolidated turnover of 125 million Euros in 2016. For more information on Proger S.p.A. please see their website: www.proger.it ----------------------------------- This information is information that Crown Energy AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below, at 8:45 AM CET on 20 April 2017.  MORE INFORMATION Please contact Andreas Forssell, CEO, Crown Energy AB +46 8 400 207 20 +46 760 15 15 95 ABOUT CROWN ENERGY Crown Energy is an international oil and gas company engaged in exploration in Africa and Middle East. Growth is created by developing assets in early stages and then maximising value by introducing appropriate industry partners in the development and production stages. For more information please visit www.crownenergy.se.

ExpreS2ion signs commercial license agreement with ABIVAX for using the ExpreS2 platform in their Ebola program

The Agreement ExpreS2ion and ABIVAX have signed a non-exclusive license agreement for the commercial exploitation of ExpreS2ion’s Drosophila S2 protein expression system, ExpreS2. ABIVAX is thereby granted rights to commercially develop ABX544 using ExpreS2ion’s proprietary technology, ExpreS2. The financial terms of the agreement are not disclosed. ABX544 – a novel prophylactic and therapeutic treatment of Ebola Ebola virus causes severe and often fatal illness in humans, as demonstrated by the 2014/15 outbreak in Africa, causing disease in >28,000 of which >11,000 died. There is currently no licensed Ebola vaccine or specific treatment on the market. The ABX544 program aims at creating an Ebola anti-serum, containing neutralising antibodies produced in animals. In contrast to vaccines, which takes time to raise a protective immune response, ABX544 will have immediate effect upon administration. It will thereby constitute a “first line of defence” for infected individuals and health care personnel during epidemic outbreaks. Following the preclinical evaluation and toxicology, ABIVAX plans to bring ABX544 into clinical trials. Dr. Steen Klysner, CEO, ExpreS2ion, commented: “I am pleased to see ABIVAX’s exciting ‘first line of defence’ program for Ebola proceed to the next level.  We have worked intensely on the program since initiation of the collaboration in 2016 and it is due to the successful outcome of this, that ABIVAX is now ready to advance the project under a commercial license to the ExpreS2system, including potential future milestones and royalties”.  About ABIVAX ABIVAX (Euronext Paris: FR0012333284 – ABVX) is an innovative biotechnology company focused on targeting the immune system to eliminate viral disease. ABIVAX leverages three technology platforms for drug discovery: an anti-viral, an immune enhancement, and a polyclonal antibody platform. ABX464, its most advanced compound, is currently in Phase II clinical trials for providing a functional cure for patients with HIV/AIDS. In addition, ABIVAX is advancing a clinical stage immune enhancer as well as multiple preclinical candidates against additional viral targets (i.e. Chikungunya, Ebola, Dengue). Certified Advisor Sedermera Fondkommission is appointed as Certified Adviser for ExpreS2ion Biotech Holding AB. 

Seamless launches Micro Credit service for airtime resellers

PRESS RELEASE Seamless Distribution Systems (SDS) announces the launch of Micro Credit service for resellers of mobile airtime. It is the first of its kind service that provides a unique value proposition of business continuity and improved market penetration by enhancing resellers’ ability to always provide topup. This service will be introduced to the market, enabling resellers to continue providing electronic airtime topup even when they do not have adequate prepaid airtime credit available. The Micro Credit Service from Seamless Distribution Systems improves market penetration and ensures continued satisfaction by providing enhanced control over Airtime Distribution. The product is tightly coupled to the ERS 360º e-recharge ecosystem with integrations towards the Online Charging System and has in-built strong analytics / report management to strengthen the offering. Micro Credit allows participants in the program to continue to offer services even when normal channels for inventory purchase are unavailable. The service profiles all participants based on their real time usage and offers customized micro credit for each participant where credit ranges may vary based on advanced profiling and risk mitigation algorithms. This service allows participants to receive commissions for every sale with a variable incentive program calculated on the risk profile and the sale pattern for every participant. SDS bears all the credit risk and associated costs and charges a commission on the credit purchased directly to the operator. This service leverages on the quality of service distribution model provided by Seamless and offers a Win-Win opportunity for operators where they can enhance their offering towards their sales workforce without incurring any additional risk or costs. “This leading-edge and innovative venture has further strengthened SDS’ position in the domain of digital distribution for prepaid markets. Looking beyond the obvious, we have catered to the latent needs of our stakeholders. The service is extended and added to the portfolio of telecom operators without any cost or risk implication,” says Tommy Eriksson, CEO of Seamless Distribution Systems. About Seamless  Seamless is one of the world’s largest suppliers of payment systems for mobile phones. Founded in 2001 and active in 35 countries, Seamless handles more than 5.3 billion transactions annually through 675 000 active sales outlets. Seamless has three main business areas including the transaction switch, the technology provider for the distribution of e-products and the mobile payment platform Seqr. www.seamless.se Seamless Distribution AB, Box 6234, 102 34 Stockholm | Visiting address: St Eriksgatan 121 D | Org. no: 556610-2660 Phone: 08-564 878 00 | Fax: 08-564 878 23 | www.seamless.se

Automotive manufacturer Plastic 7A opts for IFS Applications to modernize production

Plastic 7A, manufacturer of plastic components for the automotive industry with customers such as Audi, Opel, Seat, Ford, Bentley, Lamborghini and Porsche, has experienced tremendous growth in recent years. The expanded company structure called for a more powerful, robust and scalable ERP solution that could enable it to grow rapidly and profitably. After considering providers such as SAP and QAD, Plastic 7A opted for the integrated IFS solution. The new system offers comprehensive support for the company's modernization needs and facilitates the implementation of lean systems and compliance with IATF standards, which are essential requirements for companies in the automotive supply chain. In addition to streamlining its decision-making process, Plastic 7A expects a reduction in ERP maintenance costs and a significant improvement in reporting and KPI achievement. “We are convinced that IFS Applications will be a key contributing factor in the growth of Plastic 7A,” said Carlos González, CEO, Plastic 7A. Gustavo Brito, CEO of IFS in Spain and Portugal, added, “With Plastic 7A, IFS has strengthened its position as a leading software provider in the automotive industry. Our experience from working with companies such as Grupo Borgstena and Manufactura Moderna de Metales, coupled with the extensive industry knowledge of our partner SII Concatel, will make the project a success.” IFS and SII Concatel will implement IFS Applications across four Plastic 7A plants in Valencia, Spain. More information about how IFS supports companies in the automotive industry can be found here: www.ifsworld.com/corp/industries/automotive/.

Nel ASA: Signed final joint venture agreement with Hexagon Composites and PowerCell

(Oslo, 20 April 2017) Nel ASA (Nel, OSE:NEL) announced today that the Nel has finalised the joint venture agreement with Hexagon Composites ASA and PowerCell Sweden AB to establish a Joint Venture for the development of integrated hydrogen projects, the joint owned company will be setup as soon as practically possible. ”We have received numerous requests for projects since we announced the intention to join forces with PowerCell and Hexagon Composites for establishing our joint entity. By working with these global market leaders, we will be able to utilise each party’s respective technologies and competencies to develop world-class, integrated hydrogen solutions. The Joint Venture will have an initial focus on opportunities in the maritime and marine segments, as well as projects to leverage on renewable energy resources,” says Jon André Løkke, Chief Executive Officer of Nel. The Joint Venture will be equally owned by Nel, Hexagon Composites ASA and PowerCell Sweden AB, and will create a one-stop-shop for customers wanting to utilise hydrogen technologies across the value chain: From renewable hydrogen production, to storage, distribution and dispensing, to generating electricity via fuel cells. The jointly-owned entity will manage and develop the projects to ensure that technologies from the partners are effectively integrated into complete and optimal solutions for the customer. “After deciding to establish the Joint Venture we have been energised by working with our new partners over the last few months identifying joint business opportunities. Combined with the project requests we have already received, ranging from governmental organizations to marine transportation companies, we see significant opportunities for the Joint Venture and believe the company is positioned to deliver unparalleled customer value in the form of zero-emission power solutions,” Løkke concludes. Hexagon Composites ASA is a global market leader for storage and transport of gases under high pressure, while PowerCell is a leading fuel cell company developing and producing environmentally friendly power systems for stationary and mobile customer applications. ENDS For further information, please contact: Jon André Løkke, CEO, +47 9074 4949 Bjørn Simonsen, VP Market Development and Public Relations, +47 971 79 821 About Nel ASA | www.nelhydrogen.com       Nel is a global, dedicated hydrogen company, delivering optimal solutions to produce, store and distribute hydrogen from renewable energy. We serve industries, energy and gas companies with leading hydrogen technology. Since its foundation in 1927, Nel has a proud history of development and continual improvement of hydrogen plants. Our hydrogen solutions cover the entire value chain from hydrogen production technologies to manufacturing of hydrogen fueling stations, providing all fuel cell electric vehicles with the same fast fueling and long range as conventional vehicles today. About PowerCell Sweden AB (publ) |www.powercell.se  PowerCell Sweden AB (publ) is the leading fuel cell company in the Nordics, which develops and produces environmentally friendly power systems for stationary and mobile customer applications. PowerCell Sweden AB (publ) is listed on First North at Nasdaq Stockholm and is an industrial spinout from the Volvo Group. G&W Fondkommission is appointed Certified Adviser by the Company. Among the largest owners are Midroc New Technology, Fouriertransform, Finindus and Volvo Group Venture Capital. About Hexagon Composites ASA | www.hexagon.no Hexagon Composites ASA is a publicly listed company with its headquarters in Aalesund, Norway. The Group develops and produces composite pressure cylinders and systems for storage and transportation of various gases. It is the global leader in CNG road transportation.

The biggest wheel loader bucket in China

The first bucket is being used with one of Joy Global’s wheel loaders in the Eastern Open Pit Mine in Shuozhou, Shanxi, which is the biggest coal producing area of China. As the strategic partner and bucket supplier of the end-user, XCMG knew that to meet the end-user’s requirement and to have better performance in the coal mine, a bucket must stand up to tough working conditions and have maximum lifetime. “The original bucket had worn out and the end-user needed a reliable replacement. We have been using Hardox wear plate and Strenx high strength steel for years, but it’s the first time that we worked together with SSAB’s K1 service center in Kunshan. After having the design drawings of the bucket, K1 developed the entire solution recommending steel grades, thicknesses and welding procedures. We welded based on all the ready-made components provided by K1,“ says After-Market Service Engineer Cai Tuo of the Earthmoving Division of XCMG. The benefits – better wear life The first bucket with Hardox 450 in the main body, Hardox 400 in the side bars and Strenx 700 in the structural part of the main body has been used in the coal mine for 3 months (2,000 working hours). The measuring result showed the wear loss to be 2 mm, when the original thickness of the edge plate was 80 mm. The service life was expected to exceed 5 years, compared to 3 years for the previous bucket. “The stable quality of Hardox wear plate and Strenx performance steel, together with the great service of SSAB Shape, brought superior wear performance to the product,” continues Cai Tuo. The clear customer benefit was an increase of 70% in overall bucket lifetime using Hardox wear plate and Strenx performance steel. All bucket components were made in SSAB’s K1 service center in Kunshan and the components were welded in XCMG’s own factory. XCMG is one of China’s biggest construction machinery manufacturers and the world’s 5th largest. Joy Global Inc. is a worldwide leader in high-productivity mining solutions. 

Invitation to the presentation of Gjensidige’s results for the 1st quarter

Gjensidige Group (OSE:GJF) will publish the results for the 1st quarter on 4 May at 7.00 CET. 4 May (Oslo)CEO Helge Leiro Baastad and CFO Jostein Amdal will present the results via webcast and conference call. 9.00 CETCombined webcast and conference call with presentation of the results. The presentation will be held in English followed by a Q&A session. The webcast can be viewed live on www.gjensidige.no/ir. Participants who would like to ask questions should dial in using one of the telephone numbers below. A replay of the presentation and Q&A session will be made available on www.gjensidige.no/ir. Dial-in details for the Q&A session: Conference ID: 5101985Norway: +47 800 51084UK/ Europe: +44 (0) 800 279 6839USA: +1 (1) 888-394-8218 Other locations: Choose one of the above Confirmation code: 5101985  A replay is available from 4 May at approx. 12.00 CET.Replay phone number: +47 23 50 00 77Replay passcode: 5101985 The full presentation can also be listened to live by dialling in using the same details as above.  10.30 CETCFO Jostein Amdal will be available for a Q&A session for sell-side analysts at Gjensidige’s head office, Schweigaards gate 21 in Oslo. Sell-side analysts who wish to attend the Q&A session are requested to register by e-mail to ir@gjensidige.no by the end of business day 3 May. 9 May (London)CEO Helge Leiro Baastad and CFO Jostein Amdal will present the results in London on 9 May, together with EVP Private Krister Aanesen and EVP Analytics, Product and Price Catharina Hellerud. Pareto Securities will organise investor meetings for Gjensidige in London. 14.30 GMTCEO Helge Leiro Baastad, CFO Jostein Amdal, EVP Private Krister Aanesen and EVP Analytics, Product and Price Catharina Hellerud will be available for a Q&A session for sell-side analysts at Pareto Securities offices, 11 Berkeley Street, W1J, London – 3rd Floor.  Sell-side analysts who wish to attend the group presentation are requested to register by contacting Henriette Christensen at Pareto Securities by email to henriette@paretosec.com or phone (+47) 92 23 44 46, by the end of business day 5 May. For more information about Gjensidige, please visit www.gjensidige.no/group. Contact persons, Gjensidige Forsikring ASA:Head of Investor Relations: Janne Flessum, tel.: +47 915 14 739Head of Media Relations: Øystein Thoresen, tel.: +47 952 33 382

AAK’s Interim report for the first quarter 2017 – all-time high operating profit for a first quarter

· Operating profit reached SEK 431 million (381), an improvement of 13 percent. The currency translation impact was SEK 7 million, mainly related to Chocolate & Confectionery Fats. · Ramp-up costs for the greenfield projects in Brazil and China have, according to plan, been absorbed in the reported profit. · Total volumes continued to grow nicely and were up 10 percent (5). Organic volume growth was 5 percent (0). The demand for speciality and semi-speciality products continued to be strong and generated organic volume growth of 6 percent (2). · Food Ingredients improved by 9 percent, reaching SEK 249 million (229). However, the picture between the different segments was mixed: · The Dairy segment continued the strong trend from 2016 and reported high double-digit organic volume growth. North Latin America, Asia, and the US showed particularly strong growth. · After some challenging quarters the Bakery segment was back to organic growth in several important regions, however the European market remained a challenge. · Special Nutrition reported medium single-digit volume growth, but with a significantly better product mix compared to the corresponding quarter last year. This was driven by a continued volume growth for our Infant Nutrition product range Akonino®, building on exceptionally strong volume growth last year. Our other Infant Nutrition product range InFat®, sold through Advanced Lipids AB, a joint venture of AAK and Enzymotec, had a strong volume growth in the quarter. · Foodservice reported declining volumes in the quarter. This was mainly due to more challenging market conditions in Europe. · Chocolate & Confectionery Fats reported a result of SEK 196 million (159), an improvement of 23 percent. Both total volume growth and organic volume growth was 17 percent in the quarter. There was continued strong organic volume growth for both speciality and semi-speciality products, with several showing exceptional volume growth – in mature as well as in emerging markets.  · Technical Products & Feed reached SEK 19 million (29). Pressure from higher raw material prices had an unfavorable impact on operating profit for the fatty acids business, combined with last year’s corresponding quarter being exceptionally strong for the fatty acids business.  · Earnings per share increased by 16 percent, to SEK 6.47 (5.56), despite increased earnings in countries with high tax rates.  · Operating cash flow including changes in working capital amounted to negative SEK 408 million (negative 16). As previously predicted, cash flow from working capital was negative, amounting to SEK 740 million (negative 380). Increased raw material prices, strong organic volume growth and working capital tied up for the two greenfield investments, continued to have a negative impact on working capital. There has been a slight decrease in raw material prices during the first quarter which will have a positive impact during the second half of the year.  · Calculated on a rolling 12 months basis, Return on Capital Employed (ROCE) was 15.6 percent (15.8 at December 31, 2016).  · Our greenfield project in Brazil is progressing according to plan.   · The first very limited volumes from our new factory in China have been delivered during the first quarter. To be able to deliver the whole product range a gradual ramp-up will continue during the upcoming quarters.  · Our new company program, The AAK Way, will guide us up through 2019. Our key focus with the program is to enable the company to continue to deliver strong organic growth. This will be achieved by focusing on five priority areas: Go to Market, Operational Excellence, Special Focus Areas, Innovation and People. The implementation of the program is developing according to plan. Concluding remarks:“Based on AAK’s customer value propositions for health and reduced costs, and our customer product co-development and solutions approach, we continue to remain prudently optimistic about the future. The main drivers are the continued positive underlying development in Food Ingredients and the continued improvement in Chocolate & Confectionery Fats.”The Interim report for the first quarter 2017 will be presented today, April 20, 2017 at 1 p.m. CET at a Press & Analyst telephone conference. For participation, please see instructions under the Investor tab at the AAK website, www.aak.com.For further information, please contact:Fredrik Nilsson        CFO                Mobile: +46 708 95 22 21        E-mail: fredrik.nilsson@aak.comThis information is information that AAK AB (publ.) is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Act. The information was submitted for publication, through the agency of the contact person set out above, at 11:00 a.m. CET on April 20, 2017.AAK is a leading provider of value-adding vegetable oils & fats. Our expertise in lipid technology within foods and special nutrition applications, our wide range of raw materials and our broad process capabilities enable us to develop innovative and value-adding solutions across many industries – Chocolate & Confectionery, Bakery, Dairy, Special Nutrition, Foodservice, Personal Care, and more. AAK’s proven expertise is based on more than 140 years of experience within oils & fats. Our unique co-development approach brings our customers’ skills and know-how together with our own capabilities and mindset for lasting results. Listed on the NASDAQ OMX Stockholm and with our headquarters in Malmö, Sweden, AAK has 20 different production facilities, sales offices in more than 25 countries and more than 3,000 employees. We are AAK – The Co-Development Company.

SAS introduces new route to Eilat

A new route between Stockholm and Eilat starts on October 28 as part of SAS’ winter program for 2017/2018, with departures weekly on Saturdays during the period of 28th of October to March 24th 2018. -          SAS continues the launch of new routes to popular destinations to improve the offer to our travelers. We are adding a new direct route to Eilat, as part of our latest news in our winter program. Eilat is a destination where Swedish tourists have been traveling for decades, says Anders Wahlström, Head of Sales, Sweden. Eilat is a popular city located by the Red Sea on the south coast of Israel. The city offers its visitors white beaches, coral reefs and deserts as well as night life. -          We welcome the decision of SAS to operate a direct flight from Stockholm to Eilat. This decision was made with the cooperation and the encouragement and support of the Israeli Ministry of Tourism. We have set ourselves the goal of bringing direct routes to Israel, and we are witnessing the extraordinary momentum of airlines arriving to Israel and bringing a record numbers of tourists. We welcome the Swedish tourists who will return to Eilat to enjoy an attractive tourist destination and the unique experiences offered by the desert, especially during the winter season. Time scheduleArlanda – Eilat, SK2911 departure Saturday. 13.00. Arrival 17.50Eilat – Arlanda, SK2912 departure Saturday. 18.40. Arrival 23.45 In addition to new routes SAS is now introducing new cabins on all short- and medium-haul flights. The new cabins will be installed between 2017 and 2019. From the second half of 2017, the installation of high-speed WiFi will commence, with surfing speeds that make it possible to stream movies or TV series onboard.  For more information on Eilat se www.traveleilat.com  For more information about SAS new cabin http://www.sasgroup.net/en/images/sas-new-cabin/ 

Press release from the annual general meeting in Seamless on 20 April 2017

PRESS RELEASE  At the annual general meeting in Seamless in Stockholm today the shareholders resolved, in accordance with the proposed resolutions, upon the following: Approval of profit and loss accounts and balance sheets, and discharge from liability for the board members and the managing director The annual general meeting approved the profit and loss accounts and the balance sheets and resolved that the company’s aggregated results of SEK 61,251,726 shall be carried forward. The board members and the managing director were discharged from liability for the financial year 2016. Resolutions on board of directors and auditor as well as fees to the board of directors and auditor It was resolved that, for the time until the next annual general meeting, elect John Longhurst as Chairman of the board of directors and that, for the time until the next annual general meeting, re-elect Peter Fredell, Robin Saunders and Tomas Klevbo and elect Petra Sas as members of the board of directors. It was resolved that Öhrlings PricewaterhouseCoopers AB shall be re-elected as auditor for a term of four years. It was noted that Nicklas Renström will be the auditor in charge. The annual general meeting resolved that fees to the board of directors shall be paid in an aggregate amount of SEK 850,000, of which SEK 250,000 shall be paid to the Chairman and SEK 200,000 shall be paid to each of the other members of the board of directors, which are not employed by the company, and no remuneration shall be paid for committee work. Further, it was resolved that fees to the auditor shall be paid as per current account. Nomination committee The annual general meeting resolved to approve the proposed instructions and statutes for the nomination committee.   Guidelines for remuneration of the management The annual general meeting resolved to approve the proposed guidelines for remuneration of the management. Resolution to authorise the board of directors to resolve upon issues of shares and/or warrants and/or convertibles and to acquire and sell treasury shares The annual general meeting resolved to authorise the board of directors to resolve upon issues of shares and/or warrants and/or convertibles in a maximum number of 20,000,000. Further, the annual general meeting resolved to authorise the board of directors to acquire and sell treasury shares. The shares shall be repurchased on Nasdaq Stockholm at a price within the share price interval registered at that time and to the extent that the company’s holding of its own shares, on any occasion, does not exceed 10 percent of the total number of shares in the company. Transfers of treasury shares held by the company may be made on Nasdaq Stockholm or in connection with the acquisition of companies, businesses or parts thereof with a maximum of number of shares held by the company at the time of the board of director’s transfer resolution. Transfers on Nasdaq Stockholm shall be made only at a price within the price range registered at any given time, or, if in connection with acquisition of companies, businesses or parts thereof, on market terms, however, not to a price below the stock exchange rate. Stock option plan The annual general meeting resolved upon a stock option plan for senior executives and other key employees in the group and in total, the plan will encompass a maximum of 5 million stock options. The CEO is entitled to not more than 1.5 million stock options and the other senior executives and other key employees employed in the group are each entitled to not more than 500,000 stock options. The exercise price for the stock options corresponds to 120 percent of the volume weighted average price of the Seamless share for ten trading days after 1 July 2017. For senior executives, the vesting of stock options will be conditional upon fulfilment of financial and operational targets as determined by the board of directors. The results hereof will be published in the company’s annual report for 2020 and on the company’s website. To ensure the delivery of shares under the plan, the board of directors was authorised to, with deviation from the shareholders’ preferential rights, at one or more occasions, resolve to issue not more than 5 million warrants. Amendment of the articles of association The annual general meeting resolved on amendment of the articles of association, whereby the share capital and the number of shares will be changed so the share capital shall be not less than SEK 25,000,000 and not more than SEK 100,000,000 and the number of shares shall be not less than 50,000,000 and not more than 200,000,000. Authorisation for the Board of Directors to divest the subsidiary Seamless Distribution System AB The annual general meeting resolved to authorise the board of directors to divest the Company’s wholly owned subsidiary Seamless Distribution Systems AB (“SDS”). The divestment is envisaged to be carried out either (i) through a purchase offer and subsequent listing of the SDS share on Nasdaq First North, whereby the company’s shareholders are granted purchase rights (Sw. Inköpsrätter) for shares in SDS pro rata in relation to their holdings in the company; or (ii) to a third-party buyer, subject to the purchase price of all outstanding shares in SDS being higher than what the board of directors, with support from its advisors, has estimated as the fair trading value of the SDS shares upon listing. Complete information on each proposal adopted by the annual general meeting may be downloaded from www.seamless.se. For further information, please contact Peter Fredell, CEO, phone +46 8 564 878 00 About Seamless Seamless is one of the world’s largest suppliers of payment systems for mobile phones. Founded in 2001 and active in 35 countries, Seamless handles more than 5.3 billion transactions annually through 675,000 active sales outlets. Seamless has three main business areas including the transaction switch, the technology provider for the distribution of e-products and the mobile payment platform Seqr. www.seamless.se This information is information that Seamless Distribution AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. This information was submitted for publication, through the agency of the contact person set out above, at 2.00 p.m. CET on April 20, 2017. Seamless Distribution AB, Box 6234, 102 34 Stockholm | Visiting address: St Eriksgatan 121 D | Org. no: 556610-2660 Phone: 08-564 878 00 | Fax: 08-564 878 23 | www.seamless.se

BEHAVIOUR, STARBREEZE AND 505 GAMES BRING SURVIVAL HORROR GAME DEAD BY DAYLIGHTTM TO PLAYSTATION 4 AND XBOX ONE

Stockholm, Sweden (April 20th, 2017) The Killing Ground is set to expand as developer Behaviour Interactive  and Starbreeze Publishing , in partnership with 505 Games , prepare to publish four-versus-one asymmetrical horror game Dead by Daylight to physical and digital retail formats of PlayStation 4 entertainment system and Xbox One on June 20th, 2017 in North America and June 23rd, 2017 in Europe for a suggested retail price of $29.99. Already extremely popular on Steam/PC with more than 1.8 million units sold, Dead by Daylight is an asymmetrical multiplayer horror game in which one crazed killer hunts four friends through a terrifying nightmare. Players take on the role of both killer and survivors in a deadly game of cat and mouse. It’s a Mature Gamer take on the thrills of Hide & Seek. Players experience two styles of gameplay -- as a survivor, from third-person perspective; or the killer, in first-person perspective. Survivors can work together or act alone using their situational awareness, while killers are on the hunt in first-person, focused on their prey. With a dynamic environment that changes after every play through, players must find new ways to escape the Killing Ground without getting caught. Dead by Daylight will offer a unique batch of killer features: · A Feast for Killers – Dead by Daylight draws from all corners of the horror world. Play anything from a powerful Slasher to terrifying paranormal entity. Players can familiarize themselves with the Killing Grounds and master each killer’s unique power to be able to hunt, catch and sacrifice victims.  · Deeper and Deeper – Each killer and survivor has their own deep progression system and plenty of unlockables that can be customized to fit each player’s own personal strategy. Experience, skills and understanding of the environment are key to being able to hunt or outwit the killer. · Real Fear – Expect the unexpected. Ambience, music, and chilling environments combine into a terrifying experience. With enough time, players might even discover what’s hiding in the fog. · Survive Together… Or Not – Survivors can either cooperate with the others or be selfish. Chances for survival depend on player’s decisions. · Where Am I? – Each level is procedurally generated, so players never know what to expect. Random spawn points mean players will never feel safe as the world and its danger change every play through.  Finally, the retail versions of Dead by Daylight will come packed with extra content: · The Original Soundtrack · The 80’s Suitcase add-on · The Bloodstained Sack add-on · The Of Flesh and Mud chapter add-on · And a future DLC to be announced! Get the latest information and updates for Dead by Daylight by visiting and signing up on the official website: http://www.deadbydaylight.com/  ###  Additional Dead by Daylight Information for Press: Website and Media kit: http://www.deadbydaylight.com/  Facebook: https://www.facebook.com/DeadByDaylight/  Twitter: https://twitter.com/deadByBHVR  YouTube: https://www.youtube.com/channel/UCaSgsFdGbwjfdawl3rOXiwQ  Twitch: https://www.twitch.tv/deadbydaylight 

Passing of Agromino A/S' (previously Trigon Agri A/S) Annual General Meeting

On Thursday, 20 April 2017, the annual general meeting of Agromino A/S was held at Plesner, Amerika Plads 37, DK-2100 Copenhagen Ø. The Board of Directors' report on the activities of the Company during the financial year 2016 was approved, ref. item 1 on the agenda. The audited annual report for the financial year 2016 showing a net loss for the EUR 25,079,000 was approved, ref. item 2 on the agenda. The proposed remuneration for the financial year 2017 in the amount of EUR 30,000 (net) for the Chairman of the Board of Directors and EUR 10,000 (net) for each of the Board Members was approved, ref. item 3 on the agenda. The general meeting granted discharge of liability to the members of the Board of Directors and the Executive Board, ref. item 4 on the agenda. It was decided that the result of the year, the net loss of EUR 25,079,000, recorded in the annual report was carried forward to the next financial year, ref. item 5 on the agenda. Johannes Bertorp and Jens Bruno were re-elected to the Board of Directors for a term of 1 (one) year and Martin Rosenmejer was elected to the Board of Directors for a term of 1 (one) year. Peter Gæmelke and David Mathew resigned as they had notified the Board of Directors that they would not stand for re-election. Following the resolution, the Board of Directors consists of the following members elected by the general meeting: Johannes Bertorp Jens Bruno Martin Rosenmejer  PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab, Strandvejen 44, 2900 Hellerup was re-elected as auditor of the Company, ref. item 7 on the agenda. The proposal to increase the share capital of the Company by nominally EUR 0.29 (equal to 29 shares of each EUR 0.01), to be issued to Johannes Bertorp at a price of EUR 1 per share, with the single purpose of increasing the outstanding amount of shares from 1,742,131,271 to 1,742,131,300 shares (an amount divisible by 100, as per item 8.b on the agenda), ref. item 8.a on the agenda, was approved and the shares were subscribed for by Johannes Bertorp. The new shares will be issued and admitted to trading as soon as possible. The proposal to increase the nominal value of each share from EUR 0.01 to EUR 1.00 (reverse share split) of all of Agromino A/S' shares, ref. item 8.b on the agenda, was approved. A separate press release will be sent out shortly with detailed information about the reverse share split process. The proposal to repeal the expired authorization to issue warrants, ref. item 8.c on the agenda, was approved. The proposal to adopt general guidelines for incentive-based remuneration for the Company's management, ref. tem 8.f on the agenda, was approved. The proposal to authorize the board of directors to issue warrants to executive board members and other key employees to subscribe for an aggregate of up to 101,469,500 warrants (such number to be adjusted to 1,014,695 upon completion of the reverse share split), ref. item 8.d on the agenda, was approved.   With respect to the proposal to authorize the board of directors, ref. item 8.e of the agenda, to (i) increase the share capital of the Company by way of cash contribution or by way of conversion of debt in one or more rounds in the period until 20 April 2022 with a maximum nominal amount of EUR 2,000,000 (approximately 15% post-issue dilution of the outstanding number of shares) at market price without pre-emptive rights for the existing shareholders, (ii) increase the share capital of the Company by way of cash contribution in one or more rounds in the period until 20 April 2022 with a maximum nominal amount of EUR 2,000,000 at market price with pre-emptive rights for the existing shareholders, and (iii) increase the share capital of the Company by way of cash contribution or by way of conversion of debt in one or more rounds in the period until 20 April 2022 with a maximum nominal amount of EUR 2,000,000 at a price below market price with pre-emptive rights for the existing shareholders and with the total aggregate nominal amount of the capital increase(s) carried out by the board of directors pursuant to these authorizations not to exceed EUR 2,000,000, an amendment proposal was made by the Board of Directors to the effect that in respect of (i) and (ii) above, the authorization shall include also capital increase by way of contribution in kind. The amended proposal was adopted. The proposal to change the name of the Company to "Agromino A/S" and to retain the name "Trigon Agri A/S" as a secondary name, ref. item 8.g on the agenda, was approved. The name change will be effected as soon as possible. The proposal to change the eligible venues of the Company's general meeting to the Greater Copenhagen area, the Greater Tallinn area and the Greater Stockholm area, ref. item 8.h on the agenda, was approved. Investor enquiries  Mr. Simon Boughton, CEO of Agromino A/S Tel: +372 6191 500 About Agromino  Agromino is an integrated soft commodities production, storage and trading company with operations in Ukraine, Russia and Estonia. Agromino shares are traded on the main market of Nasdaq Stockholm. This information is information that Agromino is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 15:30 CET on 20 April 2017.

Chief Financial Officer leaves Getinge

Getinge AB today announces that Reinhard Mayer, Chief Financial Officer of Getinge, has decided to leave the company for family reasons after nearly 20 years of service. Reinhard will remain as CFO and member of the Getinge Executive Team until he leaves the position in November 2017. “It is very unfortunate that Reinhard has decided to leave Getinge as he holds deep knowledge of the company and is a respected and trusted colleague to us”, says Mattias Perjos, President & CEO. “I was looking forward to work together with Reinhard but I fully respect his private and family motives for leaving Getinge and wish him all the best in the future when he now moves back to Germany”. The process to recruit a new CFO of Getinge will commence immediately. For further information, please contact:Kornelia Rasmussen EVP Communications & Brand ManagementPhone: +46 (0)10 335 5810Email: Kornelia.rasmussen@getinge.com About GetingeGetinge is a global provider of innovative solutions for operating rooms, intensive-care units, sterilization departments and for life science companies and institutions. Based on our first-hand experience and close partnerships with clinical experts, healthcare professionals and medtech specialists, we are improving the every-day life for people, today and tomorrow. www.getinge.com This information is information that Getinge AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 16.35 CET on April 20, 2017.

Rick Perry, U.S. Secretary of Energy, keynote speaker at UTA’s ‘Responsible Shale Energy Extraction’ Conference as part of Earth Day Texas 2017

U.S. Secretary of Energy Rick Perry is keynote speaker at UTA’s “Responsible Shale Energy Extraction” Conference April 21-22 at Fair Park in Dallas, as part of Earth Day Texas. Secretary Perry’s speech is scheduled for April 21, 9:10 – 9:30 a.m. A full schedule of the conference can be seen here . This free event, chaired by UTA’s Collaborative Laboratories for Environmental Analysis and Remediation or CLEAR lab , will feature presentations by Scott Anderson of the Environmental Defense Fund, Scott Tinker of the Bureau of Economic Geology and Katharine Hayhoe of Texas Tech University, who has been named one of TIME Magazine’s 100 Most Influential People for her work as a climate scientist and communicator. “We believe that it is important to host a variety of perspectives at a venue like Earth Day Texas where we can have honest discussions about the strengths and weaknesses of shale energy extraction,” said Kevin Schug, UTA’s Shimadzu Distinguished Professor of Analytical Chemistry and director of the CLEAR lab. “Our goal through this conference is to facilitate new collaborations that will have a positive impact on the environment,” he added. The event will also feature roundtable discussions, and live technology demonstrations covering a wide range of topics, including the detection and remediation of environmental contamination events, the management of light pollution and induced seismicity and the intelligent recycling of brackish and waste waters for commercial applications. “With our knowledge of the relationship between shale energy extraction and the environment continuing to grow, so too does our need for new partnerships to help guide the development of better resource management practices,” said Zacariah Hildenbrand, scientific contributor to CLEAR and conference co-chairman. “We believe that having leaders from the environmental, governmental, academic, and private sectors coming together and sharing ideas will lead to better environmental stewardship and improved efficiency within the shale energy basins,” he added. The ‘Responsible Shale Energy Extraction’ conference is free and open to the general public thanks to the generous support of joint sponsors Earth Day Texas and the Cynthia and George Mitchell Foundation.  Those interested in attending are asked to pre-register at the conference website. On-site registration will also be accepted. For more information, pre-registration, and a detailed program, see: www.shalescience.org About The University of Texas at Arlington The University of Texas at Arlington is a Carnegie Research-1 “highest research activity” institution. With a projected global enrollment of close to 57,000, UTA is one of the largest institutions in the state of Texas. Guided by its Strategic Plan 2020 Bold Solutions|Global Impact , UTA fosters interdisciplinary research and education within four broad themes: health and the human condition, sustainable urban communities, global environmental impact, and data-driven discovery. UTA was recently cited by U.S. News & World Report as having the second lowest average student debt among U.S. universities. U.S. News & World Report lists UTA as having the fifth highest undergraduate diversity index among national universities. The University is a Hispanic-Serving Institution and is ranked as the top four-year college in Texas for veterans on Military Times’ 2017 Best for Vets list.    

Agromino A/S (previously Trigon Agri A/S): Notice to warrant holders as part of the reverse share split at a consolidation ratio of 100:1

On Thursday, 20 April 2017, the Annual General Meeting (the “AGM”) was held in Agromino A/S (the “Company”). At the AGM, a share consolidation of all the Company’s shares was adopted through a reverse share split at a consolidation ratio of 100:1. The reverse share split will reduce the number of issued shares in the Company by the consolidation of 100 shares of a nominal value of EUR 0.01 each into one share of a nominal value of EUR 1.00. As a consequence of the share consolidation of all the Company’s shares, an amendment to the terms of the warrants issued by the Company on 9 March 2017 will be completed to the effect that a warrant holder will be required to hold 100 warrants to subscribe for one (1) share of nominal value EUR 1.00 to reflect the 100:1 reverse share split. As a consequence hereof, the exercise price of the warrants will be adjusted to the effect that the If a warrant holder exercises one or more warrants inside the 36th calendar month after the date of issuance, the exercise price per share of nominally EUR 1.00 shall be EUR 3.00. If a warrant holder exercises one or more warrants in connection with an Extraordinary Event (as defined in clause 3.2 of the Company's Articles of Association), the exercise price per share of nominally EUR 1.00 shall be EUR 2.00 plus 11 per cent annual interest, calculated from the date of issuance, compounded and accrued annually. The interest shall be calculated per calendar day from the time of grant of the warrants and until the time at which the warrant holder exercises the warrants. It is expected that the changes to the terms of the warrants will effected on or around 19 May 2017. Draft Articles of Association showing the changes to the warrant terms is enclosed to this press release. Yours sincerely On behalf of the Board of Directors Johannes Bertorp Investor enquiries  Mr. Simon Boughton, CEO of Agromino A/S Tel: +372 6191 500 About Agromino  Agromino is an integrated soft commodities production, storage and trading company with operations in Ukraine, Russia and Estonia. Agromino shares are traded on the main market of Nasdaq Stockholm. This information is information that Agromino is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 18:50 CET on 20 April 2017. 

Notice of the Extraordinary General Meeting

Notification of attendance Shareholders who wish to attend the extraordinary general meeting must -       be listed in the shareholders’ register maintained by Euroclear Sweden AB on Thursday, 11 May 2017, and -       give notice of their intention to attend the meeting no later than Thursday, 11 May 2017. Notification may be given in any of the following manners: -       by telephone +46 8 402 90 59, weekdays between 8 a.m. and 5 p.m. -       on the company website www.sca.com -       by mail to Svenska Cellulosa Aktiebolaget SCA, Group Function Legal Affairs, P.O. Box 200, SE-101 23 Stockholm, Sweden. In addition to notification, shareholders who have their shares registered through a bank or other nominee must request to be entered into the share register by Thursday, 11 May 2017, in order to be entitled to attend the meeting. Such registration may be temporary. In such cases, the shareholder should instruct the nominee of this well in advance of Thursday, 11 May 2017. Name, personal identity number/corporate registration number, address and telephone number, and accompanying persons, if any, should be stated when notification is given. Shareholders represented by proxy should deliver a proxy in the original to the company prior to the extraordinary general meeting. Proxy forms are available upon request and on the company website www.sca.com. Anyone representing a corporate entity must present a copy of the registration certificate, not older than one year, or equivalent authorization document, listing the authorized signatories. Proposed agenda 1. Opening of the meeting and election of chairman of the meeting. 2. Preparation and approval of the voting list. 3. Election of two persons to check the minutes. 4. Determination of whether the meeting has been duly convened. 5. Approval of the agenda. 6. Resolution on the number of directors and deputy directors. 7. Resolution on the remuneration to be paid to the board of directors. 8. Election of new directors. Election of     (i) Charlotte Bengtsson     (ii) Lennart Evrell     (iii) Ulf Larsson     (iv) Martin Lindqvist     (v) Lotta Lyrå 9. Closing of the meeting. Proposal for resolution under Item 1 The nomination committee proposes Eva Hägg, attorney at law, as chairman of the extraordinary general meeting. Proposal for resolution under Items 6–8 The nomination committee proposes the following: - The number of directors shall be nine with no deputy directors. - Remuneration shall be paid by an amount of SEK 600,000 to each of the board members elected by the general meeting and who is not employed by the company, and of SEK 1,800,000 to the chairman of the board of directors. In addition, remuneration for committee work shall be paid in accordance with the resolution adopted by the annual general meeting on 5 April, 2017. With respect to the board members elected by the annual general meeting on 5 April, 2017 and who shall remain as board members, the proposal means a reduction of the remunerations with SEK 100,000 for each board member and with SEK 300,000 for the chairman of the board, based on a term of office of one year. - Election of Charlotte Bengtsson, Lennart Evrell, Ulf Larsson, Martin Lindqvist and Lotta Lyrå as new directors. The proposal for new elections is presented as a result of the board members Ewa Björling, Maija-Liisa Friman, Magnus Groth, Johan Malmquist, Louise Svanberg and Lars Rebien Sörensen having declared that they are not at the disposal for the board in SCA following a listing of SCA Hygiene AB (under name change to Essity Aktiebolag (publ)). The proposed board members are proposed to take office on the first day of trading of the shares of SCA Hygiene AB on Nasdaq Stockholm. It is noted that the board of directors from the first day of trading of the shares of SCA Hygiene AB thereby will be composed of Pär Boman (chairman), Charlotte Bengtsson, Lennart Evrell, Annemarie Gardshol, Ulf Larsson, Martin Lindqvist, Bert Nordberg, Barbara Milian Thoralfsson and Lotta Lyrå. The resolutions pursuant to items 6–8 are conditional upon SCA Hygiene AB (under name change to Essity Aktiebolag (publ)) being admitted to trading on Nasdaq Stockholm. If the condition is not met, no changes in the board of directors elected at the annual general meeting on 5 April, 2017 will be made. Charlotte Bengtsson has a Master of Science in Engineering, Steel and Wood Construction and is a Technology Licentiate and Doctor in Technology from Chalmers University of Technology. Since 2015 Charlotte Bengtsson is Managing Director of Skogsforsk research institute and previously, in 1999–2014, she served as Department Manager of Wood Engineering and Wood Construction as well as researcher/project leader in wood construction at SP Technical Research Institute of Sweden. Further, Charlotte Bengtsson is Adjunct professor of Wood Building Technology at Linnaeus University. Independent in relation to SCA’s major shareholders. Lennart Evrell, has a Master of Science in Engineering from Royal Institut of Technology and is an Economist from Uppsala University. Since 2008, Lennart Evrell is President and CEO of Boliden. Further, Lennart Evrell holds the position as Chairman of the board of Umeå University and of Gruvornas Arbetsgivareförbund, and as board member of the Confederation of Swedish Enterprise. Since 1985 Lennart Evrell has also held a numerous of senior positions, e.g. as President and CEO of Sapa and Munters, and various positions within ASEA, Atlas Copco and Sphinx Gustavsberg. Independent in relation to the company, management and SCA’s major shareholders. Ulf Larsson, has a Bachelor of Science in Forestry from Swedish University of Agricultural Sciences, and is President of SCA Forest Products AB since 2008. Ulf Larsson is also Executive Vice President of SCA since 2016, and has experience from executive positions within Scaninge Timber, SCA Skog, SCA Timber and Domänverket since 1987. Further, Ulf Larsson is board member of the Confederation of Swedish Enterprise and former board member of Mid Sweden University and Heinzel Holding GmbH. Independent in relation to SCA’s major shareholders. Martin Lindqvist has a Bachelor of Economics from Uppsala University and is President and CEO of SSAB since 2011, and board member of Industriarbetsgivarna and BasEL. Previously Martin Lindqvist has held positions such as board member of Indutrade AB and Chief Controller for NCC. Since 1998 Martin Lindqvist has held numerous senior positions within SSAB, including Business Area Manager, Divisional Manager, CFO and Financial Manager. Independent in relation to the company, management and SCA’s major shareholders.] Lotta Lyrå has a Master of Science in Economy from Stockholm School of Economics and is President and CEO-elect of Clas Ohlson. Since 2009, Lotta Lyrå has held senior positions within the Ikea Group, including Head of strategy as well as Head of development. Prior to this Lotta Lyrå was Head of development at Södra Timber, sawmill manager at Södra’s sawmill in Mönsterås and former employee of McKinsey & Company. Independent in relation to the company, management and SCA’s major shareholders. The nomination committee The nomination committee is composed of Helena Stjernholm, AB Industrivärden (chairman), Petter Johnsen, Norges Bank Investment Management, Håkan Sandberg, Handelsbankens Pensionsstiftelse and others, Marianne Nilsson, Swedbank Robur and Pär Boman, chairman of the board of SCA. Additional information Documentation, which, according to the Companies Act, shall be made available at the extraordinary general meeting, as well as proxy forms will be available at the company and on the company website, www.sca.com, no later than 25 April 2017, and will be distributed free of charge to shareholders upon request and notification of postal address. The board of directors and the president shall, if any shareholder so requests and the board of directors believes that it can be done without material harm to the company, provide information regarding circumstances that may affect the assessment of an item on the agenda. The total number of shares in the company amounts to 705,110,094 shares, of which 64,594,523 are series A shares and 640,515,571 are series B shares, representing a total of 1,286,460,801 votes. The series A share carries ten votes and the series B share carries one vote. The company holds 2,767,605 series B shares, which may not be represented at the general meeting. In accordance with a resolution on the 2017 annual general meeting, these shares are subject to a so-called process of cancellation of shares. The information pertains to the circumstances as per the time of issuing this notice. Stockholm in April 2017 Svenska Cellulosa Aktiebolaget SCA (publ) The board of directors NB: The information was submitted for publication at 19:00 CET on April 20, 2017.

1Q 2017 Summary Cleantech Invest Plc

Please note that this is not a fully comprehensive report of all events, nor is it in any way a financial performance report. It is a summary of the main events that are public and that affect us and our portfolio during the quarter.  In the quarterly report we will not comment on every portfolio company every time but focus on portfolio companies where we feel the company has achieved milestones or had development that are worth reporting. To get a comprehensive view of individual portfolio companies’ businesses one should review additional documents such as the company description and the supplement to the company description that were published in 2016 . General During Q1 Cleantech Invest carried out a directed share issue of approx. 2.6MEUR to institutional investors and investors of strategic value to the company. In the offering, 933,000 new class A shares were subscribed at the subscription price of EUR 2,74 per share. The offer shares represented approximately 4,1% of the outstanding shares in the company after the offering. Significant events in Portfolio companies We have finished the first quarter of 2017 and the strong growth (combined revenue of portfolio firms grew 150% in 2016 compared with 2015) seems to continue. A couple of recent key developments from them include: · Nocart’s major development in Q1 was the announcement of a US$200m facility in the Shangombo region of Zambia. Significant projects in Kenya, Gambia and elsewhere in Zambia are also taking shape. Finance for the off-takers continues to be the biggest challenge in the new projects. Nocart has also been expanding its global presence with registered entities in Singapore and the UK.  The company is developing its product range to include portable energy solutions and more efficient solar power management and gasification processes. In what might be a blueprint for the future Nocart has been asked to join Scandinavian partners in production of solar energy to arrange a showcase facility for use by the United Nations in deprived areas such as refugee camps in the Middle East and Jordan. · Eagle Filters got an approval from the world’s largest gas turbine utility, Engie, for its air filtration solution after a rigorous two year testing and evaluation process. Engie has informed it will now start deploying Eagle’s products in several of its power plant locations. · Swap.com made its record quarter and record month in Q1 2017 and keeps on growing fast. A specific event was the announcement of Swap.com's 2 million item milestone. In Q1 Swap.com has been shifting its marketing efforts from paid search strategies to brand based marketing and this strategy has been one of the key drivers in Q1 growth. Brand development work summarized the awesomeness of Swap.com in three key elements: 1) environmentally friendly consumption, 2) thrifty deals for smart customers, 3) unique finds from the inventory of millions of items. During Q2 Swap.com is concentrating in execution of its growth business plan. On the marketing and business development fronts company is developing brand assets to communicate its brand message for wider audiences. Example of this work has been published as part of company's Earth Day campaign. · Enersize closed a pre-IPO round with approximately 1,2MEUR in new funding which included strategic investors Scania Growth Capital and Heinz Dürr Invest. Pre-IPO investors also committed to a significant part of the investment in the planned IPO. Enersize secured a second contract with current customer Beijing Opto Electronics for system installation in their second Beijing Factory. The new project has a savings potential of three times that of the ongoing project. Enersize also closed two new independent installation contracts with BBMG, one of Chinas largest building material provider as well as with Foton Cummins, a joint venture between US fortune 500 Cummins diesel and Foton Beiqi Motor, an existing Enersize customer. Enersize opened an R&D office in Lund, Sweden for development of its next generation software for fully automated analysis and monitoring of industrial compressed air systems. · Nuuka Solutions closed a financing round in early Q1 and started recruiting key people to further accelerate growth. Nuuka has added new resources to the Dutch team, found a Global head of sales and marketing based in Sweden and Director of business development to Finland. Nuuka also kicked off their project in China with a local partner. · Sofi Filtration received its first Sofi Filter volume order as three standard Sofi Filter units were delivered to a channel partner in the power industry. The company successfully concluded piloting for a major mining client. Sofi also initiated its first field trial in oil industry for drilling fluids treatment.  · Metgen started to supply its first customer in Pulp and Paper and Biogas sectors. The company has also created a new route to FDCA as well as enzymatic solution for lignin valorization. · ResQ Club had a growth spurt in the Swedish market during Q1, expanding to more than 13 municipalities, acquiring over 15,000 registered users and over 300 partner venues as well as reaching close to 10,000 SEK/day in sales over the platform in Sweden. ResQ’s overall registered user base exceeded 100,000, and they resQ'd over 60,000 portions of quality food in Q1 alone. During Q1 ResQ has conducted extensive recruiting and partnership building in central Europe to lay the grounds for fast expansion. · Watty received an order from a major energy company, Solaris, to equip 1000 apartments and houses in Chile with Watty’s end-to-end platform. The order value for the project is approximately 200 000 EUR and installations start during Q3. Watty will during Q 2 start shipping hardware to trial customers in Berlin, Munich and Stockholm. · Aurelia Turbines moved to a new facility that enables manufacturing of the turbines. The company was awarded with the German Energy Efficiency Award by DENEFF, the German Industrial Association for Energy Efficiency. In Q2 Aurelia will focus on preparing the new facility in order to start manufacturing of the turbines. · PlugSurfing increased payable charging points by 14% during Q1 compared to previous quarter and the number of charging sessions using Plugsurfing is up 71% during Q1 from previous quarter and up 350% from Q1 2016. · Savo-Solar received orders from Finland and Sweden and finalized successfully in the beginning of the year the capacity investments doubling the capacity in the Mikkeli factory. The market demand for large solar thermal systems is growing in Europe and with strong position and excellent references in Denmark Savo-Solar is considered as one of the suppliers with highest potential by the customers. Customers also expect to receive more complete systems, for which the company has strengthened its capabilities especially in sales and system design, and recruited more people for these tasks in Denmark and Germany.

Q1 2017 Interim report January-March

Q1 2017 Highlights · Record Q1 sales of SEK 4,228m (3,826) with 8% organic growth · Operating income up 15% to SEK 183m (159) · Net income of SEK 118m (50) and total basic earnings per share of SEK 1.44 (0.55) · Cash flow from continuing operations of SEK 187m (75) · Net debt of SEK 2,439m (2,688) equivalent to 1.5x trailing 12 month EBITDA before IAC Financial Overview +-----------------------------------+-------+-------+--------------+|(SEKm) |Q1 2017|Q1 2016|Full year 2016|+-----------------------------------+-------+-------+--------------+|Continuing operations | | | |+-----------------------------------+-------+-------+--------------+|Net sales | 4,228| 3,826| 17,299|+-----------------------------------+-------+-------+--------------+|Change in reported net sales | 10.5%| 3.4%| 6.7%|+-----------------------------------+-------+-------+--------------+|   Organic growth | 7.9%| 3.3%| 5.4%|+-----------------------------------+-------+-------+--------------+|   Acquisitions/divestments | 0.4%| 1.8%| 1.2%|+-----------------------------------+-------+-------+--------------+|   Changes in FX rates | 2.2%| -1.7%| 0.1%|+-----------------------------------+-------+-------+--------------+| | | | |+-----------------------------------+-------+-------+--------------+|Operating income | 183| 159| 1,347|+-----------------------------------+-------+-------+--------------+|Operating margin | 4.3%| 4.2%| 7.8%|+-----------------------------------+-------+-------+--------------+|Items affecting comparability (IAC)| -| -| -|+-----------------------------------+-------+-------+--------------+| | | | |+-----------------------------------+-------+-------+--------------+|Net income | 118| 119| 963|+-----------------------------------+-------+-------+--------------+|Basic earnings per share (SEK) | 1.44| 1.59| 12.88|+-----------------------------------+-------+-------+--------------+|Cash flow from operations | 187| 75| 940|+-----------------------------------+-------+-------+--------------+| | | | |+-----------------------------------+-------+-------+--------------+|Discontinued operations | | | |+-----------------------------------+-------+-------+--------------+|Net income [1] | -| -70| -1,072|+-----------------------------------+-------+-------+--------------+| | | | |+-----------------------------------+-------+-------+--------------+|Total operations | | | |+-----------------------------------+-------+-------+--------------+|Net income | 118| 50| -109|+-----------------------------------+-------+-------+--------------+|Basic earnings per share (SEK) | 1.44| 0.55| -3.19|+-----------------------------------+-------+-------+--------------+|Net debt | 2,439| 2,688| 2,186|+-----------------------------------+-------+-------+--------------+ [1] Comprises MTG’s interest in CTC Media, Inc, which was divested in 2016 and gave rise to a non-cash charge due to the reclassification of accumulated currency translation differences.President & CEO’s commentsHigh organic growth & higher profitsSales were up 8% on an organic basis to new record Q1 levels. This was the third consecutive quarter with organic sales growth of more than 5%, which demonstrates that we have more relevant products available to more customers than ever before.Operating profits were up 15% and driven by higher profits for both the Nordic and International entertainment businesses. This reflected both the sales growth and ongoing positive impact of the cost transformation programme launched in 2015, and more than offset the higher investments in MTGx and esports in particular.Accelerated transformationThe actions that we have taken to shape our Nordic business for the future reflect the changes in how and when consumers want to be entertained. Our investments in both our linear and streamed entertainment products in the Nordics have driven 11% organic sales growth and delivered 22% EBIT growth. Viaplay had another fantastic quarter and Viafree is rapidly expanding its content offering.In addition, the portfolio realignment that is a key element of our strategic transformation has accelerated in recent quarters. We have announced the sale of our shareholdings in the Czech and the Baltic operations. The proceeds from these disposals will be used to invest in the development of our Nordic entertainment products and the MTGx businesses, and to increase our ownership in online games developer InnoGames to 51%.The gaming industry has been transformed by high broadband speeds, the broad availability of connected mobile devices, and the emergence of professional competitive gaming – esports. The evolution of gaming is still in its early stages and we are committed to providing gamers and fans with world-class entertainment experiences such as the recent Intel® Extreme Masters in Katowice, which attracted 173,000 visitors and over 46 million unique online viewers, and by now closing partnerships deals with Facebook, Twitter and others to make esports available to billions of users.Prioritising opportunitiesThe steps that we have taken to capitalise on the consumer trends in digital entertainment and become a relevant player for the future, present a number of opportunities, which is why we are more focused than ever on capital allocation. We have leading positions in the Nordic streaming market and are stepping up our investments in original TV drama series. We are the global leader in esports and now have a great first investment in the online gaming market. We are also part of creating the World Boxing Super Series as a new global platform for the sport. All of these initiatives are about generating sustainable value for all of our stakeholders. These are exciting times at MTG as we continue to shape the future of entertainment.Jørgen Madsen LindemannPresident & Chief Executive Officer“Our operating profit was up 15% in Q1 due to a combination of organic growth and cost transformation. These are exciting times at MTG with many opportunities, which is why we are more focused than ever on capital allocation.”2017 Annual General MeetingThe 2017 Annual General Meeting will be held on Tuesday 9 May 2017 in Stockholm. The Board of Directors will propose the payment of an annual ordinary cash dividend of SEK 12.00 (11.50) per share to the Annual General Meeting. The total proposed dividend payment would therefore amount to approximately SEK 801m (767), based on the maximum potential number of outstanding ordinary shares. The Board of Directors will propose that the remainder of the Group’s retained earnings for the year ended 31 December 2016 be carried forward into the accounts for 2017. The proposal is in line with the dividend policy to distribute a minimum of 30 per cent of each year’s recurring net profit to shareholders in the form of an annual ordinary cash dividend.The notices to the Meeting and related materials can be found at mtg.com.2017 Financial calendar Annual General Meeting       9 MayQ2 2017 interim report 18 JulyQ3 2017 interim report 19 October Conference callThe company will host a conference call today at 09.00 Stockholm local time, 08.00 London local time and 03.00 New York local time. To participate in the conference call, please dial: Sweden:            +46 (0) 8 5065 3942UK: +44 (0) 330 336 9411US: +1 719 457 2086 The access pin code for the call is 2725910. To listen to the conference call online and for further information, please visit www.mtg.com. Questions?press@mtg.com (or Tobias Gyhlénius, Head of Public Relations; +46 73 699 27 09)investors@mtg.com (or Stefan Lycke; Head of Investor Relations; +46 73 699 27 14)mtg.com Facebook Twitter LinkedIn Instagram MTG (Modern Times Group MTG AB (publ.)) is a leading international digital entertainment group and we are shaping the future of entertainment by connecting consumers with the content that they love in as many ways as possible. Our brands span TV, radio and next generation entertainment experiences in esports, digital video networks and online gaming. Born in Sweden, our shares are listed on Nasdaq Stockholm (‘MTGA’ and ‘MTGB’). This information is information that MTG (Modern Times Group MTG AB (publ.)) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 07:30 CET on 21 April, 2017.

President and CEO Henri de Sauvage-Nolting comments on the results for the first quarter of 2017

Sales were down, predominantly within pick & mix and contract manufacturing. The lower sales in combination with higher selling, general and administrative expenses resulted, which we now are addressing, in a somewhat lower operating profit, adjusted for items affecting comparability. Operating profit was also affected by items affecting comparability, mainly related to acquisition cost for Candyking. Decreased net debt/EBITDA Cash flow from operating activities amounted to SEK 155m (253). The net debt/EBITDA ratio improved to 2.34x (2.78). Confectionery market The confectionery market declined in all of Cloetta’s core markets. The decline in Finland is related to the abolishment of the confectionery tax. Sales development Cloetta’s sales for the quarter declined by –0.8 per cent, of which organic growth accounted for –2.0 per cent and positive exchange rate differences for 1.2 per cent. Sales increased or was unchanged in Finland, the Netherlands, UK, Denmark, Norway and in the export markets. The increase was mainly offset by a decline in sales in Sweden and in contract manufacturing. In Sweden, sales only declined within pick & mix, mainly due to the Easter effect, but also from a tough comparator when new pick & mix concepts were introduced in the same quarter last year. In Finland sales increased driven by the abolition of the confectionery tax and in the Netherlands sales increased within candy. Acquisition of Candyking approved I am very pleased with the acquisition of Candyking Holding AB (“Candyking”) that we announced in February. Candyking, a leading concept supplier of pick & mix candy in the Nordic countries and UK, will strengthen Cloetta’s position within pick & mix and create substantial synergies. The synergies are expected to be gradually realized during the years 2017–2020. In addition, the acquisition will also strengthen our position within natural snacks through the Parrots brand. The acquisition was approved by the Swedish Competition Authority on 5 April 2017 and is expected to be closed on 28 April 2017. We are now preparing for a year of integration and a team has been appointed in order to plan and implement the integration. Focus on profitable growth My focus since I became CEO on 15 February 2017 has been on visiting all markets and functions to get an overview of what the organization believes are our strengths and challenges. Overall, my view is that Cloetta is a stable and strong company, but organic growth has not been good enough during the last years. My key focus for the coming years will therefore be to increase the organization’s focus and capability on organic growth through a relentless focus on consumers and customers while at the same time strengthen our brands through a clear positioning and sharper investments. Cloetta has reached the target of a net debt/EBITDA below 2.5x. The Annual General Meeting in early April decided to pay a dividend of SEK 0.75, representing 53 per cent of profit for the year, adjusted for the impairments, well in line with our policy of 40–60 per cent. Our strategic review of Cloetta Italy is ongoing. The aim is to improve growth and margins in Cloetta and could potentially include a divestment of the Italian business. Our key focus now is profitable growth and to make sure the integration of Candyking is successful. It is an important acquisition that will strengthen Cloetta. Henri de Sauvage-NoltingPresident and CEO This information constituted before the publication inside information and is such that Cloetta AB (publ) is required to disclose pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted, by the below contact person, for publication on 21 April 2017 at 08:00 am CET.

Interim report January - March 2017

Kai Wärn, President and CEO:"The preseason sell-in to trade partners constitutes a good start of the year for the Group with a net sales increase of 7% adjusted for currency. Group operating income was 22% higher than last year, totaling SEK 1,425m (1,166) and the corresponding margin reached 11.2% (10.3). The execution of the profitable growth strategies in the Husqvarna, Gardena and Construction divisions are proceeding well. The Consumer Brands Division experienced a lower first quarter sell-in, impacted by a couple of larger retail customers adjusting their buying patterns to tighter just-in-time order scheduling. We view this as a periodization between quarters. The improved operating income for the Group was mainly driven by higher volumes and a strong product mix development. Changes in exchange rates had a positive impact, however partly offset by increased raw material costs. Sales in the Husqvarna Division increased 11% currency adjusted, with continued strong development of robotic lawn mowers and other battery-powered products. Operating income increased 24% to SEK 1,047m (844). In the Gardena Division sales rose 9% currency adjusted. Further geographical expansion and new sales channels as well as a large number of new product introductions impacted sales positively, even compared to a strong first quarter last year. Operating income increased 11% to SEK 251m (226). Net sales in the Consumer Brands Division were 4% lower adjusted for currency, which impacted operating income and margin negatively. During the quarter the acquisition of Pullman Ermator was completed. It is an exciting step in the Construction Division’s ambition to build a market-leading position and take share in the attractive concrete surfaces and floors market. In the second quarter we also expect the acquisition of the floor grinding solutions market leader HTC to be finalized, which will further improve our product portfolio and ability to better serve our customers in this important area. Sales in the Construction Division grew 18% in the first quarter adjusted for currency, of which 9% was attributable to acquisitions whereof mainly Pullman Ermator. The strong sales growth impacted operating income positively, which increased 59% to SEK 141m (89) and the operating margin increased to 11.8% (9.2). To support our profitable growth journey, we continue to invest in strategic growth initiatives along with efforts to improve efficiency. Focus for the second quarter, following the successful sell-in phase, will be to support our trade partners to deliver an equally positive sell-through." · Net sales increased to SEK 12,746m (11,361), corresponding to a currency adjusted* growth of 7%. · Operating income increased 22% to SEK 1,425m (1,166), corresponding to a margin of 11.2% (10.3). · Changes in exchange rates, net of raw material costs, impacted operating income by around SEK 80m.  · Operating working capital as a percentage of net sales for the last twelve months was 28.1% (27.1).  · Earnings per share after dilution increased 30% to SEK 1.72 (1.32).  Telephone conferenceA combined press and telephone conference, hosted by Kai Wärn, President and CEO, and Jan Ytterberg, CFO, will be held at Husqvarna Group’s office, Regeringsgatan 28, Stockholm at 10:00 CET on April 21, 2017. To participate, please dial +46 (0) 8 5033 6434 (Sweden) or +44 (0) 8444933800 (UK) ten minutes prior to the start of the conference. The conference call will also be audio cast live on www.husqvarnagroup.com/ir . A replay will be available later the same day. 

MUNTERS FIRST QUARTER 2017

First quarter 2017 • The order backlog increased by 17% to SEKm 1,998 (1,713). • Order intake totaled SEKm 1,654 (1,617), an increase of 2%, of which 1% organically. Last year´s figure for the first quarter includes a record high Data Center order worth SEKm 240. • Net sales increased by 25% to SEKm 1,519 (1,220), of which 23% organically. • Operating profit (EBIT) increased by 1% to SEKm 75 (74). • Adjusted EBITA increased by 23% to SEKm 147 (119), corresponding to an adjusted EBITA margin of 9.7% (9.8%). • Net income amounted to SEKm -41 (-29). • Cash flow from operating activities was SEKm -20 (53). • Acquisition of 60% of the shares in MTech Systems was completed on February 1. The purchase price amounted to SEKm 222. • Helen Fasth Gillstedt was appointed as a member of the Board and as Chairman of the Audit Committee. • Lena Olving was appointed as a member of the Board. Events after period end • On April 1, Munters completed the acquisition of Kevin Enterprises Private Limited, a privately-owned company headquartered in Mumbai, India.  Comments from the CEO NET SALES GROWTH OF 25% IN THE FIRST QUARTER DRIVEN BY DATA CENTERS AND AIR TREATMENT The first quarter of 2017 showed strong growth for Munters with an increase in net sales of 25% and increased adjusted EBITA. The strong net sales growth in the quarter was mainly driven by the continued strength of our Data Center and Air Treatment businesses in the US and Europe and solid performance in Asia across the business areas. Order intake growth for the Group was 2% but the first quarter of 2016 benefitted from a record high Data Center order of SEKm 240. Data Center orders are lumpy in nature and we expect to see similar characteristics in the current year. Nonetheless, the order intake continued to show robust growth in Data Centers and in Air Treatment order intake grew. Munters benefits from strong demand in our key market segments The business area Air Treatment continued its strong growth trend during the quarter with a 23% increase in order intake with robust growth both in the industrial and commercial end-markets. In industrials, high demand within the lithium-ion battery, pharmaceuticals and other industrial end-markets were the main growth areas during the period. In commercial, the supermarkets end-market had another strong quarter following the lower demand witnessed during parts of 2016. Air Treatment net sales grew by 18% in the quarter, mainly driven by deliveries to customers in food, pharmaceutical and electronics. Order intake in Data Centers decreased by 49% (or SEKm 155) in the quarter, with growth in the quarter impacted by the record high order of SEKm 240 received in the first quarter in the previous year. Data Centers net sales in the first quarter of 2017 showed strong development with an increase of 183% driven by strong demand in the US and Europe. Munters continue to see high activity in the Data Center end-market. Given our highly competitive customer offering, based on our innovative technology for significantly improved energy efficiency, we continue to take market shares in our focused end-market. The business area AgHort showed solid performance during the quarter with continued growth in order intake and net sales of 10% and 12% respectively, supported by positive currency effects and the acquisition of MTech Systems. The AgHort business area has experienced lower investment levels mainly in the poultry and swine industries but the impact has been less pronounced than in previous downturns since we are more diversified today with additional customers in new geographies and end-markets. Long term, we continue to believe that the underlying growth drivers of more efficient and safe food production as well as increasing importance of animal welfare will remain intact. Our business area Mist Elimination had a soft start of the year with a 2% decline in order intake compared to the very strong first quarter in 2016, impacted by anticipated lower volumes in the power end-market in the US, partly offset by continued solid demand in Asia for super clean flue-gas desulfurization equipment. We believe that the underlying demand in the power end-market, supported by increasingly stricter environmental legislation, remains intact. As an effect of the lower order intake in the US during the last six months 2016, net sales declined by 14%. All business areas showed growth in China in the quarter and Group order intake growth in this region exceeded 50%. It is also encouraging to see that our aftermarket Service business continued to perform well across all regions, up 17% to SEKm 151 (129) in Q1 2017, as a result of the significant investments we have made into this business during the last three years. Adjusted EBITA growth from higher volumes Adjusted EBITA increased to SEKm 147 (119) in the first quarter corresponding to an adjusted EBITA margin of 10% (10%). The improvement was mainly achieved through increased volumes. During the past years, we have made significant achievements in increasing operational excellence in our production, procurement and sales processes. In addition, our long-term investments in growth areas such as Services and Data Centers, have yielded good results. We have continued to invest in our organization and in our production facilities around the globe to further improve efficiency. Strong platform for continued growth Munters´ value proposition is based on our mission to deliver the perfect climate to customers globally where the climate is mission critical. Our solutions are based on our proprietary technologies and application expertise built over half a century. On the back of long-standing customer relationships, we will continue to expand our product offering to become a complete solutions provider leveraging our controls, software and service businesses. During the past years, we have transformed our business towards high-growth application areas. All of Munters’ current end-markets are expected to demonstrate resilient and positive growth, driven by population and GDP growth, the need for increased energy efficiency, increased food and protein consumption, industrialization, urbanization and rising living standards globally. Munters has a strong track record of synergetic acquisitions and will continue to pursue M&A opportunities in a disciplined and systematic manner. Acquisitions will be made in selected segments to expand the portfolio of core technologies, customer relationships and/or grow our presence in emerging markets. The recently completed acquisitions of MTech Systems and Kevin Enterprises, the latter after the period end, is in line with this strategy and illustrates how we continuously work to further differentiate our offering to competition and thereby drive long-term growth. John Peter Leesi, CEO For more information: John Peter Leesi, CEO Munters Group Phone: +46 8 626 63 01 Jonas Ågrup, CFO Munters Group Phone: +46 8 626 63 01 Anna Beausang, Director Corporate Communications Phone: +46 70 698 63 60 About Munters Group Munters is a global leader in energy efficient air treatment and climate solutions. Using innovative technologies, Munters creates the perfect climate for customers in a wide range of industries, the largest being the food, pharmaceutical and data center sectors. Munters has been defining the future of air treatment since 1955. Today, around 3,500 employees carry out manufacturing and sales in more than 30 countries. Munters reports annual net sales in the region of SEK 6 billion and is owned by Nordic Capital Fund VII. For more information, please visit www.munters.com.

Interim report January – March 2017

Continued growth · Net sales increased by 20.2% to 192.2 (159.9) MSEK · Operating income amounted to 7.1 (8.9) MSEK · Net income amounted to -1.9 (8.3) MSEK · Earnings per share amounted to -0.09 (0.40) SEK · 15 (14) EBM systems were delivered during the period · Order intake increased to 8 (6) EBM systems  For the first quarter:  · An Extraordinary General Meeting was held on February 7, when a new board for the company was elected · The company has received an unconditional shareholder contribution of 16.9 MSEK Continued growth The Arcam Group continues to grow and during the first quarter the increase in sales was 20%. Sales for the first quarter amounted to 192.2 (159.9) MSEK and trailing twelve month sales amounts to 680.6 (624.6) MSEK. Operating profit for the period amounts to 7,1 MSEK and trailing twelve months the operating profit is -31.6 MSEK. The operating income trailing twelve months includes non-recurring costs of 44.8 (0) MSEK, which relates to financial and legal advice, as well as costs related to an early redemption of the company's share saving program. The EBM order intake during the period was 8 (6) EBM systems and the metal powder manufacturer AP&C increased its order intake compared to the same period 2016. We continue to pursue and develop our long-term strategy to industrialize the EBM technology and simultaneously developing the metal powder manufacturing and contract manufacturing business. We are making significant investments to continue to meet our customers’ demands and growing expectations of the EBM systems' productivity and reliability. Business status During the quarter, we delivered 15 EBM systems and the majority went to customers in the implant or the aerospace industry. Six systems were delivered to companies owned by our largest shareholder GE. The demand for EBM systems is driven by the aerospace industry that is now moving into production, but also by the increasing interest for Additive Manufacturing from the orthopedic industry. In the period, we received 8 new orders and the order book by the end of the quarter amounts to 18 EBM systems. The demand of metal powder for Additive Manufacturing continues to grow rapidly. In the beginning of the year we have secured several long-term supplier agreements to important customers within the orthopedic and the aerospace industries. DTI added new customers to the EBM part of the contract manufacturing business.  A strengthened organization We continue to build our organization for growth and during the quarter we have strengthened our organization throughout the group. In early April 2017 Karl Lindblom joined as General Manager for Arcam EBM. We have also strengthened our sales organization within Arcam EBM in the USA, and at AP&C and DTI. At AP&C we have expanded the organization to prepare for the opening of our new metal powder manufacturing plant. The expansion of AP&C's new plant is proceeding according to plan and the new facility is expected to be completed late summer. More than adding resources within our companies, we also now can access GE's expertise and resources, something that will help us to faster develop our technology and ability both on the EBM side and at AP&C and DTI. With some of the world's largest companies as customers, a strong major owner with high ambitions and, most important, a team of dedicated and skilled employees, we are well positioned to take advantage of our opportunities on the fast-growing market for Additive Manufacturing. Mölndal, Sweden, April 21, 2017 Magnus René,President & CEO The information has been made public in accordance with the Securities Market Act and/or the Financial Instruments Trading Act. The information was published on April 21, 2017 at 08.30 (CET).

Diamyd Medical enters agreement with global CRO for the DIAGNODE-2 trial

”We are very pleased to have TFS as our partner for this decisive trial with our diabetes vaccine”, says Ulf Hannelius, President and CEO of Diamyd Medical. “Their extensive experience of conducting multinational clinical studies in diabetes is of course valuable and our highest mutual priority is now to advance the DIAGNODE-2 trial as efficiently and quickly as possible.” DIAGNODE-2 will be conducted at a number of selected clinics in some countries in Europe including Sweden. The trial includes approximately 80 patients aged 12-24 years, recently diagnosed with type 1 diabetes, and the patients will be followed for 15 months. The aim of the trial is to evaluate the effect of the treatment in preserving the patients' insulin producing capacity. The Coordinating Investigator for the trial is Professor Johnny Ludvigsson at Linköping University. The process of having the trial approved by the Competent Authorities and Ethics Committees in each country is underway and the trial is expected to start in the fall of 2017. The decision to conduct the trial is based on highly promising preliminary clinical results from the ongoing open-label DIAGNODE-1 trial in which children and adolescents recently diagnosed with type 1 diabetes are given Diamyd® directly into the lymph node. The clinical effect of preserving the patient’s own insulin production is estimated to be significantly improved when the diabetes vaccine Diamyd® is administered directly into the lymph node, as compared to injecting it under the skin as in previous Phase III trials. The Diamyd Medical patent pending concept can be compared to the development of allergy treatment where it has been found that the administration of allergen into the lymph node significantly improves the treatment effect.  About Diamyd MedicalDiamyd Medical is dedicated to finding a cure for diabetes and other serious inflammatory diseases through pharmaceutical development and investments in stem cell and medical technology. Diamyd Medical develops the diabetes vaccine Diamyd®, an antigen-specific immunotherapy based on the exclusively licensed GAD-molecule. Five clinical trials are ongoing with Diamyd®. An exclusive license comprising the therapeutic use of GABA in diabetes and inflammatory diseases constitutes alongside with the diabetes vaccine a key asset and the Company is developing a proprietary GABA drug product. Diamyd Medical is one of the major shareholders in the stem cell company NextCell Pharma AB and has holdings in the medtech company Companion Medical, Inc., San Diego, USA and in the gene therapy company Periphagen, Inc., Pittsburgh, USA. Diamyd Medical’s B-share is traded on Nasdaq First North under the ticker DMYD B. FNCA Sweden AB is the Company’s Certified Adviser. Further information is available on the Company’s website: www.diamyd.com.

Celebrating 1 million robotic lawn mowers on a growing market

Husqvarna Group is a pioneer in robotic grass cutting technology and through the success of its range of products and solutions the global market leader in robotic lawn mowing. Western Europe is the main market for robotic mowers and is estimated to grow well above 20 percent per year. “Celebrating 1,000,000 environmentally friendly robotic mowers is a milestone for the Group. More than twenty years ago, we created the robotic mower market and have developed the market ever since. We naturally have a strong market leadership within this category while many of our competitors still are fairly new in the market. We see that in many countries the market for robotic mowers still remain small, while others have grown substantially - meaning sizeable growth opportunities in this exciting segment remains. Our aim is to maintain our leadership position by providing the most reliable, safe and efficient products and solutions”, says Kai Wärn, CEO and President for Husqvarna Group. 20 years of innovationExtensive knowledge and experience built into the products mean reliable, safe and proven products. With a mindset of continually making improvements, the robotic mowers have become more robust, easier to install and use and can handle even more complex gardens. A robotic mower is energy efficient and has almost no emissions during use. The electricity consumption for maintaining a 1,000m² lawn is approximately equal to a 11W light bulb. Today it is possible to control, program and track your robotic mower via a smartphone or tablet app as well as easily control the watering and lawn care from anywhere, anytime.  During the years, much effort has also been invested to reduce the product’s noise level to a minimum. Husqvarna Group sells robotic mowers under the brands Husqvarna, Gardena, McCulloch and Flymo and offer solutions for different end-customer and market segments. “Our advanced robotic mower solutions has created our market leading position. All our robotic mowers are designed in Sweden and produced at our state of the art plants in Europe, before they are shipped all over the world. As the market leader we are committed to continue stand at the forefront, delivering the best end-customer solutions as well as  continuously evolve our offer based on how people connect and engage within this area”, continues Kai Wärn. For additional information, please contactÅsa Larsson, Global Media and Sustainability Manager, Husqvarna Group Phone: +46 8 738 90 80 or press@husqvarnagroup.com

The Descendant - featured in the Adventure Discovery Bundle by Microïds

The Adventure Discovery Bundle is available on Steam right now. http://store.steampowered.com/bundle/3031  The Descendant is an episodic adventure game series with all 5 episodes released for PC and MAC on Steam.   “We are honored to be part of this huge bundle alongside Syberia and many other recognized adventure games. Thanks to Microids, The Descendant is getting more visibility than ever before!” – Jean-Marc Broyer, President, Gaming Corps. About Microïds: Created in 1985, Microïds is an international publisher of multi-platform video games based in Paris (France). Today, it represents Anuman Interactive’s video game business in all its forms. Managed by creator Elliot Grassiano, Microïds keeps getting stronger and continues to widen its large game catalogue with genres as varied as adventure, management, simulation and action. Through its adaptations of iconic titles such as "Syberia" or "Amerzone" on new supports or through its original creations ("Subject 13", "The A.B.C. Murders", "Yesterday Origins”…),  Microïds is developing on PC, Mac, Playstation, Xbox One as well as iOS and Android. Besides its heroes and heroines from original creations (Kate Walker from "Syberia», Victoria Mc Pherson from "Still Life"…), Microïds also creates new titles including other characters or authors from other media (comic books, cinema, literature) such as Garfield, Lucky Luke or Agatha Christie. Microïds is currently developing Syberia 3 scheduled for 2017. For more information, visit the official website www.microids.com, the Facebook Page , Twitter  or Instagram .  About Gaming Corps AB: Gaming Corps develops computer games based on their own IP’s and well-known international brands. The Company's shares are traded on Nasdaq First North under the ticker GCOR. The company's Certified Advisor is Remium Nordic AB. More About Gaming Corps: http://www.gamingcorps.com/

Recipharm delivers first serialised batch to Saudi Arabia

The €300,000 project, which is in addition to a wider €40 million investment into new serialisation technology and processes to comply with the European Falsified Medicines Directive (FMD), enables Recipharm to supply serialised products to Saudi Arabia. Since the Saudi Food and Drug Authority (SFDA) enforced the latest version of the Saudi Drug Code (SDC), which aims to protect against counterfeit pharmaceuticals, Recipharm has serialised, packed, QP released and shipped more than 240,000 units to this market from its facility in Lisbon, Portugal. This includes three different stock keeping units (SKUs) and drug formulations including tablets to treat nausea and discomfort caused by gastroparesis and powder and tincture for skin infections. The CDMO’s company-wide serialisation project is being led by Staffan Widengren, director corporate projects at Recipharm. He said: “Recipharm has been supplying serialised products to markets including Turkey, Korea and China for many years and our investment in the Saudi Arabian market is the latest step in our goal to assist pharmaceutical companies with the complex web of requirements in the US, Europe and Asia." “We are already supplying serialised products in several markets including Turkey, Korea and China, which was a major advantage when preparing for the new Saudi requirements. That said, the project required a significant outlay, a high degree of technical complexity and the need to involve multiple stakeholders, including quality assurance, IT, packaging, engineering and dedicated serialisation teams, as well as our serialisation hardware and software partners.” In June 2016, Recipharm announced Marchesini and SEA Vision as its hardware and software providers for pharmaceutical serialisation. The new solution is completely integrated with the customer’s operations at enterprise resource planning (ERP) level and connected directly to its own Level 4 platform to manage serialisation and regulatory data. Recipharm has facilities in more than 20 locations across the globe and plans for a further six in the UK, Germany, Sweden, Spain and France to supply serialised products to Saudi Arabia according to customer requirements. Staffan Widengren continued: “Global regulatory requirements are advancing to overcome the growing challenge of counterfeit medicines. As a CDMO with customers in most territories, we must be ready and able to meet the varying regulations across the globe and have invested heavily in new serialisation technologies and processes in recent years." “Those companies that delay their preparations risk disruption to product supply, with potentially significant consequences for patients. In the case of Saudi Arabia, we were ready to meet the compliance deadline and having already launched our pilot line for European requirements, we will also be prepared for this challenge.” Recipharm serves 250+ customers and expects 80% of its production to require serialisation in line with the European FMD. The CDMO will also be ready to meet US serialisation requirements from November 2017 set out by the US Drug Supply Chain Security Act (DSCSA). Contact informationKjell Johansson, President Manufacturing Services Europe, kjell.johansson@recipharm.com, + 46 8 6024 670Staffan Widengren, Director Corporate Projects, staffan.widengren@recipharm.com, +46 8 6024 475 For media enquiries, please contact Lindsay Baldry at ramarketing: lindsay@ramarketingpr.com, + 44 (0)191 222 1242, www.ramarketingpr.com, Twitter: @ramarketingpr, Facebook: /ramarketingpr, Linkedin: /ramarketing About serialisationSerialisation is a means to trace and track pharmaceuticals from manufacture through to prescription, using barcodes to record information about product origin, shelf life and batch. This will help the fight against counterfeit products entering the supply chain and ultimately improve patient safety.   About RecipharmRecipharm is a leading Contract Development and Manufacturing Organisation (CDMO) in the pharmaceutical industry employing around 5 000 employees. Recipharm offers manufacturing services of pharmaceuticals in various dosage forms, production of clinical trial material and APIs, and pharmaceutical product development. Recipharm manufactures several hundred different products to customers ranging from big pharma to smaller research and development companies. Recipharm’s turnover is approximately SEK 5.3 billion and the company operates development and manufacturing facilities in France, Germany, India, Israel, Italy, Portugal, Spain, Sweden, the UK and the US and is headquartered in Stockholm, Sweden. The Recipharm B-share (RECI B) is listed on Nasdaq Stockholm.For more information on Recipharm and our services, please visit www.recipharm.com 

New Volvo VNR regional haul truck in North America

“Our goal with the new VNR was to give our customers a versatile tool to meet their individual needs and challenges in the critical regional haul market,” said Göran Nyberg, president of Volvo Trucks North America. “Our investment in this new truck is a clear signal of Volvo’s commitment to meeting the needs of regional haul customers in North America today and in the future. Everything about the new Volvo VNR represents the shape of trucks to come.” Defined by innovations in every area – new aerodynamic design, reimagined working environment, improved engine and transmission options, gearing and loading efficiencies, passive and active safety systems and integrated connectivity – the new Volvo VNR is ideal for urban areas, pickup and delivery, liquid tankers, dry bulk, flatbed and other regional haul applications. With the new Volvo VNR model, customers will see an overall fuel efficiency gain of up to 3.5 percent compared with the previous regional haul model. “I’m truly excited for our customers to drive the new VNR, and to hear how it makes every aspect of the job better and their businesses more profitable,” said Nyberg. The Volvo VNR will be produced at Volvo’s New River Valley assembly plant in Dublin, Virginia, while the Volvo engines and transmissions powering the Volvo VNR will be produced at Volvo’s powertrain manufacturing facility in Hagerstown, Maryland. 2017-04-21 For more information: www.volvotrucks.us Journalists who would like further information, please contact: Brandon Borgna, Volvo Trucks, phone 336-823-2687, email brandon.borgna@volvo.com For more stories from the Volvo Group, please visit www.volvogroup.com/press. The Volvo Group is one of the world’s leading manufacturers of trucks, buses, construction equipment and marine and industrial engines. The Group also provides complete solutions for financing and service. The Volvo Group, which employs about 95,000 people, has production facilities in 18 countries and sells its products in more than 190 markets. In 2016 the Volvo Group’s sales amounted to about SEK 302 billion (EUR 31,9 billion). The Volvo Group is a publicly-held company headquartered in Göteborg, Sweden. Volvo shares are listed on Nasdaq Stockholm. For more information, please visit www.volvogroup.com. 

Agromino (previously Trigon Agri) comments on changing its name

As announced on 20 April 2017, the Annual General Meeting of shareholders of Agromino A/S (previously Trigon Agri A/S) (the “Company”) approved of changing the name of the Company. 2016 was a year of significant changes for the Company as it, due to being unable to meet the deadline for repayment of the Bonds, underwent the major debt restructuring process that started in April 2016 with the changes in the management structure and progressed up until December 2016, reaching its final point with completion of a full debt to equity swap. For a metamorphosis into a fully operationally focused entity to be completed, we felt the next important step was to change our name to something more connected with our core business driver, “sound basic agronomy”.   Committed to a fresh start, with an operational focus, we were very pleased to announce our new name “Agromino”. Agromino is a word play that combines Agronomy with the Japanese given name of “Mino 望” which means to have high aspirations. Simon Boughton, the CEO, commented: “Agromino couples both our high aspirations and sound agronomic practices, to ensure a profitable business moving forward”. Investor enquiries  Mr. Simon Boughton, CEO of Agromino A/S Tel: +372 6191 500, e-mail:  mail@agromino.com  About Agromino  Agromino is an integrated soft commodities production, storage and trading company with operations in Ukraine, Russia and Estonia. Agromino shares are traded on the main market of Nasdaq Stockholm. For subscription to Agromino A/S announcements please contact us: mail@agromino.com If you do not want to receive Agromino A/S press releases automatically in the future please send an e-mail to the following address: unsubscribe@agromino.com. The information was submitted for publication at 12:10 CET on 21 April 2017.

Autoliv delivers Active Safety to the new Mercedes S-Class

Through the deliveries to the new S-Class Autoliv continues its relationship with Daimler in active safety. Autoliv supplies 77GHz radars, stereo- and mono vision cameras and the central ADAS ECU - the brain of the active safety system, to the new S-Class, which is scheduled to be launched in the second half of 2017. Depending on the configuration of the vehicle, Autoliv supplies either a mono, or stereo vision camera. The launch of the new S-Class marks the first time that Autoliv supplies road surface detection functionality through its advanced stereo vision camera solution. The vision cameras are utilizing Autoliv’s in-house developed software algorithms. Additionally, they can detect and classify objects like pedestrians, cars and trucks, lights from on-coming traffic, lane markings, traffic signs and road edges.     Inquiries:Thomas Jönsson, Group Vice President Communications.Tel +46 (0)8 58 72 06 27     About AutolivAutoliv, Inc. is the worldwide leader in automotive safety systems, and through its subsidiaries develops and manufactures automotive safety systems for all major automotive manufacturers in the world. Together with its joint ventures, Autoliv has more than 80 facilities with 70,000 employees in 27 countries. In addition, the Company has 22 technical centers in ten countries around the world, with 19 test tracks, more than any other automotive safety supplier. Sales in 2016 amounted to about US $10.1 billion. The Company's shares are listed on the New York Stock Exchange (NYSE: ALV) and its Swedish Depository Receipts on Nasdaq Stockholm (ALIV sdb). For more information about Autoliv, please visit our company website at www.autoliv.com.

RESOLUTIONS OF CLEANTECH INVEST PLC'S ANNUAL GENERAL MEETING AND BOARD OF DIRECTORS

The Annual General Meeting of Cleantech Invest Plc was held on 21 April 2017 in Helsinki. A total of 50 shareholders, 3.115.388 series A shares, 3.430.072 series K shares and 71.716.828 votes were represented in the meeting. The Annual General Meeting resolved on the following issues: Adoption of the annual accounts, result for the financial period and resolution on payment of dividend, resolution on the discharge from liability The Annual General Meeting adopted the annual accounts for 2016 and resolved that the net loss of EUR 1,136,957.05 be transferred to retained earnings / loss account and that no dividend be paid. The Annual General Meeting discharged the members of the Board of Directors and the CEO from liability for the year 2016. Resolution on the remuneration of the members of the Board of Directors and election of members of the Board of Directors The Annual General Meeting resolved that the members of the Board of Directors be paid EUR 400 per month and granted additionally 10,000 stock options as annual remuneration. The stock options shall be issued based on the authorization granted by the Annual General Meeting. The remuneration of the members of the Board of Directors is not paid to persons working for the company. The members of the Board of Directors are reimbursed for reasonable travel and lodging costs. Travel and lodging costs will not be compensated to those members of the Board of Directors who reside in the greater Helsinki area when the meetings are held in the greater Helsinki area. The Annual General Meeting resolved that six (6) members be elected to the Board of Directors. The Annual General Meeting re-elected the current members of the Board of Directors Mr. Thomas Bengtsson, Mr. Peter Carlsson, Mr. Lassi Noponen, Mr. James Penney and Mr. Matti Vuoria as members to the Board of Directors and elected Mrs. Gudrun Giddings as a new member to the Board of Directors. Remuneration and election of the auditor The Annual General Meeting resolved that the auditor’s fees are paid according to the auditor’s invoice approved by the company. The Annual General Meeting re-elected Deloitte & Touche Oy, Authorized Public Accountants as the company’s auditor. Deloitte & Touche Oy has informed that the principal auditor will be Mr. Aleksi Martamo, Authorised Public Accountant. Authorizing the Board of Directors to decide on issuance of shares The Annual General Meeting authorized the Board of Directors to decide, in one or more transactions, on the issuance of class A shares as follows: The number of class A shares to be issued based on the authorization may in total amount to a maximum of 5,000,000 shares. The Board of Directors decides on all the terms and conditions of the issuances of shares. The authorization concerns both the issuance of new shares as well as transfer of treasury shares. The issuance of shares may be carried out in deviation from the shareholders’ pre-emptive rights (directed issue), if there is a weighty financial reason for the company. The authorization cancels the authorization granted by the Extraordinary General Meeting on 9 March 2016 to decide on the issuance of shares. The authorization is valid until 30 June 2018. Authorizing the Board of Directors to decide on issuance of options The Annual General Meeting authorized the Board of Directors to decide, in one or more transactions, on the issuance of options as follows: The number of new class A shares that can be subscribed to based on the options that can be issued on basis of the authorization may in total amount to a maximum of 1,200,000 shares. The options may be issued to the key personnel, including members of the Board of Directors of the company, and to cooperation partners and advisors of the company as part of the company's incentive scheme to be established by the Board of Directors. The options shall be divided into three equal-size tranches A, B and C: -        Tranche A: Share subscription period shall be 1 January 2020 – 31 December 2022 and the original subscription price EUR 2.74. However, the share subscription period for tranche A shall not begin prior to the trade volume weighted average quotation of the company’s class A share on First North Finland has been not less than EUR 4.00 during four (4) consecutive weeks. -        Tranche B: Share subscription period shall be 1 January 2021 – 31 December 2022 and the original subscription price EUR 2.74. However, the share subscription period for tranche B shall not begin prior to the trade volume weighted average quotation of the company’s class A share on First North Finland has been not less than EUR 5.00 during four (4) consecutive weeks. -        Tranche C: Share subscription period shall be 1 January 2022 – 31 December 2022 and the original subscription price EUR 2.74. However, the share subscription period for tranche C shall not begin prior to the trade volume weighted average quotation of the company’s class A share on First North Finland has been not less than EUR 6.00 during four (4) consecutive weeks. The original share subscription price for the options is equal to the subscription price per share used in the previous share issue of the company. Should the company distribute dividends or assets from reserves of unrestricted equity, the original share subscription price of the stock options shall be decreased by the amount of the dividend and the amount of the distributable unrestricted equity decided before share subscription, as per the dividend record date or the record date of the repayment of equity. The weighted average quotation, which constitutes the precondition for beginning of the share subscription period, shall in this case be decreased by a percentage corresponding to the decrease in the equity of the company following the distribution of assets. Should the company reduce its share capital by distributing share capital to the shareholders, the original share subscription price of the stock options shall be decreased by the amount of the distributable share capital decided before share subscription, as per the record date of the repayment of share capital. The weighted average quotation, which constitutes the precondition for beginning of the share subscription period, shall in this case be decreased by a percentage corresponding to the decrease in the equity of the company following the distribution of assets. The Board of Directors decides on the effects of a potential partial demerger on the options and the terms and conditions of the options, including the share subscription price. The Board of Directors resolves the persons receiving the options and all other terms and conditions of the options. However, the General Meeting resolves on granting of options to members of the Board of Directors should the options be remuneration for membership in the Board of Directors. For the avoidance of doubt, the Board of Directors may resolve on granting of options to members of the Board of Directors who are also working for the company in an operative role or as an advisor, if the options are granted based on their operative or advisor role in the company. The authorization cancels the authorization granted by the Extraordinary General Meeting on 9 March 2016 to decide on the issuance of options and other special rights entitling to shares. The authorization is valid until 21 April 2022. Authorizing the Board of Directors to decide on acquisition of the company’s own shares The Annual General Meeting authorized the Board of Directors to decide on acquisition of the company’s own shares on the following terms and conditions: The Board of Directors is authorized to repurchase a maximum of 1,145,000 company's own class A shares and/or accept company's own class A shares as pledge on the company's unrestricted equity. This amount corresponds to approximately 5.0 per cent of the company's shares. The acquisition may take place in one or more instalments. The purchase price shall not be lower than the lowest price paid for the company's class A shares in multilateral trading on the acquisition date and shall not be higher than the highest price paid for the company's class A shares in multilateral trading on the acquisition date. In connection with the execution of the acquisition of own shares derivatives, share lending or other contracts customary to capital markets and permitted by laws and regulations may be entered into at price determined by the markets. The authorization entitles the Board of Directors to decide on the acquisition in deviation from the shareholders’ shareholding (directed acquisition). Shares may be repurchased to be used as consideration in possible acquisitions or other business arrangements of the company, to finance investments, as part of the company's incentive scheme or to be retained, otherwise conveyed or cancelled. The Board of Directors shall decide on other terms and conditions relating to acquisition of own shares. The authorization is valid for eighteen (18) months from the decision of the General Meeting. Organizing meeting of the Board The new Board of Directors held its organising meeting after the Annual General Meeting and elected Lassi Noponen as the Chairman of the Board and Thomas Bengtsson as the Vice Chairman of the Board. CLEANTECH INVEST PLC Board of Directors

Temporary injunction stops Gore-tex’s “eco claim”

Munich / Unterföhring, 21 April 2017 – The civil chamber 12 of the Hamburg district court sustained an injunction suit of Sympatex Technologies GmbH against W. L. Gore & Associates GmbH as from 12 April 2017. Thus, Gore must no longer claim that the ecologically disputed PTFE – core of Gore’s basic product – would be environmentally friendly to the extend it is produced without any PFCs of environmental concern – a change recently announced by Gore for the years to come for at least outdoor clothing. The incorrect statement of the company that this allegedly was scientific consensus is also part of the sustained injunction suit.   “We decided to take this step after several requests to correct this truth-perverting statement have been vain for weeks”, explains Dr. Rüdiger Fox, CEO of Sympatex Technologies, the measure of his company. “If we as a civil society allowed that the ecological collateral damage of industrial actions that is already obvious all over the world is belittled in such a way, we would soon be seen as the generation which has deliberately evaded its responsibility.” The reasoning of Sympatex is based, amongst others, on the emission of greenhouse gases of PTFE membrane production which is 50 times* higher than Sympatex’ own technology and which consequently contributes to global warming – the biggest and at the same time most likely risk to humanity according to the assessment of the world economic forum**. In addition, there are no established industrial ways yet of reusing resources of functional textiles in a comprehensive value maintaining manner at the end of the life cycle through recycling – whereas the uncontrolled burning of PTFE, which is still one of the most frequently used methods of disposal in particular of collected old textiles in third countries, can notoriously lead to direct health risks, such as the so-called “Teflon flu”.  “Even if Gore manages to keep its promise made at ISPO to produce its membrane without any PFCs of environmental concern by 2020, a series of highly important ecological questions would still remain unanswered.” “In view of yearly approx. 1.4 million tons of old textiles in Germany alone we all still have many tasks to do in the textile industry until we have closed the loop so that the generations to come don’t have to pay for our failures. The attempt to mislead the end consumers with “alternative facts” in order to distract from the issue risks compromising the credibility of the entire sector.”  * Calculation based on SAC data per kg (SAC = sustainable apparel coalition)** WEF The Global Risks Report 2016                             

Annual General Meeting of NetEnt AB (publ) on April 21, 2017

At NetEnt AB (publ)’s annual general meeting on Friday April 21, 2017 the following was resolved. Adoption of financial statements and dividendThe meeting adopted the income statement and balance sheet along with the consolidated income statement and balance sheet and resolved that no dividend is to be paid for the financial year 2016. Please note the section regarding share split and automatic redemption procedures below. Board of DirectorsThe Board of Directors and the President and CEO were discharged from liability for the financial year 2016. The meeting resolved on re-election of Vigo Carlund, Fredrik Erbing, Peter Hamberg, Pontus Lindwall, Michael Knutsson, Maria Redin and Jenny Rosberg and new election of Maria Hedengren. Vigo Carlund was elected chairman of the Board. It was decided that remuneration for the Board of Directors shall be SEK 700,000 for the chairman and SEK 300,000 for each of the members of the board elected by the annual general meeting who are not employees of the company and addition thereto, remuneration to the chairman of the audit committee shall be SEK 110,000 and to each of the other members of the audit committee SEK 30,000. Remuneration for the auditor shall be in accordance with approved invoice. Nominating CommitteeThe AGM decided that the nominating committee shall be formed during October 2017 after consultation with the largest shareholders as per August 31, 2017. The mandate period shall run from the release of the interim report for the third quarter 2017 until the next nominating committee is formed. The chairman of the Board of Directors shall be a member of the nominating committee and is responsible for summoning the nominating committee. In addition to the chairman of the Board of Directors, the nominating committee shall consist of three members. Guidelines for remuneration to senior executivesThe meeting resolved to adopt the Board of Directors’ proposal regarding guidelines for remuneration to senior executives. Share split and automatic redemption procedureThe meeting resolved to adopt the Board of Directors’ proposal regarding share split and automatic redemption procedures, resulting in a value transfer to the shareholders corresponding to SEK 2.25 per share. In the statutory meeting following the general meeting the Board of Directors resolved, in accordance with the mandate from the general meeting, the record day for the share split to be May 5, 2017 and the record day for redemption of redemption shares to be May 26, 2017. Incentive program comprising of issuance of warrants to employeesThe meeting resolved to adopt the Board of Director’s proposal regarding an incentive program comprising of issuance of warrants to employees. Authorization for the Board to resolve on acquisition of own shares and transfer of own sharesThe meeting resolved to adopt the Board of Director’s proposal regarding authorization for the Board of Directors to make decisions on acquisition and transfer of the company’s own shares. The complete resolutionsThe minutes for the annual general meeting including the complete resolutions as per above will be available shortly on the company’s website. In addition, there is an information brochure regarding the splitting of shares and automatic redemption procedures on the website www.netent.com/agm. For additional information please contact;Therese Hillman, CFO NetEnt AB (publ)Phone +46 8 57 85 45 00therese.hillman@netent.com This press release contains information that NetEnt AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, on April 21st, 2017 at 19.00 CET. About NetEntNetEnt AB (publ) is a leading digital entertainment company, providing premium gaming solutions to the world’s most successful online casino operators. Since its inception in 1996, NetEnt has been a true pioneer in driving the market with thrilling games powered by a cutting-edge platform. NetEnt is committed to helping customers stay ahead of the competition, is listed on NASDAQ Stockholm (NET–B) and employs 900 people in Stockholm, Malta, Kiev, Krakow, Gothenburg, Gibraltar and New Jersey. www.netent.com

Interim Report First Quarter 2017

CEO comment:“At Tele2, we aim to fearlessly liberate people to live a more connected life. We do this by being the customer champion of connectivity, enabling our customers to connect more of their devices to even more of the content they love, no matter when and no matter where they are. Our customers are increasingly enjoying this freedom and this is driving strong momentum for the Group.” Financial highlights: ·Tele2 AB’s net sales for the first quarter amounted to SEK 7,875 (6,446) million and EBITDA amounted to SEK 1,723 (1,226) million ·Continued strong mobile end-user service revenue growth of 19 percent, or 10 percent on a like-for-likebasis ·12 months rolling operating cash flow more than doubled to SEK 2.5 billion ·Sweden mobile end-user service revenue growth of 9 percent, or 5 percent like-for-like, and Baltics 12 percent ·Kazakhstan JV operating leverage strengthens and achieves an EBITDA margin of 19 percent ·Around 40 percent of the Dutch mobile customer base are now active VoLTE customers ·Jon James assumed the position as CEO of Tele2 Netherlands on March 6th The report is available on www.tele2.com Presentation Q1 2017 resultTele2 will host a presentation with the possibility to join through a conference call, for the global financial community at 10:00 am CEST (09:00 am BST/04:00 am EDT) on Monday, April 24, 2017. The presentation will be held in English and also made available as a webcast on Tele2’s website: www.tele2.com Dial-in information:To ensure that you are connected to the conference call, please dial in a few minutes before the start of the conference call to register your attendance. Ask for the Tele2 Q1 Interim Report. Dial-in numbers:Sweden: +46(0)8 5065 3938United Kingdom: +44(0)20 3427 1919USA: +1212 444 0895 For more information, please contact:Erik Strandin Pers, IR Inquiries, Tele2 AB, Phone: +46 733 41 41 88Angelica Gustafsson, Press Inquiries, Tele2 AB, Phone: +46 704 26 41 42 This information is information that Tele2 AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact persons set out above, at 07:00 CEST on April 24, 2017. TELE2’S MISSION IS TO FEARLESSLY LIBERATE PEOPLE TO LIVE A MORE CONNECTED LIFE. We believe the connected life is a better life, and so our aim is to make connectivity increasingly accessible to our customers, no matter where or when they need it. Ever since Jan Stenbeck founded the company in 1993, it has been a tough challenger to the former government monopolies and other established providers. Tele2 offers mobile services, fixed broadband and telephony, data network services, content services and global IoT solutions. Every day our 17 million customers across 9 countries enjoy a fast and wireless experience through our award winning networks. Tele2 has been listed on the NASDAQ OMX Stockholm since 1996. In 2016, Tele2 had net sales of SEK 28 billion and reported an operating profit (EBITDA) of SEK 5.3 billion. For definitions of measures, please see the last pages of the Annual Report 2016. Follow @Tele2group on Twitter for the latest updates.

Bittium exhibits its innovative IoT design and R&D services; and the new SafeMove® Zone solution at Hannover Messe 2017 industrial fair

Press release Free for release on April 24, 2017 at 10.15am (CEST +1) Bittium exhibits its innovative IoT design and R&D services; and the new SafeMove® Zone solution at Hannover Messe 2017 industrial fair Bittium launches SafeMove® Zone solution, which is designed to improve the safety of lone and remote workers Oulu, Finland, April 24, 2017 – Bittium exhibits its innovative IoT (Internet of Things) design and R&D services; and the new SafeMove® Zone worker protection solution at Hannover Messe 2017, to be held in Hannover, Germany on April 24–28, 2017. Bittium SafeMove® Zone  solution helps organizations improve the safety of their lone and remote workers by monitoring their location and vital signs in real-time with the help of various sensors. The Bittium SafeMove® Zone solution features include location tracking; geofencing; emergency button and acknowledgment requests and confirmations. The real-time situational view is displayed on a map-based user interface in the command and control center. The solution is initially available for Android devices and can be complemented with wearable devices for additional sensor data. Bittium will also exhibit “Bittium wearable platform for health monitoring” targeted for preventive healthcare; and secure and durable Bittium Tough Mobile™ LTE smart phone with the related Bittium Secure Suite™ device management and encryption software. Products and services presented at the event: · R&D services: Bittium provides innovative design and development services to customers who demand the development of customized, purpose-built IoT devices according to industry-specific requirements. Bittium has strong expertise on system design, technology integration, wireless radio and antenna technologies, and power optimized, small form-factor device development. Bittium’s competitiveness on these markets is based on strong technology and data security expertise, and on an established reputation for reliability and quality.  · Bittium SafeMove® Zone is an application and background software solution designed for Android devices to improve the safety of lone and remote workers. Its features include location tracking; geofencing; emergency button and acknowledgment requests and confirmations. The device management and analytics tools enable the secure collection, transfer and analysis of sensor based data. The solution can be complemented with a wearable device for additional sensor support. Development of the Bittium SafeMove® Zone solution was initially started in the EIT Digital’s innovation project called “Advanced Connectivity Platform for Vertical Segments”. · Bittium wearable platform for health monitoring is a wearable device platform integrated with four sensors: 3-axis accelerometer, Optical Heart Rate (OHR), skin temperature and EmoGraphy skin conductance sensor. These sensors allow the measurement of person’s stress level, fatigue and sleeping quality. The wearable platform provides an easy way to develop and test new healthcare and well-being specific products and services such as patient monitoring or lone workers applications. · Bittium Tough Mobile is a secure and durable Android-based LTE smartphone combining the latest information security and commercial device technologies. Bittium Tough Mobile incorporates a hardware-based security platform, which enables strong device security as well as deep integration of both customers' own and third party software security solutions. · Bittium Secure Suite is a device management and encryption software product that complements the Bittium Tough Mobile smartphone with a scalable set of new software services for remote management, remote attestation and securing the network connections of the device. Bittium Tough Mobile smartphone and Bittium Secure Suite form a unique, complete, reliable system for processing and transferring sensitive and classified material and securing critical communication. Bittium’s products and solutions are exhibited at Team Finland’s stand D10 in hall 16. Further information about Bittium’s products and services can be found on our web site at: www.bittium.com Further information: Klaus MäntysaariSenior Vice President, Connectivity Solutions & Head of Technology DevelopmentTel. +358 (0)40 3443507Email: sales1global(a)bittium.com Distribution:Main media Bittium Bittium specializes in the development of reliable, secure communications and connectivity solutions, drawing on its 30 year legacy of expertise in advanced radio communication technologies. Bittium provides innovative products and customized solutions based on its product platforms and R&D services. Complementing its communications and connectivity solutions, Bittium offers proven information security solutions for mobile devices and portable computers. Starting from November 10th, Bittium also offers healthcare technology products and services in biosignal measuring in cardiology, neurology, rehabilitation, occupational health and sports medicine. Net sales in 2016 were EUR 64.2 million, and operating profit was EUR 2.5 million. Bittium is listed on the Nasdaq Helsinki Exchange. www.bittium.com